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According to the National Cancer Institute, in 2019, there were approximately 17 
million cancer survivors in the United States, of whom 3.7 million were prostate cancer (PC) 
survivors. Due to an increase in life expectancy, extensive screening, and novel therapies, this 
number is expected to continue rising in the coming years. PC survivors in advanced stages 
(III, IV, or recurrent) are particularly prone to experience a wide range of harmful effects that 
stem from cancer and the many treatments they undergo during this cancer’s long trajectory. 
Past research has highlighted the importance of implementing supportive care as a standard 
for cancer survivors due to its multiple benefits, such as reducing morbidity and improving 
both quality of life (QOL) and health outcomes. However, little is known about supportive 
care needs and implementation among this subset of survivors. This information is vital to 
inform future patient-centered, holistic supportive care strategies that aim to optimize this 
population’s QOL and rehabilitation.    
This dissertation work found robust guidance from the Supportive Care Framework 
for Cancer Care due to its comprehensive taxonomy and holistic view of the cancer 
continuum. The first manuscript explored the supportive care interventions available to men 
with advanced prostate cancer. Next, a holistic needs assessment in American advanced 
disease PC survivors was conducted using a mixed-methods approach in order to provide a 
more comprehensive picture of their perceived supportive care needs. Finally, an exploration 
of the existing barriers and facilitators to supportive care implementation was performed 
before taking the next step in this line of research. 
The results of the three manuscripts included in this dissertation reported that 
advanced disease PC survivors suffer from unmet needs that affect every dimension of the 
individual. Existing supportive care interventions were promising but limited, focusing 
primarily on specific domains of needs. Implementing supportive care can only become a 
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standard of care if researchers and clinicians find ways to minimize identified barriers while 
they maximize facilitators. 
Keywords: Prostate cancer, advanced stage, survivors, supportive care, interventions, unmet  






Over the last few decades, research and implementation of new cancer treatments 
have led to an increasing number of cancer survivors.1 However, the need for effectively 
addressing the unmet supportive care needs in advanced disease prostate cancer (PC) 
survivors still exists. The incidence of PC varies globally. In the United States specifically, it 
remains the leading type of cancer, accounting for 21% of all cancers detected in males. One 
in eight men will develop PC in the course of their lives, up to 30% of whom will suffer from 
a recurrence or progression.2 This trend will continue its ascending trajectory as direct results 
of a higher life expectancy, improvements in screening, and innovative treatments.3 As the 
number of survivors increase, advanced PC has subsequently become a significant health and 
economic challenge for the American society and healthcare system.4 Given the fact that 3.7 
million PC survivors currently live in the United States and that they will most likely deal 
with the advanced PC effects for the remainder of their lives, it is essential to provide them 
with more cost-effective, holistic, and patient-centered supportive care that meets their 
current and future needs.5  
Advanced PC Cancer Survivor 
There are multiple definitions in the existing literature of what constitutes a PC 
survivor. In the past, general definitions of  “cancer survivors” focused primarily on 
individuals who had completed curative treatment and were in remission or cured.6 However, 
in 2013, the National Cancer Institute (NCI) presented the National Coalition of Cancer 
Survivors’ more inclusive definition along with some survivorship guidelines, that were later 
endorsed by the National Comprehensive Cancer Network (NCCN). According to this new 
standard, the term “cancer survivor” refers to any individual with cancer “from the time of 
diagnosis, through the balance of his or her life.”7 Advanced PC survivors are considered 
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men with a diagnosis of regionally advanced (III), metastatic (IV), or recurrent/refractory PC, 
no matter their treatment status or the years that have passed since the initial diagnosis.8 
Debilitating Disease Effects on Advanced PC Survivors 
 
PC may follow an indolent course and be asymptomatic at the early stages (I and II) 
of the disease remaining that way for long periods of time, contributing to its chronic 
nature.3,9 Precisely because of this natural long-term trajectory, survivors usually undergo 
several types of treatment throughout the course of the illness to control progression or 
alleviate ongoing symptoms.10 Prostatectomy, androgen deprivation therapy, radiation, 
chemotherapy, and cryotherapy are the most usual treatments for advanced PC. These 
therapies’ harmful effects are varied and noteworthy, including toxicity, urinary and bowel 
dysfunctions, impotence, decreased libido, hot flushes, fatigue, pain, weight changes, anxiety, 
depression, cognitive decline, and even increased risk for suicide.1,11,12 Since survivors must 
continuously live with these effects, they are more susceptible to suffer from a lower quality 
of life (QOL) and develop long term supportive care needs that will require continued access 
to multidisciplinary supportive care.  
Supportive Care Needs and Supportive Care 
 Although supportive care needs can be diverse, they are often needs arising from 
chronic illnesses such as cancer, the treatments, and the follow-up, at any time between the 
initial diagnosis and end of life.13  Greater number of supportive care needs are often 
associated with an increased risk for morbidity and distress. Since the diagnosis of advanced 
cancer can affect the physical, psychological, spiritual, and social dimensions of the being, it 
can lead to more complex and overlapping supportive care needs in these survivors. In 
addition, the survivor may experience lack of information and practical issues that can make 
coping with this illness even more dismal.13,14  
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Supportive care has been used as a euphemism for palliative care in past literature.15   
While both are important aspects of cancer care, there are some differences between them. 
Palliative care refers to a subspecialty that focuses on issues that are frequently seen at the 
end of life.15,16 According to the Multinational Association of Supportive Care in Cancer 
supportive care attempts to prevent and manage the adverse effects and associated needs of 
the cancer and treatment.16,17 It is a patient-centered and holistic approach that ensures the 
provision of all necessary interventions to prevent further deterioration and optimizes both, 
rehabilitation and QOL.13,14 
During the last decades, supportive care in cancer has gained momentum among 
researchers and healthcare providers alike. Several factors have contributed to accepting 
supportive care as the new benchmark to improve health outcomes and QOL in cancer 
survivors. Its multiple benefits—improved treatment-related health outcomes and QOL, 
reduced morbidity and mortality, and decreased healthcare resource usage—have made this 
approach an indispensable component of high-quality standard cancer care. Furthermore, the 
integration of supportive care services has been progressively regarded favorably as part of 
modern oncology.17-19 
Quality of Life in Cancer Survivorship 
There is no accepted definition of QOL. The World Health Organization defines QOL 
as the self-report of the individual’s position in life in relation to their life expectations, goals, 
standards, and concerns.20 It is a broad, multifaced, and subjective construct. Despite the 
variations, there is a consensus that QOL must include domains such as physical health, 
emotional/psychological functioning, social life, roles, and overall quality of life.21  Specific 
to cancer survivorship, achieving a good QOL often means finding wholeness after the life-
changing experience, which in turn restores a sense of purpose in life.22 
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Due to the steady rise in prostate and other cancer survivors, there has been an 
increasing interest in researching QOL in these populations.23 QOL research emphasizes how 
well these survivors are living instead of how long.21 Among its multiple important 
applications, QOL research data may be used to assess the needs and quality of supportive 
care received by advanced PC survivors who experience persistent or late effects of diverse 
treatments to guide patient-centered, holistic interventions.21 
Theoretical Frameworks 
Advanced PC survivors suffer from a wide variety of unmet supportive care needs 
that affect every dimension of the person. Although multiple theoretical foundations have 
been used in past cancer needs assessments, this dissertation work found robust guidance 
from Fitch’s Supportive Care Framework for Cancer Care (SCFCC). This framework 
outlines a comprehensive taxonomy of seven domains of needs (i.e., physical, emotional, 
social, spiritual, informational, practical psychological), formulated to ensure that cancer 
survivors were cared for in a holistic manner from the time of diagnosis to the end of life 
(Figure 1).13 This multidomain framework has a successful record of assessing the unmet 
needs of several advanced cancer survivors’ populations, including breast and 
gynecological.25,26 It has also guided supportive care intervention development in studies 
from the United States and abroad.26  
The SCFCC domains of needs provided guidance for the three manuscripts of this 
dissertation in several ways: (1) defining the criteria for the article selection during the 
integrative and the scoping reviews, (2) selecting a validated instrument to measure the 
comprehensive set of unmet SC needs for the mixed methods study, (3) informing the 
qualitative interview guide development, (4) organizing the data of all three manuscripts, and 





Figure 1: SCFCC Diagram Applied to Advanced PC Survivors (with permission)15 
 
To complement the application of the SCFCC, this work also used the Theoretical 
Domains Framework (TDF) to explore the barriers and facilitators to supportive care 
implementation (manuscript 3). The TDF includes a schema derived from theory that assists 
with identifying behavioral factors that may affect the implementation of supportive care. 
This schema classifies the factors in 14 different domains: Knowledge; Skills; Memory, 
Attention, and Decision Processes; Behavioral Regulation; Social/Professional Role and 
Identity; Beliefs About Capabilities; Optimism; Beliefs About Consequences; Intentions; 
Goals; Reinforcement; Emotions; Environmental Context and Resources; and Social 
Influences. This theoretical foundation was appropriate for manuscript 3 because it has been 
 
 6 
used in multiple previous literature reviews investigating barriers and facilitators of care 
implementation. The TDF structured the analysis and the categorization of the existing 




Following the recent publications of the American Society of Clinical Oncology 
survivorship agenda and the American Cancer Society survivorship guidelines, Jacobsen et 
al. reported that more research focusing on optimal supportive care for cancer survivors was 
needed.10 This dissertation attempts to address several research gaps. First, current literature 
on supportive care interventions for advanced PC survivors is limited as most focuses on PC 
localized disease. Therefore, there was a need to synthesize the existing evidence with 
regards to the availability and effectiveness of these interventions in addressing the unmet 
supportive care needs and QOL in advanced PC survivors. Second, most reports on advanced 
PC have focused primarily on describing the survivors’ experiences with the disease or on the 
results of piloting diverse psychosocial and exercise interventions.12,30,31 Several holistic 
supportive care needs assessments have been conducted, reporting a wide range of unmet 
needs in a large proportion of advanced PC survivors.1,16,32-34 However, none has been 
performed in American men specifically. Since many of these U.S. survivors are also at risk 
for a wide array of long-term needs, this was a necessary step to inform future design, 
development, and implementation of individualized, multidimensional, cost-effective 
supportive care interventions. And third, to better understand why supportive care is not 
being consistently delivered, it was essential to investigate the primary barriers and 
facilitators potentially affecting its implementation.35,36 Altogether, these gaps have formed 
the premise for this dissertation work. The conclusions of the manuscripts have expanded the 
state of the science on supportive care for advanced disease PC survivors, directing special 
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attention to specific areas that have been recognized as essential to be addressed by future 
studies: common cancers aside from breast cancer, older populations (>65 years), long-term 
survivors, and QOL during survivorship.10 
Manuscripts  
This dissertation comprises three interrelated manuscripts contributing to supportive 
care in advanced PC survivors. The first manuscript, Supportive Care Interventions and 
Quality of Life in Advanced Disease Prostate Cancer Survivors: An Integrative Review of the 
Literature, initiated this work by critically appraising and characterizing the evidence-based 
supportive care interventions and their effects on QOL in this subset of survivors. The 
conclusion was that these types of interventions were needed but scarce. This conclusion led 
to the second manuscript, Unmet Supportive Care Needs in Advanced Disease Prostate 
Cancer Survivors: A Mixed-Methods Exploration of the Prevalence and Association with 
Quality of Life, which explored the unmet supportive care needs in advanced PC survivors 
living in the United States. Part of the study also identified a preliminary association between 
the prevalence of those unmet needs and QOL in this population. This work enhanced the 
understanding of supportive care needs and represents a necessary step before embarking on 
developing new holistic, patient-centered supportive care interventions. The third and last 
manuscript, Barriers and Facilitators to Supportive Care Implementation in Advanced 
Disease Prostate Cancer Survivors: A Theory-Informed Scoping Review, achieved a dual 
purpose. First, it helped identify commonly implemented supportive care interventions for 
advanced PC survivors in the sample of reviewed studies. Second, it synthesized the main 
barriers and facilitators to implementing those supportive care interventions among this 
subset of survivors in practice. This information is vital for continuing with this line of 
inquiry successfully. Developing and implementing novel supportive care interventions will 
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significantly depend on the ability to focus on the most prevalent needs, overcoming existing 
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Background: Supportive care interventions can improve quality of life and health outcomes 
of advanced prostate cancer survivors. Despite the high prevalence of unmet needs, 
supportive care for this population is sparse. 
Methods: The databases PubMed, SCOPUS, CINAHL, and ProQuest were searched for 
relevant articles. Data were extracted, organized by thematic matrix, and categorized 
according to the seven domains of the Supportive Care Framework for Cancer Care. 
Results:  The search yielded 1678 articles, out of which 18 were included in the review and 
were critically appraised. Most studies were cross-sectional with small, non-diverse samples. 
Supportive care interventions reported for advanced prostate cancer survivors are limited 
with some positive trends. Most outcomes were symptom-focused and patient self-reported 
(e.g., anxiety, pain, self-efficacy) evaluated by questionnaires or interview. Interventions 
delivered in group format reported improvements in more outcomes.  
Conclusions: Additional supportive care intervention are needed for men with advanced 
prostate cancer. Because of their crucial position in caring for cancer patients, nurse scientists 
and clinicians must partner to research and develop, patient-centered, culturally relevant 
supportive care interventions that improve this population’s quality of life and health 
outcomes. Efforts must concentrate on sampling, domains of needs, theoretical framework, 
guidelines and measurement instruments. 
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Prostate cancer (PC) is the most commonly diagnosed non-cutaneous malignancy in 
men, with more than 1.2 million new cases diagnosed every year worldwide. Due to 
favorable prognoses and advances in treatment, the number of PC survivors has progressively 
grown, amounting to more than 3.6 million in the United States alone (ASCO, 2019). 
Presently, there are variations in defining cancer survivors. According to the National 
Comprehensive Cancer Network, PC survivor refers to any man with a history of PC, from 
the time of the initial diagnosis until the end of life (Delinger et al., 2015). While the 5-year 
survival rate for early-stage PC is exceedingly high, once the disease has spread, the survival 
rate decreases to 30%, with higher illness-related mortality and morbidity than men with 
early-stage PC (Dickey & Ogunsanya, 2018; NCI, 2015). Most PC survivors receive the 
diagnosis in earlier stages of the disease, but up to one third will progress into regionally 
advanced (stage III) or metastatic (stage IV) disease, remaining treatable but no longer 
curable (Holm et al., 2018; PCEC, 2019). Men with stage III or IV PC are identified as 
“advanced disease survivors”. 
Men surviving PC report an array of overlapping supportive care needs associated 
with the debilitating effects of the various treatment modalities. These needs stem from pain, 
urinary incontinence, bowel and sexual dysfunction, fatigue, hot flashes, depression, and 
distress (Crawford-Williams, 2018). Advanced disease survivors are often treated with 
chemotherapy, androgen-deprivation therapy (ADT), or participation in clinical trials to slow 
progression or control disease (Jacobsen et al., 2017). While these treatments prolong life, 
they are associated with additional physical effects, such as treatment toxicity, deteriorating 
bone health, increased fat mass, and reduced vitality. Also, the treatment impacts can also 
increase the susceptibility for certain psychological problems, such as risk for suicide and 
cognitive decline. Altogether, these challenges affect advanced PC survivors’ quality of life 
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(QOL) and functional well-being beyond their physical needs (Chambers et al., 2018; 
Darwish-Yassine et al., 2014). 
In 2005, the Institute of Medicine recommended consistent, quality survivorship care 
for all cancer survivors (NRC, 2005). In 2014, the American Cancer Society published a set 
of PC survivorship guidelines, later endorsed by the American Society of Clinical Oncology 
to assist clinicians in caring for these survivors. The guidelines ensure uniformity and 
coordination of care through individualized interventions to meet the specific and often 
complex needs of PC survivors (Handberg et al., 2018; Noonan et al., 2016; Skolarus et al., 
2014). Supportive care is a holistic, patient-centered approach to prevent and manage the side 
effects of the cancer and its therapies, with the goal of optimizing rehabilitation and QOL 
(Fitch, 2008). Despite the reported benefits, supportive care is delivered inconsistently due to 
reduced clinician time, insufficient evidence on optimal care delivery modes, and providers’ 
lack of knowledge about survivors’ specific needs (Post & Flanagan, 2016).  
Literature on PC survivors covers diverse topics, such as available psychosocial 
interventions or unmet supportive care needs while undergoing specific treatments (Holm et 
al., 2018; McIntosh et al., 2019; Parahoo et al., 2013). A systematic review and qualitative 
synthesis by King et al. (2015) that explored men’ experiences of and needs for supportive 
care, reported that more patient-centered, nurse-led supportive care is required. A separate 
systematic review by Crawford-Williams et al. (2008) identified that survivorship 
interventions did not address the real needs of this vulnerable population. Recent studies 
show that 33% to 81% of PC survivors report inadequate support for their unmet needs (King 
et al., 2015; Watson et al., 2016). 
Due to the high prevalence of unmet needs among PC survivors, an apparent lack of 
adequate supportive care, and the underrepresentation of the topic in the literature, a synthesis 
of the available supportive care interventions and their effect on QOL is needed. Thus, the 
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aim of this integrative review was to critically appraise and characterize existing evidence-
based supportive care interventions and their effects on QOL for advanced disease PC 
survivors through the lens of the Supportive Care Framework for Cancer Care (SCFCC) 
(Fitch, 2008). Results of this review may assist clinicians caring for this population and better 
inform future intervention development according to the current practice guidelines and 
recommendations. 
Methods 
Theoretical Framework and Application to Population 
The SCFCC was initially formulated as a tool to help healthcare providers ensure that 
cancer patients’ supportive care needs were being met throughout the various stages of 
illness, including survivorship (Fitch, 2008). The framework outlines a comprehensive 
taxonomy of seven domains of needs. The physical domain encompasses an absence of 
physical symptoms and the ability to carry out normal daily activities (ADL) (Fitch, 2008). 
Common adverse effects of advanced PC, measured as outcome indicators within this 
domain, include body composition, physical activity, fatigue, and urinary dysfunction, which 
impact QOL negatively (Dickey & Ogunsanya, 2018; Park et al., 2017; Shakeri et al., 2015). 
For example, up to 38.5% of advanced disease PC survivors report clinically relevant fatigue 
affecting overall well-being (Antolin et al., 2019). 
The emotional domain relates to a sense of reassurance in times of distress (Fitch, 
2008). Advanced disease PC survivors face many emotional unmet needs, including 
depression, anxiety, distress, fear of recurrence, or lifestyle changes due to the illness and the 
various treatments, which can lead to a lower overall QOL (Paterson et al., 2015). The need 
for information relates to improving decision-making and decreasing misunderstanding 
between survivors and providers (Fitch, 2008; Freire et al., 2014). 
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Cancer affects not only the patient but also the family and the community, potentially 
leading to higher levels of social withdrawal, a commonly reported unmet need. Positive 
social roles and support are indicators of higher health-related QOL in many cancer 
survivors, including PC (Shakeri et al., 2015). The same is true for the practical domain. 
Leaving practical needs unattended can reduce the survivors’ overall QOL as they are a 
supporting vehicle to perform their usual ADL (Fitch, 2008; Park et al., 2017). 
Advanced PC can often generate spiritual distress, leading to despair, suffering, and 
existential crises. The spiritual domain relates to a sense of purpose in life (Fitch, 2008). 
Unmet spiritual needs could lead to a loss of dignity and values, as the spiritual dimension of 
QOL is commonly a priority in people s’ lives (Freire et al., 2014). The psychological 
domain relates to coping with the disease (Fitch, 2008). Past evidence has outlined the 
relationship between coping styles and psychological-related QOL (Park et al., 2017).  
This multidomain framework has been used successfully in past studies assessing the 
unmet needs of breast and gynecological cancer survivors (Fitch & Steel, 2010; Fitch, 2012). 
It has also guided supportive care and educational oncology interventions in the U.S. and 
abroad (Busolo & Woodgate, 2016; Cheah et al., 2016). The SCFCC guided criteria for 
article selection, extraction and organization of data during analysis, and presentation of 
findings for this review, according to the framework domains of needs. 
Design and Search Strategy 
To ensure the highest rigor, this integrative review followed the five-stage process 
proposed by Whittemore and Knafl (2005). This process includes problem identification, 
literature search, data evaluation, data analysis, and presentation. The search strategy was 
designed after consulting with an expert research reference librarian. A comprehensive 
literature search was performed in the following electronic databases: PubMed, SCOPUS, 
CINAHL, and ProQuest, following an identical format. Key words included: (advanced-
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disease OR advanced-stage OR late-disease OR late-stage OR metastatic OR stage III OR 
stage IV) AND (prostate cancer OR prostate neoplasm OR prostate tumor) AND 
(interventions OR intervention). Hand searching of studies’ reference lists identified 
additional records for evaluation. 
Inclusion and Exclusion Criteria 
Studies were eligible if they were peer-reviewed, and reported quantitative, 
qualitative, or mixed methods original research focused on supportive care interventions for 
advanced PC, and included reported outcomes corresponding with one or more SCFCC 
domains. Exclusion criteria addressed studies targeting other types of neoplasms, solely 
localized PC, and unrelated subjects such as purely pharmacological or surgical interventions 
with curative or palliative intent. The search was limited to studies published in English from 
2009 to 2019 to capture the most relevant articles. The PRISMA statement and flow chart 
(2015) guided the screening and selection of the relevant publications (Figure 1). 
Data Extraction and Methodological Quality Assessment 
During the first electronic database search, a total of 1678 articles were initially 
identified. Hand searching identified ten additional articles. After duplicates were removed 
(n=466), the first author (AS) independently screened 1,222 titles and abstracts for eligibility, 
with 1,190 articles excluded because they did not meet the inclusion criteria. A final count of 
32 articles underwent a thorough full-text review by the first author, with 14 studies excluded 
because they did not report the full study results, were single-case studies, or involved an 
instrument validation or a palliative care intervention (care for those with a time limiting 
cancer). Twenty percent of the title, abstracts, and full-text were reviewed by a second 
reviewer (SQ) for validity and trustworthiness of the studies selected. All authors agreed on 
the final 18 studies that met the criteria for inclusion.  
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Data analysis proceeded through the development of a comprehensive evidence table, 
which included authors, year, purpose, design, setting, sample, intervention, outcomes, 
results, domain, and MMAT number of  “Yes” (Table 1). Data on the reported intervention 
components and outcomes were extracted and categorized according to the domains of the 
SCFCC framework (Laughery & Woodgate, 2015). The findings were organized from the 
most to the least prevalent SCFCC domains. The methodological quality of the studies was 
appraised using the Mixed Methods Appraisal Tool (MMAT). The MMAT provides 
checklists that guide the concurrent appraisal of quantitative, qualitative, and mixed-methods 
studies in systematically conducted reviews (Hong et al., 2018). It is rooted in an extensive 
systematic literature review posing seven questions according to the study design: 
randomized-controlled trial, non-randomized, descriptive, mixed-methods, and qualitative 
(Hong et al., 2018). Methodological are evaluated as “Yes”, “No”, or “Can´t tell”. More 
“Yes” responses indicate greater methodological quality. The final evidence table was 
reviewed by all authors to ensure accuracy of the findings. 
Results 
Overall Characteristics of the Sample Studies  
The sample of selected studies (n=18) reported on original intervention research. 
Sixteen used quantitative designs and two studies used a qualitative or mixed-methods 
methodology. Twelve of the quantitative studies were randomized controlled trials (Table 1). 
The remaining used a quasi-experimental, a prospective observational cohort, and a 
retrospective descriptive design. Overall, sample sizes across studies were moderately small, 
ranging from 19 to 189 participants, with the exception of one study including 859 subjects 
(Beydun et al., 2014). All studies included advanced stage PC survivors (III, IV), either 
exclusively or in combination with earlier stage PC. The majority of studies included only 
White participants; only three included Black participants (Badger et al., 2011; Yanez et al., 
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2015; Yennurajalingam et al., 2012). Studies were conducted in Turkey (n=1), United States 
(n=4), Canada (n=1), Europe (n=6), and Australia/New Zealand (n=6). The methodological 
quality of the reviewed studies was high: 44.4% of the studies met all criteria (5/5 “Yes” out 
of 5 in the MMAT tool), while the remaining 55.6% met 4 out of 5 criteria. None of the 
studies ranked lower than 4. 
Addressing the multidomain supportive care needs is an essential part of the 
therapeutic management of cancer to maintain QOL (Afiyanti et al., 2018; Comert et al., 
2013). All the studies included supportive care interventions that aimed to support QOL, 
improve coping with the disease and the side-effects, and maintain their dignity by 
addressing one or more SCFCC domains (Fitch, 2008). Three major intervention categories 
emerged from the studies: 1) exercise; 2) cognitive-behavioral/psychosocial; and 3) 
educational (Table 2). Two studies combined psychosocial counseling and educational 
components and one combined a physical activity intervention with daily life education 
(Badger et al., 2011; Beydun et al., 2014; Huri et al., 2015). One study included all three 
categories (Bourke et al., 2014). Interventions that were delivered face-to-face or were 
supervised, reported improvements in a greater number of study outcomes compared to 
interventions delivered using technology or teleconferencing. Four interventions were 
unsupervised or used mixed delivery methods (some components delivered in person and 
components unsupervised) (Table 1).  
 The number of outcomes measured in the studies ranged from one to 13. All studies 
reported various primary outcomes, typically more than three (Tables 1 & 2). Over half of the 
outcomes assessed a wide array of symptoms and perceptions (e.g., anxiety, pain, QOL, self-
efficacy), were patient self-reported, and were measured either by questionnaires or 
individual interviews. The remaining outcomes were objectively measured (e.g., biomarkers, 
blood pressure, weight). None of the studies reported the psychometric properties of the 
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measurement instruments. Only the physical domain was assessed using objective measures 
such as biomarkers (e.g., maximum oxygen consumption, resting heart rate).  
Self-reported QOL was measured as an outcome in 12 studies using various 
instruments (e.g., FACT, EORTC, SF-36) (Table 1). The results across these studies reported 
that although there were no significant differences observed in the overall QOL total score, 
some improvements were noted on the physical, emotional, and social subscale scores.  
Summary of Interventions by SCFCC Domain 
Physical Domain  
The physical domain encompasses physical comfort and the ability to carry out usual 
ADL (Fitch, 2008). This domain was represented most frequently in the selected evidence. 
Fourteen studies reported on interventions aiming to alleviate ongoing effects pertaining to 
the physical domain (Tables 1 & 2). The most frequent primary outcomes included fatigue, 
body composition changes, physical activity function, muscle strength, and urinary 
symptoms. Additional outcomes associated with the physical domain included pain, vitality, 
and survival. Overall, most studies representing this domain reported a moderate degree of 
improvement in one or more of the outcomes measured. 
Fatigue: Ten studies attempted to decrease fatigue, but only 5 reported statistically 
significant improvements (Badger et al., 2011; Bourke et al., 2014; Paterson et al., 2018; 
Taaffe et al., 2017; Yennurajalingam et al., 2012). Interventions included several modalities 
of health education, exercise training programs (impact loading, aerobic, or resistance), 
bladder rehabilitation, individual needs assessment, interpersonal counseling, or a 
combination of these. One study testing a multimodal supportive care intervention reported a 
7% reduction in fatigue after 3 months (Paterson et al., 2018). Another study evaluating two 
exercise modalities (impact loading and aerobic with resistance training) reported a reduction 
of 5 points in the fatigue module of the measuring instrument (Taaffe et al., 2017). The 
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interventions occurred in three different settings: hospital, exercise clinics, or at home via 
telephone. The intervention adherence ranged from 67% to 94%. Some interventions were 
supervised, and some were independently managed. The duration of the interventions ranged 
from 8 weeks to 12 months. 
Body Composition: One of the most effective advanced PC treatments is ADT. 
However, changes in body composition including gains in fat mass and losses in bone health 
have been often reported by PC survivors (Comert et al., 2013; Mina et al., 2013). Six studies 
evaluated interventions by measuring body composition through body weight, body mass 
index (BMI), waist and hip circumference, body fat mass, whole-body and appendicular lean 
mass, and certain biomarkers (e.g., leptin and insulin-like grown factors 1,3) (Table 1). Only 
one study that tested combined resistance and aerobic exercise with an education program 
reported a statistically significant reduction in waist and hip circumference (p<0.0001) 
(Beydun et al., 2014). A home-based aerobic versus resistance exercise training intervention 
showed a decrease in body weight and BMI associated with a non-significant reduction in 
leptin (Mina et al., 2013). An unsupervised exergaming intervention (exercise through 
videogames) reported numerical reduction in fat mass and increase in lean mass, though these 
were also not statistically significant (Villumsen et al., 2019). All other exercise interventions 
with or without an educational component reported modest or no changes in body 
composition. The interventions were implemented at home or in exercise clinics and had a 
duration from 10 weeks to 12 months. When reported, adherence was high, ranging from 70 
to 91%. 
Muscle Strength and Physical Activity: Five studies tested interventions that targeted 
muscle strength. Measures included resistance, muscular power, and chest and leg extension 
muscle strength. All interventions reported a significant improvement in the measures, were 
supervised, and shared common components, such as aerobic, impact, and resistance training. 
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A resistance exercise intervention resulted in an 11% improvement in muscle strength when 
measuring leg extension (Cormie et al., 2013). Regarding physical activity, the majority of 
the studies assessing physical activity measures reported a positive improvement favoring the 
intervention group, three of them with statistical significance (p<0.001). Measurements 
included ambulation, exercise behavior, chair rise time(s), 6-Minute Walking Ability Test 
(6MWT), Godin Leisure-Time Exercise score, and self-reported physical function. An 
intervention testing resistance exercises improved ambulation by 12% (Cormie et al., 2013). 
A home-based exergaming intervention reported a 4.2% improvement in physical activity 
function by assessing the 6MWT (Villumsen et al., 2019). The interventions targeting muscle 
strength and physical activity were all delivered at a hospital, exercise clinics, or were home-
based. All interventions ranged from 10 weeks to 12 months.  
Urinary Symptoms: One study involved a progressive urinary rehabilitation program 
with the purpose of reducing prostate-related urinary symptoms, resulting in a moderate 
reduction of difficulty, frequency, and nocturia (Serda et al., 2010). Four other studies tested 
interventions measuring the prostate-specific QOL, including urinary symptoms, via a self-
administered instrument (FACT-P, UCLA PC Index, or EORTC-QOQ-30 PR25) but did not 
include urinary-specific outcome measures (Badger et al., 2011; Bourke et al., 2014; Huri et 
al., 2015; Villumsen et al., 2019). 
Social Domain  
The social domain addresses needs related to relationships, communication, and 
support systems within the family and the community (Fitch, 2008). This domain was the 
second most frequently represented within the body of evidence based on the nature of the 
intervention delivery. Thirteen studies delivered the intervention in a group format either 
face-to-face or via technology (Table 1). Outcomes included social well-being, social 
support, social functioning, sense of belonging, peer learning, and socialization. These 
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outcomes were secondary in all studies except in one, which measured social well-being and 
social support with instruments (Social Well-Being scale & PSS-FA) (Badger et al., 2011). 
The interventions that included a psychosocial component such as group counseling, 
cognitive-based occupational therapy, or stress reduction reported an improvement in social 
well-being among the participants in the treatment group (Badger et al., 2011; Huri et al., 
2013; Yanez et al., 2015). Group mindfulness sessions delivered by teleconference provided 
an increased sense of social belonging to the participants (Chambers et al., 2017; Chambers 
et al., 2012). There were also interventions evaluating various exercising modalities, such as 
aerobic, impact loading, or resistance training conducted in groups (Beydun et al., 2014; 
Bourke et al., 2014; Cornie et al., 2013; Galvao et al., 2014; Serda et al., 2010; Taaffe et al., 
2017; Winters-Stone et al., 2015). Despite a lack of social-specific outcomes, all group 
exercising programs resulted in better social functioning and group interaction by 
encouraging socialization among participating survivors. Additionally, one study evaluating a 
multimodal supportive care intervention that included group seminars reported an 
improvement in social support (Primeau et al., 2017). All interventions took place at home 
via teleconference, at a hospital, or at exercise clinics. They were implemented for periods of 
8 weeks to 12 months and demonstrated high adherence rates (65%-100%).  
Informational Domain 
Fitch’s SCFCC associates the informational domain with adequate information 
regarding the disease trajectory, treatments, care processes, and available resources (2008). 
Although every type of intervention can be considered “educational” to some degree, 10 
studies included interventions that represented the informational domain, by presenting 
resources to the participants and/or the caregivers; educating on diet; exercise, relaxation and 
self-management; or by informing them about symptom-related burdens (Table 1). No 
specific informational outcomes related to informational supportive care needs were 
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measured in any of the studies. Three studies included nutritional education. One intervention 
contained nutrition advice seminars and reported a non-statistically significant reduction in 
total fats consumption (Bourke et al., 2014). A polyamide-reduced diet proved its safety and 
suggested an increase in the participants’ median cancer-specific survival time to 36 months, 
versus 17 months in the control group (Cipolla et al., 2010). The health promotion group in 
the study by Yanez et al. (2015) was provided with health educational information on sleep, 
nutrition, and physical fitness, proven to be “somewhat” helpful. 
One commonality across studies was that the majority of the information 
disseminated in these interventions was about cancer treatments or supportive care. After an 
educational intervention about the effects of the ADT, 98% of the participants reported a 
positive impact from this information on physical fitness level and no further deterioration 
from the adverse effects of ADT (Yennurajalingam et al., 2012). A web-assisted group 
intervention with education on stress awareness and reduction resulted in better coping skills 
regarding prostate-related symptomatology (Yanez et al., 2015). The two studies that 
included an educational seminar about ADT side effects, self-management, emotion and 
stress control, nutrition, exercise, and financing reported fewer unmet informational needs 
about treatment choices and disclosure of test results (Paterson et al., 2018; Primeau et al., 
2017). In addition, an early outpatient palliative care consultation addressing symptom 
burden resulted in an increased sense of general well-being and an increased lifespan 
(Yennurajalingam et al., 2012). Despite not having a direct effect on QOL, the interventions 
including an informational component had a positive effect on some of the outcomes 
measured, such as fat intake, mindfulness, survival, and overall well-being. 
Emotional Domain  
The emotional domain relates to the need for comfort and reassurance when adjusting 
to stressful situations (Fitch, 2008). Eight studies assessed an intervention with at least one 
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component addressing emotional needs (Table 1). Intervention methods included 
interpersonal counseling, occupational therapy, stress reduction, or mindfulness. Depression, 
anxiety, stress, and cancer-specific distress were the most commonly measured primary and 
secondary outcomes. The duration of the interventions averaged between 8 weeks and 12 
months. Half were delivered via telephone and half were face-to-face at the hospital.  
Two studies tested mindfulness-based cognitive therapy in groups using self-help 
materials and meditation CD delivered via teleconference (Chambers et al., 2012; Chambers 
et al., 2017). Although not statistically significant, one reported improved levels of anxiety, 
fear of recurrence, and avoidance in the subscales of the distress-measuring instruments 
(Chambers et al., 2012). An 8-week telephone intervention combining interpersonal 
counseling and cancer education reported a statistically significant reduction in depression 
and disease-related stress (p<0.001) (Badger et al., 2011). A multimodal supportive care 
intervention (ThriverCare) demonstrated no improvement in reducing stress, anxiety, or 
depression in the treatment group, but did report lower prevalence of fear and worries 
(Paterson et al., 2018). A technology-assisted psychosocial intervention to reduce stress also 
reported better scores in relaxation and fewer depressive symptoms upon completion (Yanez 
et al., 2015). One additional study evaluating the impact of an outpatient palliative care 
consultation on symptom burden in advanced PC survivors improved seven out of the 10 
symptoms, including depression and anxiety (Primeau et al., 2017). Despite the mixed results 
of some of the interventions, several reported a statistically significant improvement in the 
emotional needs (e.g., depression, anxiety) of the study participants (p < 0.05). 
Practical Domain  
Practical needs associated with the cancer journey include supports that reduce the 
demands on the person’s life at home (e.g., finances), facilitate transportation to the care 
center, and access to supportive care and resources, childcare, and shopping (Fitch, 2008). 
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Across multiple studies, intervention accessibility was facilitated  through alternatives to in-
person participation (e.g., telephone, teleconference or Web-assisted) (Table 1). The majority 
of these technology-assisted interventions were psychosocial in nature, such as interpersonal 
counseling, mindfulness, or stress reduction, and reported no significant differences in most 
primary outcomes (e.g., fatigue, QOL, physical function, psychological well-being) despite 
the degree of “feasibility and helpfulness.”  
The practical domain was addressed by one study that explored the relationship 
between ADL and consequences of the PC treatments (Huri et al., 2015). The intervention 
included a combination of individualized ADL training, group recreational activity, and 
education about PC and relaxation. Practical issues that were negatively affected by advanced 
PC included: personal activities such as grooming, driving, bathing, or dressing; productive 
activities such as typing, storing groceries, home repair, leisure, walking the pet, moving after 
rest, using the phone, or reading the newspaper in bed. Participants reported some 
improvement in functioning upon completion of the intervention. A web-based exergaming 
intervention, implemented in the participants’ home using devices that can be acquired 
inexpensively in any technology-selling store, indicated modest, non-significant 
improvement of the physical activity outcomes (Villumsen et al., 2019). Overall, 
interventions representing the practical domain were limited to facilitating study 
participation. Despite being helpful, they did not report any specific practical outcomes. 
Spiritual Domain 
The spiritual domain relates to finding a personal sense of meaning in life and the 
need to practice some sort of spirituality, whether in the form of a religious or alternative 
beliefs (Fitch, 2008). Only one study addressed the spiritual domain as a secondary outcome 
(Badger et al., 2011). The study compared an 8-week interpersonal counseling via 
teleconference with education (interventional group) and 8-weeks of health education by 
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telephone using written materials regarding nutrition, exercise, resources, and quitting 
smoking (control group). The influence of the participants’ illness on spiritual well-being was 
measured with the 8-item spiritual well-being subscale of the Quality-of-Life Breast Cancer 
version questionnaire. The study reported a statistically significant improvement in spiritual 
well-being in the health education by telephone group (p<0.01).  
Psychological Domain 
The primary feature of the psychological domain is the development of skills to cope 
effectively with illness-related stressors (Fitch, 2008). One study testing web-based group 
sessions for stress reduction, coping skills, and social network (CBSM) addressed the 
psychological domain (Yanez et al., 2015). The intervention included stress awareness 
development, learning stress reduction skills, changing negative stressor appraisals, and 
developing effective coping skills. The retention rate was 85%. Despite not having outcomes 
for those targets, results reported high interventional endorsement and feasibility. Statistically 
significant intervention effects were consistent with medium effect sizes on the health-related 
QOL scale domains (measured with the Functional Assessment of Cancer Therapy–General 
scale and subscales of the Measure of Current Status) favoring the intervention. 
Discussion 
This integrative review confirms that supportive care interventions for advanced PC 
exist but they remain limited in number and scope despite the disease’s uncurable nature, its 
growing prevalence, and the most current supportive care guidelines. Advanced PC is often 
associated with long-term challenges leading to greater levels of unmet needs and decreased 
QOL (Chambers et al., 2012; Cockle-Hearne et al., 2013). Evidence indicates that supportive 
care interventions are an acceptable and potentially efficacious way to improve some aspects 
of PC and other cancer survivors’ QOL (Chambers et al., 2018; Forbes et al., 2019; Young et 
al., 2020).  
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The majority of interventions in this review focused on supportive care needs from 
the physical domain, such as fatigue, muscle strength, or body composition changes. Despite 
the mixed results in reducing fatigue, physical outcomes such as muscle strength, specific 
anthropometric measures (waist circumference), and physical function improved across all 
studies. Possible explanations for the mixed results in fatigue could be that the studies 
considered different outcomes, utilized various measuring instruments, or that the 
interventions lacked implementation fidelity (intervention dose, intensity, or frequency). This 
finding is consistent with past studies that have reported supportive care interventions being 
ineffective in improving QOL in diverse cancer populations due to inadequate doses or 
variable timeframes (Carey et al., 2012). Supervised interventions with adequate dosages and 
frequency to increase functional capacity, QOL, and ability to conduct ADL, such as 
exercise, have shown effectiveness among advanced PC and other cancer survivors (Dickey 
& Ogunsanya, 2018). Moreover, all exercise interventions that were delivered in group 
formats motivated socialization, social support, and sense of belonging among participating 
survivors despite social well-being not being a specific outcome measured. 
The high prevalence of emotional needs in this population is commonly associated 
with more advanced stages of the disease, uncertainty about the future, and the harmful 
effects of the treatments (Paterson et al., 2015). Interventions addressing emotional needs are 
limited and often lack demonstrated efficacy. Only five in this review reported significant 
improvements in outcomes, such as depression, anxiety, distress, or fear. The heterogeneity 
of these studies makes it difficult to draw conclusions about the most effective way to 
provide emotional supportive care. Barriers to emotional health may include traditional 
masculine stoic roles, a restricted emotional response, and embarrassment (Ettridge et al., 
2018; Wood et al., 2017).  
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A similar situation was found within the spiritual, practical, and psychological 
domains. Evidence shows that despite 79% of Americans identifying with some spiritual 
doctrine, spiritual needs are the least represented in cancer research, and the studies reviewed 
are no exception (Busolo & Woodgate, 2016). Challenges in coping with advanced PC can 
lead to increased suffering, grief, and loss, contributing to a poorer overall QOL (Laughery & 
Woodgate, 2015). Educational interventions have showed promising results in enhancing 
study participants’ spiritual well-being.  
A study involving web-based group sessions of stress reduction, coping skills, and 
social network (CBSM) contributed to the psychological domain and reported improvements 
on the health-related QOL subscales (Yanez et al., 2015). However, the study did not use any 
exiting instrument to assess patients’ coping such as the Cancer-Coping Questionnaire 
(Moorey et al., 2003). No studies specifically targeted practical needs, but one study 
described the impact of advanced PC on daily life, and other studies reported intervention 
delivery acceptability. Interventions using teleconferencing or the Web were implemented 
conveniently in the comfort of the home. The majority of those, predominantly psychosocial 
interventions, reported moderate acceptability and feasibility, with high compliance and  
retention rates. However, they had mixed results: only one resulted in significant decreases in 
anxiety, fear, and mindfulness abilities (Chambers et al., 2012). This result coincides with a 
study reporting that telemedicine care delivery was moderately effective in addressing 
survivorship symptomatology (Agochukwu et al., 2018).  More extensive studies are 
warranted to demonstrate the usefulness of these delivery formats for advanced PC survivors. 
All the studies included advanced disease PC survivors, exclusively or in conjunction 
with varying disease stages. However, there was a noteworthy lack of racial and ethnic 
diversity in the studies. Interestingly, the three studies with participants other than White 
were conducted in the U.S. The majority of the studies reviewed were exploratory with small 
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sample sizes. Also, studies used different outcome measures and the interventions varied in 
dose, frequency (ranging from 1 to 5 days per week), and length (8 to 24 weeks), making it 
difficult to determine which supportive care interventions were the most effective (Bossert et 
al., 2020; Carey et al., 2012). Despite some promising results, it is premature to generalize 
the findings to practice in all the settings caring for these survivors. Longitudinal 
confirmation of the most effective interventions that meet this group’s unique and complex 
needs is needed from more rigorous, multicenter, blinded RCTs that are sufficiently and 
diversely sampled (Ross et al., 2020).  
There were three noteworthy findings from this review. First, the interventions 
delivered in a group format, whether in person or via technology, resulted in significant 
improvements in social-related measures (social support, social well-being, or a sense of 
belonging). This finding supports conclusions from past reviews reporting that the social 
domain is positively associated with a better overall QOL in advanced PC and breast cancer 
survivors (Dickey & Ogunsanya, 2018; Post & Flanagan, 2016). Second, the intervention 
results do not appear to be dependent on the number of domains addressed by the 
intervention. Some interventions showed positive trends, whether they addressed only one or 
several of the SCFCC domains. Third, some of the SCFCC domain —social or the practical 
domains—were impacted by the intervention even when they were not explicitly targeted. 
Limitations 
Several methodological limitations may limit the generalizability of the findings. The 
majority of studies were of high methodological quality. However, none of the studies 
reported a theoretical framework guiding the intervention development or delivery. It is 
possible that relevant articles were missed since our focus was on supportive care 
interventions in advanced PC survivors. The search terms were narrow to reflect this specific 
interventional category, dropping other areas that may have produced additional relevant 
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evidence. Limiting studies to the English language and the last ten years could have resulted 
in the omission of relevant evidence.  
Implications for Research 
This review highlights several gaps. First, different sampling approaches need to be 
considered to advance research in this area. Future research must include racial and ethnic 
diversity to reduce health disparities and promote QOL across communities suffering from 
chronic illnesses such as advanced PC (NINR, 2016). Second, researchers must focus on 
studying interventions that combine several components addressing the maximum number of 
supportive care domains since those interventions can be more cost-efficient in the long run. 
Third, interventions need to be guided by a theoretical framework and align with the 
recommended guidelines for survivorship care (ASCO, 2019; CCO, 2019). An absence of 
theory makes it difficult to understand how and why the interventions were or were not 
successful in addressing this growing population’s unmet supportive care needs (Nilsen, 
2015). Finally, some of the mixed results may be attributable to the dissimilarities in 
psychometric properties of the instruments used across studies, making a comparison of the 
results very challenging. Future research must consider assessing the validation properties 
and quality of all measurement instruments as well as utilizing the same instruments to 
measure the same outcomes. Also, there is a need to diversify research methodologies and 
include more qualitative and mixed methods research studies. These methodologies can 
provide a more in-depth understanding of advanced disease PC survivors’ experiences and 
perceptions of regarding supportive care interventions.  
Conclusion 
Supportive care in advanced PC remains underserved and overlooked. This review 
reveals valuable insights regarding available supportive care interventions that improve the 
QOL in this growing population. Findings suggest that the majority of the interventions 
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reported some effectiveness. However, no intervention can be recommended over another 
and the results must be interpreted with caution due to the existing limitations. This review 
supports the need for further interventional research, specifically longitudinal studies with 
larger, more racially diverse samples and methodologies. Future directions may include 
multi-domain designs and systematic use of theories and cancer survivorship guidelines. 
Finally, it also is critical to focus on the spiritual, practical, and psychological domains, as 
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Men with advanced prostate cancer can endure a wide range of long-term side effects 
from cancer and therapies, negatively affecting their quality of life. Few studies have been 
published about the supportive care needs for this specific population and the correlation of 
needs with the quality of life. The aim of this study was to conduct a holistic supportive care 
needs assessment among advanced disease PC survivors guided by the Supportive Care 
Framework for Cancer Care. Using a convergent mixed-methods approach, 188 American 
survivors diagnosed with advanced prostate cancer completed a cross-sectional survey 
(Supportive Care Needs Survey-Short Form 34, PC module, Functional Assessment of 
Chronic Illness Therapy – Spiritual Well-Being, European Organization for the Research 
and Treatment of Cancer Quality of Life Questionnaire). A subset of 20 survivors agreed to 
participate in qualitative interviews. Participants identified unmet supportive care needs in 
every domain of the framework. A negative correlation between needs and quality of life was 
also established. Results revealed that 95.2% of the survivors had at least one unmet need. 
The item with the highest prevalence (62.2%) was “fears about the cancer spreading.” The 
findings’ integration revealed several areas of convergence (fatigue, sexual dysfunction, 
practical, and emotional/psychological domains) and divergence (informational and spiritual 
domains, depression, urinary dysfunction). A priority goal is for advanced prostate cancer 
survivors to maintain quality of life while reducing their unmet supportive care needs. This 
study’s results can inform the future development of individualized supportive care 










Despite massive screening and development of novel treatments, the incidence of 
prostate cancer (PC) in the United States continues its ascending trend, from 98.8 new cases 
per 100,000 people in 2014 to 108.0 per 100,000 in 2017.1  Furthermore, this incidence is 
estimated to rise 33.6% by 2040, partly due to an increase in men aged 65 years and older.2  
There are more than 3.6 million PC survivors living with this disease in the U.S., a third of 
whom will experience progression or recurrence  (stage III-regionally advanced, stage IV-
metastatic, or recurrent / refractory).3,4,5,6 Treatment with curative intent is no longer an 
option for survivors with advanced PC. These survivors are typically managed with a 
combination of therapeutic agents, such as chemotherapy, androgen-deprivation therapy 
(ADT), and ongoing clinical trials testing individualized immunotherapy, DNA repair 
inhibition, vaccines, or prostate-directed radiotherapy.7,8 Although promising, these 
treatments are often associated with long-term and negative effects that significantly 
compromise overall quality of life (QOL) and health outcomes.9,10,11 Unmet physical, 
emotional, social, psychological, informational, spiritual, and practical supportive care (SC) 
needs often stem from those effects, costing the U.S. health care system more than $9 billion 
annually. 4,9-16 
SC needs are defined as survivors’ desire for support to maximize QOL and minimize 
functional and psychosocial deterioration for a problem that arises from the illness or 
treatments.17 Evidence from past studies suggests that, despite current cancer survivorship 
recommendations and guidelines, between 33% and 81% of PC survivors report SC needs 
that have not been adequately addressed.14,18 Specifically, the unmet needs include emotional 
needs (52.9%),  physical needs (47.1%), practical and spiritual needs (23.5%), and social 
needs (11.8%), further impacting QOL.18  SC is a patient-centered approach that focuses on 
the prevention and proper management of the side effects of PC and its treatments, 
improvement of coping and decision-making skills, and reduction of functional impairments 
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throughout the entire cancer continuum, including survivorship.16,20,21 The Institute of 
Medicine, the American Society of Clinical Oncology (ASCO), and the American Cancer 
Society (ACS) endorse SC as a way to improve QOL and rehabilitation, and lessen the 
economic hardship of cancer care on healthcare systems.21 However, the implementation of 
SC varies significantly across settings, partially due to the SC needs remaining unknown for 
this subset of survivors.19,21 
Research to date has investigated PC survivors’ lived experiences, predictors of QOL, 
and the sequelae of PC treatments with curative intent at various stages of the disease. But 
relatively few published studies have focused solely on advanced disease PC survivors and 
their specific needs, or have investigated the relationship between unmet SC needs and QOL 
in this population.11,15,23,24 Some literature exists on unmet physical and informational SC 
needs in advanced PC survivors using quantitative or qualitative approaches, but not mixed 
methods.11,25 Therefore, a holistic needs assessment was warranted to enhance the 
understanding of this vulnerable subset of survivors’ perception regarding their unmet SC 
needs. The findings of this study can be translated into development of patient-centered, cost-
effective SC interventions aimed at enhancing advanced PC survivors’ QOL and reduce 
burdens to healthcare systems. 
The purpose of this convergent parallel mixed-methods study was to conduct an SC 
needs assessment among advanced disease PC survivors guided by Fitch’s Supportive Care 
Framework for Cancer Care (SCFCC). Specifically, the authors addressed the following 
research questions: (1) What are the unmet supportive care needs in advanced disease 






Outlining a comprehensive taxonomy of seven domains (physical, emotional, social, 
spiritual, practical, informational, and psychological), the SCFCC served as the guiding 
theoretical framework for this study (Figure 1). The SCFCC was initially developed as a tool 
for healthcare providers to understand the global and complex needs of diverse cancer 
patients throughout the illness continuum.26 This framework has been used successfully in 
previous needs assessment studies with various types of cancer survivors.27,28 The SCFCC 
guided the identification and selection of a previously validated instrument to measure unmet 
SC needs due to the similarities between the framework and the Supportive Care Needs 
Survey (SCNS) domains.29 It has also helped inform the development of the qualitative 
interview guide because of its holistic view of SC for cancer.29,30 Lastly, it has guided the 
categorization and interpretation of the findings, identifying SC needs across domains that 
were particularly prevalent and had the potential to impact this population’s QOL and overall 
health outcomes negatively. 
Study Design and Setting 
This exploratory study used a convergent parallel mixed-methods design. After 
obtaining IRB approval, cross-sectional quantitative and qualitative data were collected 
concurrently from advanced disease PC survivors between July and October 2020. We used a 
multichannel recruitment strategy to identify eligible participants. For the quantitative phase, 
recruitment settings included a prominent cancer center of an academic medical institution in 
the southern U.S., Research Match (an online research recruitment tool), various prostate 
cancer support groups and organizations, and online social media. The study had a waiver of 
informed consent; however, every eligible participant was provided with a written statement 
of research with all pertinent study information along with the survey introduction. The 
survey assessed overall and PC-specific unmet SC needs, spiritual well-being, and cancer 
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Figure 1: SCFCC Diagram Applied to advanced PC (with permission) 26 
Study Sample  
In the quantitative phase, a convenience sample of survivors were enrolled if they 
reported meeting the following inclusion criteria: (1) had an advanced disease PC diagnosis 
(stages III, IV, or recurrent); (2) were ≥18 years; (3) were able to read, understand, and speak 
English; and (4) resided in the United States or its territories. Excluded were those who 
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endorsed being enrolled in palliative or hospice care or having a physical or mental 
impairment preventing survey completion.  
For the qualitative phase, we purposively enrolled a subsample of participants who 
completed the survey and indicated willingness to participate in the qualitative interview. 
Diversity by sociodemographic and clinical factors (e.g., race, ethnicity, age, disease stage, 
treatments, time since diagnosis, level of education, marital status, and geographical location) 
was prioritized when possible to ensure maximum variation and to capture the perspective of 
potentially neglected and underserved populations. Recruitment continued until data 
saturation was achieved.31  
Data Collection  
Quantitative Data: A cross-sectional online survey was administered nationally using 
Research Electronic Data Capture (REDCap). Respondents who were eligible and completed 
the entire survey (n=188) received an electronic gift card as compensation for their time and 
effort. The survey included the following validated measures: 
Socio-demographic and clinical questionnaire. Self-reported data included age, race, 
ethnicity, marital status, employment, years of education, insurance status, state of residence, 
age and stage at diagnosis, treatments received, and current disease stage. 
Supportive Care Needs Survey-Short Form 34 (SCNS-SF34). The participants’ unmet SC 
needs were assessed with a self-report questionnaire consisting of 34 items mapped onto five 
domains: physical & daily living (5 items), health care & information (11 items), 
psychological (5 items), patient care & support (10 items), and sexual (3 items). This 
instrument has robust similarities with the most relevant domains of the SCFCC.32,33 
However, some domains are not separated within the instrument subscales. For example, the 
items that measure emotional needs are included in the psychological subscale. The items 
that measure psychological needs are included in two separate subscales (psychological and 
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health system and information). Respondents reported the extent to which they needed help 
with each item over the past month on a 5-point Likert scale (1=not applicable (no need), 
2=satisfied (had need but need for help was satisfied, 3=low need, 4=moderate need, 5=high 
need). All responses were summed within need domain and standardized from 0 to 100, with 
higher scores representing higher level of needs. The instrument has excellent internal 
reliability (Cronbach´s α coefficients between .86 and .95), internal consistency, and robust 
content validity (coefficients between .87- and 96).34  
Supplementary SCNS PC Module. This module assessed PC-specific unmet needs and it is 
appropriate for use with patients at varied PC disease stages, treatment modalities, and time 
since the initial diagnosis. It consists of 8 additional items with the same SCNS-SF34 
response set and scoring.34 
Functional Assessment of Chronic Illness Therapy – Spiritual Well – Being (FACIT-Sp 12). 
This questionnaire was used to collect data on the participants’ spiritual well-being (meaning, 
faith, and peace). It includes 12 items, derived from a longer questionnaire, with summary 
scores ranging from 0 to 48. A higher score indicates greater spiritual well-being.35 This 
subscale has been validated across multiple cultures and has strong reliability (Cronbach 
coefficient 0.87).36 To adapt to the other instruments used in this study, a minor change to the 
FACIT-Sp questionnaire was made, modifying its time frame from 7 days to one month so 
that all the unmet needs findings are consistent with the same specific time frame.37 
European Organization for the Research and Treatment of Cancer Quality of Life 
Questionnaire (EORTC QLQ-C30. The EORTC QLQ-C30 is an integrated system consisting 
of 30 items divided in five functional scales, three symptom scales, one global health/QOL 
scale and 6 individual symptom items. It uses a four-point Likert response set for all the items 
except for the health status and QOL scales, which are measured on a 7-point scale. Scores 
were calculated by scale or by item and transformed into a 0 to100 summary score with a 
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higher score representing higher QOL or higher symptomatology level. It possesses a high 
degree of consistency with Cronbach’ s α coefficients ranging between .70 and .96.4,38                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
Qualitative Data: Qualitative description guided the qualitative arm of the study. Individual, 
semi-structured interviews were conducted via telephone to explore the influence of SC 
unmet needs on the QOL of survivors more in-depth. Following the identification of the 
participants, the principal investigator (PI) contacted them to arrange the interview at a 
day/time of their convenience. Socio-demographic and clinical information were collected 
including age, race, ethnicity, education level, marital status, employment status, insurance 
status, PC stage at diagnosis, current PC stage, age at initial diagnosis, and treatments 
received. The interview guide was developed based on the SCFCC. Probes were used 
throughout the interview to elicit additional explanations or to redirect the participant.31,39 
The PI maintained a reflective journal to record impressions about the interview. Every 
interview lasted between 15-52 minutes, depending on how much the participant wanted to 
share and was audio-recorded and professionally transcribed using Rev.com. 
Data Analysis 
Quantitative Data. All statistical analyses were performed using SPSS v25. software.40 
Socio-demographic and clinical data were analyzed using descriptive statistics to provide a 
summary of the sample characteristics. The SCNS-SF34 and the EORTC-QLQ-C30 
instruments were scored according to the manual and the scores converted to a standardized 
0-100 scale.34,38 To identify the unmet SC needs, the mean number of needs, and the 
prevalence (i.e., frequency, proportion, mean, standard deviation, range) were calculated per 
domain and individually per item of the SCNS-SF34, the PC-module, and the FACIT-Sp 
instruments. A total score for the FACIT-Sp and the EORTC-QLQ-C30 was also obtained. 
The SC needs items with the highest prevalence were also identified and reported. Bivariate 
correlational analyses with Pearson’s r computation were performed to determine the strength 
 
 67 
and direction of the relationship between each domain of SC needs and QOL. A p value of 
less than 0.05 was used to determine a statistically significant value.41 Missing data were 
reported; no imputation was carried out. 
Qualitative Data. Descriptive statistics were used to summarize the sample’s characteristics. 
The recordings were transcribed verbatim. The PI cross-checked and read each transcript 
several times for accuracy, removing any identifying information. Qualitative deductive-
inductive content analysis was conducted using NVivo12 to provide a rich account of the 
data.16,42,43 The PI performed several coding levels that were further categorized into final 
themes/subthemes guided by the domains of the SCFCC. An iterative comparative method 
was followed throughout the qualitative data collection and analysis until data saturation was 
achieved, using each interview’s analysis to inform subsequent interviews 39,44,45  Throughout 
the analyses, emergent themes were compared across transcripts.  
The concepts identified by Lincoln and Guba were followed to ensure rigor.46 
Credibility was established by providing a statement of research to each participant prior to 
the interview, by writing impressions about the interview, by conducting several levels of 
data coding, and by having several members of the research team verify the transcripts and 
themes (S.N and S.Q). Dependability was achieved by keeping an audit trail of all decision-
making procedures. Confirmability was established during the interviews through repetitive 
questioning and probes for clarification, and by including direct quotations as evidence of the 
data collected. Transferability was ensured by the sampling strategy and documentation of 
the recruitment and data collection processes.46 Additional triangulation was performed by 
contrasting the results with those from the quantitative survey and comparing the final results 
with prior studies conducted with similar populations.11,16,39  
Quantitative and qualitative data were analyzed separately. The merging and 
integration occurred in a subsequent step. Both sets of results were reviewed and synthesized 
 
 68 
to compare and contrast emerging themes. This process enabled side-by-side comparison of 
quantitative and qualitative data to find similarities, differences, and/or inconsistencies.39 
Results 
Demographic and Clinical Characteristics 
From a total of 670 survivors who accessed the quantitative survey, 188 were eligible 
for inclusion in the study. The remaining did not meet the inclusion criteria or started the 
survey but exited it before completion. Overall, the mean (SD) age of the sample was 69.0 
(8.8) years. Most men were White (93.1%), married (82.4%), college degree holders (79.3%), 
and retired (68.1%). The majority (63.5%) lived in southern states. Almost half of the 
participants (49.7%) reported having a stage IV cancer. The mean (SD) age at diagnosis was 
61.6 (8.1) years. Most participants had completed multiple treatments, such as ADT (74.5%), 
radiation (63.3%), or surgery (60.1%) (Table 1).  
A total of 43 survivors were invited to participate in the qualitative semi-structured 
interview, but 21 declined or were lost to follow-up. A total of 22 interviews were performed, 
but two were not included in the analysis because the participants did not meet the inclusion 
criteria due to a discrepancy on the current disease stage discovered as the interview 
progressed. The mean (SD) age for the 20 participants was 67.4 (8.4) years (Table 1). Most 
were White (90%), married (70%), retired (50%), and held a college degree (90%). Current 
disease stages of III, IV, and recurrent were somewhat evenly represented (25%, 40%, and 
35%, respectively). The mean (SD) age at diagnosis was 59.4 (8.8) years. Surgery, radiation, 











Table 1. Sample Demographic and Clinical Characteristics 
 
a Some of the participants did not provide an answer for some of the sociodemographic and clinical characteristics. 





Theme 1: Survivors’ Perception and Prevalence of Supportive Care Needs 
 
Overall, needs were reported in all seven domains. Up to 95.2% of the PC survivors 
surveyed reported having at least one unmet SC need. The proportion of survivors reporting 
PC-specific needs was 83.5%, while 79.8% endorsed emotional/psychological needs, and 
74.5% reported sexual needs. Needs were also identified within the physical (64.4%), 
informational (59.6%), practical (45.7%), and spiritual domains. The mean total number of 
unmet SC needs was 14.9±10, ranging from zero to 42 for each domain.  
Of all the SCNS domains, in those reporting some need (either low, moderate, or high 
need)32 the highest level of need was endorsed for the sexuality domain (39.4±29.2), 
followed by the psychological domain (37.6±22.9) and the physical & daily life (29.9±23.4). 
In contrast, the lowest levels of need were endorsed for patient care & support (27.2±21.0). In 
three out of the six SCNS domains greater than 50% of respondents reported some level of 
need in the psychological, sexuality, and PC-specific module items. In addition, 38.3% of the 
participants who completed the spiritual well-being subscale expressed they had “little” or 
just “somewhat” level of peacefulness. A detailed account of the unmet SC needs’ mean 














a Some of the participants did not provide an answer to some of the SCNS and FACIT questions. 
   b Higher score represents better spiritual well-being. 




The 12 most prevalent individual unmet SC needs items are presented in Table 3. 
Almost half (5 out of 12) of the top 12 needs items were associated with the 
emotional/psychological domains. The remaining belonged to the sexuality (2), PC-specific 
(3), and physical (2) domains. The three most commonly endorsed items included “fears 
about the cancer spreading” (62.2%), “having changes in sexual feelings” (59%), and 
“uncertainty about the future” (58.0%). 
 
Table 3. Top 12 Reported Supportive Care Needs.  
 
 
Quantitative and Qualitative Findings as per SCFCC Domains 
1.1. Unmet Physical Needs  
Needs that stem from physical symptoms and the inability to carry out activities of 
daily life belong to the physical domain, reflected in items in the sexuality, physical, and PC-
modules of the SCNS domains.26 A total of 39.5% of the participants reported some degree of 
needs in the physical domain. The mean scores of the three subscales were 39.4±29.2 
(sexuality), 29.9±23.4 (physical), and 29.6±19.4 (PC-module), ranking first, third, and fourth 
out of the six categories in this instrument respectively. Participants reported several types of 
cancer and treatment-related unmet SC needs related to this domain. The highest level of 
need was related to the respondents’ sexuality/intimacy (59% “changes in sexual feelings” 
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and 45.2% “changes in sexual relationships”), followed by fatigue (49.4% “lack energy / 
tiredness” and 46.3%  “not being able to do the things I used to do”), and “urinary 
incontinence” (44.1%). Additional unmet needs included “hot flushes” (43.1%), 
gastrointestinal problems (29.3%), and “pain” (25.5%).  
The qualitative interviews revealed similar findings. As reflected in the survey data, 
men also complained of urinary dysfunction, fatigue, and sexual problems in interviews. 
Urinary dysfunction was reported by 14 out of the 20 men in several forms: urinary 
frequency, incontinence, and even caring for a urostomy as the result of the treatments. One 
participant shared: “Urination, well, my urination, the doctor who removed the prostate left 
me incontinent and I worked real hard with physical therapy, didn't gain anything. So I wear 
diapers and I have a penile clamp…” 
Approximately 65% of the interviewees reported fatigue to the point of sometimes 
interfering with their past hobbies, daily activities, and even socialization. Although some 
men stated that part of the fatigue was probably the effect of age, some recognized that it 
became more evident after the diagnosis and treatments, particularly after radiation or ADT. 
One man said: “I am more tired than I ever used to be. And I've noticed that.”  
Loss of sexual function was a primary concern for many of the participants (n=10). 
The causes were reported to be either surgery or taking ADT. While one participant seemed 
content with his sexual function due to a new pumping prosthesis, others qualified sex as  
“inexistent” and talked about the deep effect that it had on their overall QOL and well-being: 
“Well, it has an effect on my sexual interest…And I didn't realize before the surgery, how 
important that was just to my wellbeing and my mental health”  
Some of the participants described additional physical needs not captured by the 
quantitative survey. Although unpleasant, most have accepted these needs as expected 
consequences of advanced PC and the treatments. Participants talked about hot flushes at 
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night, pain, weight gain after taking ADT, and sleeplessness, all of which impacted their 
daily life: “There's a certain amount of pain that I have to try and manage. So, the pain, in 
some ways, prohibits me from doing things that I would like to do. So, I'd say it's a great 
impact.”  
1.2. Unmet Emotional Needs 
Emotional needs arise from a lack of reassurance and comfort related to living in 
distress due to the cancer.26 The mean score of the psychological subscale was 37.6±22.9, 
reflecting the second highest reported by the total sample, with 44.4% of the respondents 
endorsing some needs in this domain. The greatest reported emotional needs included “fears 
about cancer spreading” (62.2%), and “uncertainty about the future” (58%), followed by 
“worry about results of treatment” (50%), “anxiety” (46.6%), and “depression”/”feelings of 
sadness” (42.6%). 
 In the interviews, men spoke of emotional health as one of the most affected areas. 
Some of the survivors were diagnosed a few years earlier and were still facing unresolved 
needs related to feelings of anxiety, fear, or depression. Four men even expressed anger and 
regret about the decisions that they had made after the initial diagnosis. They believed that if 
they had been better informed, their outcomes, including emotional outcomes, would have 
been more optimal and they would not feel angry or regretful. One survivor shared: “And I 
wish I knew then what I know now, I guess is what I'm trying to say, regarding just the literal 
day-to-day, how is this going to affect your life.”  
 Nine men also spoke about the emotional consequences of advanced PC and the 
treatments, emphasizing that sometimes existential concerns trigger excessive worry and loss 
of confidence about the future, mainly due to a possible loss of role within their family: “I 
spend a fair amount of time thinking about the future and worrying. It all has impacts. I 
spend a lot of times trying to figure out how to deal with the side effects and that takes time 
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away from the things I want to do.” However, only 25% of the participants revealed strong 
fear about the disease recurring in the near future. The reason may be that many of those men 
already had a recurrent or metastatic disease at the time of the interview. 
 One survivor talked about the emotional toll of becoming an advanced cancer 
survivor. Anxiety was a problem for half of the interviewees (n=10). Consciously or not, they 
have suffered from high levels of anxiety at some point during their advanced disease 
trajectory: “Sure, definitely as I've mentioned it, I get a kind of a little great worry or anxiety 
always kind of running in background” Depression was also a concern reported by 25% of 
these men, primarily tied to the effects of surgery or as a consequence of prolonged ADT 
treatment: “Initially, I had quite a terrible experience my second year of my cancer. And that 
was due to the Lupron, Leuprolide that I was taking. I was severely depressed…”  
1.3.  Unmet Informational Needs 
 Informational needs stem from a lack of or insufficient information for adequate 
decision-making.26  27.2% of the sample reported some informational needs. 
The mean score (29.5±21.5) was the second lowest, after patient care & support. The top two 
needs reported under this domain included “be informed about things you can do to yourself 
to get well” (34%) and “have member of hospital staff with whom you can talk about all 
aspects of condition” (30.8%). All the remaining items had a prevalence of less than 30%.  
 During the interview, all the participants said that they received information on 
advanced PC and related treatments from various sources. These sources were formal, 
through their medical team (e.g., pamphlets), or informal, by joining support groups or by 
personally researching about topics online. However, up to 80% voiced repeated 
dissatisfaction with the type and/or amount of information they received throughout their 
journey. For some, the problem arose from the time of diagnosis: “…the conventional 
wisdom, the cliché that you're going to get is, "Oh, prostate cancer's no big deal…” For 
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others, the information was insufficient regarding the side effects of the therapies: “But the 
hormone therapy, the side effects from it, I had no idea what they were. I was told... I was 
kind of jokingly told that, "Oh, you're going to have difficulty with a lot of things like sexual 
ability, et cetera." And it's injecting the female hormone, so I will have a lot of different 
issues that women have with women's hormones. So that was the end of it. It really didn't go 
into great detail about it.” Some complained about the lack of information regarding 
available sources of support. But no less important was the insufficient guidance regarding 
latest treatments developments outside their healthcare team that they could benefit from: “I 
think one of the challenges is trying to access kind of more emerging information about for 
example, clinical trials that might be going on. Finding that kind of information seem to be a 
little bit harder to kind of pinpoint.”  
 One survivor expressed regret about not asking questions or communicating 
effectively with the medical team. However, this was not the only problem. 20% of the 
participants explained that they had issues understanding the information received, not 
finding the information they were looking for, or feeling anxious about the information 
overload: “Well, reading a lot about prostate cancer in itself is anxiety-provoking.”  
1.4. Unmet Practical Needs 
Practical needs are related to the cancer journey itself and the demands of the disease  
on the person and their daily life.26  In total, 25.1% of the survey participants reported some 
needs under this domain and patient care & support items had the lowest total prevalence 
among the various SCNS subscales, with a mean of  27.2±21.0. Only 22.3% responded 
having needs with “hospital staff to attend promptly physical needs”. However, a third of all 
respondents wished for “more choice about cancer specialist you see”. Practical needs 
stemming from transportation or finances were not specifically measured by any item of the 
SCNS or the FACIT, despite the topic coming up during the qualitative interviews.  
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Most interview participants felt that they were sufficiently supported regarding their 
disease, whether it was by their medical team or the informal internet support community, 
and none reported transportation challenges. However, some reported having other unmet 
practical needs. 35% explained that, due to the illness and the side effects of the treatments, 
they encountered difficulties working around the house. Some even wished they had some 
assistance with certain home chores: “I do have difficulty bending over and picking things up. 
And so housework, a good stove... I get behind on the housework. I could use help there. 
That's for sure.” In addition, finances were also cited as a reason for worry in some cases. 
Most participants expressed satisfaction about their medical insurance and monetary situation 
but 45% of the interviewees said that paying for the insurance premium or for medical 
expenses related to advanced PC was challenging at times: “So, from a financial viewpoint, I 
guess we kind of keeping an eye on our situation because we're somewhat anxious over 
possible and unanticipated additional medical expenses.”  
1.5. Unmet Spiritual Needs 
Needs arising from a loss of meaning in life and changed personal values are included 
under the spiritual domain.26 The mean FACIT-Sp total score was 27.0±9.2, on a 0-48 scale. 
Survey respondents expressed a high level of peace/meaning with a mean subscale of 22.9 
(range 0-32). Likewise, their level of faith was expressed as slightly above average, with a 
mean of 8.2 (range 0-16). Regarding individual items, 50% of the participants endorsed “My 
illness has strengthened my faith/beliefs” and 38.3% endorsed “I find strength in my 
faith/spiritual beliefs” as none or little. 
Interviews highlighted that 65% of the participants considered that spirituality had a 
prominent role in their lives despite individual differences in spiritual beliefs. Most did not 
experience any spiritual crises or changes in their relationship with God. For some, their level 
of faith grew throughout their cancer journey or came back after a brief turndown: 
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“…gradually, I started going back to church to see how it would go, and it came back. I'm 
not even sure when and how, but it did. And it's very supportive for me right now.”  
None of the participants specifically blamed their disease on themselves or their 
beliefs/religion or searched for a special meaning regarding their diagnosis. Overall, their 
spirituality and related activities (e.g., church) did not change and they expressed belief that 
life had become more precious since the time of diagnosis. However, 30% reported that their 
current PC situation had some degree of impact on their spirituality or personal values: 
“Okay. I don't hold on to my own life as fiercely as I once did. I'm more content now to see 
myself as part of a much larger process…”  
1.6. Unmet Social Needs 
Social needs derive from affected social roles and/or lack of social support during the 
cancer experience.26 Aside from one isolated item included under the health system & 
information subscale, “feeling like what you say is not taken seriously by others”, the social 
domain was not evaluated thoroughly in the quantitative data. However, “feeling like what 
you say is not taken seriously by others” was endorsed as a need in 22.8% of the participants 
who completed the survey. 
The qualitative data also highlighted the limited impact of advanced PC on social 
well-being. The majority of participants explained that their social life was maintained more 
or less as usual (e.g., going out to eat, visiting friends or family). Up 50% of the survivors 
described having some sort of social support, whether it was family members, spouse, 
friends, church, or the medical or internet communities. However, 25% acknowledged PC 
having some impact on social life, whether it was in the form of intimacy changes, lack of 
understanding, or changes in socialization: “…having cancer is like living in a different 
world that a lot of people don't understand and will never.”  
1.7. Unmet Psychological Needs 
 
 79 
According to the SCFCC, psychological needs are associated with inappropriate 
coping styles or problems with changes in body image.26 The SCNS and PC modules do not 
measure any changes in body image but do evaluate coping through three separate items. The 
item “learning to feel in control” had 42.5% of respondents expressing some degree of need. 
The other two items, “keeping a positive outlook” and “have access to professional 
counseling”, showed needs in 37.2% and 32.9% of the respondents respectively. 
Interview participants explained that they did not have much difficulty coping with 
the disease. Coping mechanisms were varied and included learning to live with it, 
considering advanced PC a wake-up call in life, trying to keep a positive attitude, praying, 
exercising, or showing resignation:“…it's more it's becoming a resignation, if you will, that 
either I'm going to live with this and die from something else or I'm going to die from this.” 
However, 4 participants shared having some problems with their coping. A couple of 
survivors even admitted needing professional help: “In terms of coping with the 
psychological aspect, I realized pretty early on that I was mentally going into a very bad 
place, dark place. I knew that I needed to reach out to someone…”  
Theme 2: Survivors’ Perception of Quality of Life 
In terms of survivors’ QOL, the mean EORTC-QLQ-C30 total score was 78.6±14.6 
(out of possible 100). The global health/QOL subscale had the lowest score (68.5±20.8). A 
statistically significant negative correlation was found between all the domains of the SCNS 
and the total QOL score (all p<.001), indicating that a higher level of unmet needs was 
associated with a lower QOL. The correlation magnitude ranged from -.37 (sexuality domain 
and QOL) to -.76 (physical and QOL). 
Most survivors participating in the qualitative interviews had a positive perception of 
their QOL. However, five men spoke openly about the reasons why they believed their QOL 
was poor. Often times these reasons were related to the harmful effects of the advanced PC 
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therapies: “I feel like I have a good quality of life right now, in part because I'm not in active 
treatment.”  By contrast, others believed that a lower QOL was associated directly with their 
impaired emotional health: “Probably a four, probably sounds terrible but it's more 
emotional than it is physical. Quality of life physically, I'm probably an eight. But quality of 
life overall, four or five and that's anxiety related…”  
Integration of Results  
After analyzing both strands of data separately, the integration was completed in a 
separate step. A joint display was created guided by the SCFCC domains (Figure 2). Through 
triangulation, we were able to note the extent to which both sets of data produce a more 
comprehensive understanding of the prevalence and type of unmet SC needs among 
advanced PC survivors and the relationship of those unmet needs with QOL through 
convergent and divergent points.39 For instance, while talking to participants about their 
informational needs (under theme 1), most complained about receiving insufficient 
information regarding the various aspects of their condition (grey box qualitative codes, 
figure 2). Notably, this was an area of divergence, as the quantitative findings described a 
totally different picture (grey bar quantitative mean); only between 17.6% and 34% of the 






















To the best of our knowledge, the present study is among the first to categorize the 
prevalence and types of unmet SC needs in American men affected by advanced PC using a 
mixed-methods design. There were several important findings. First and foremost, this study 
reported that respondents had unfulfilled needs in every item representing every domain of 
the SCFCC. This suggests that these survivors experience a wide variety of unmet SC needs. 
Second, we found that more unmet SC needs were associated with lower QOL among these 
PC survivors. These findings coincide with multiple past studies conducted in Canada, 
Australia, and Europe that suggested an association between advanced PC and greater levels 
of unmet needs and poorer QOL in this population.4,11,47 Third, more than fifty percent of the 
items in the three instruments used to collect the quantitative data reflected needs in at least 
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30% of the participants. This is important for two reasons: (1) most of those needs were also 
identified during the qualitative interviews, and (2) the prevalence exceeds the threshold 
suggested by the SCFCC, indicating clinically relevant unmet SC needs that have not been 
addressed effectively by healthcare systems.26,30  
There were several areas of convergence between the two sets of data. Consistent 
with prior research reporting high prevalence of fatigue and sexual dysfunction among 
advanced PC survivors, both survey and interview respondents identified those as unmet 
priority physical SC needs. Further, they explained how both fatigue and sexual issues 
interfered with daily life, leading to a range of negative feelings.47,48 Regarding fatigue, most 
of these participants explained that they tried to continue with their life as usual despite its 
complex and multidimensional effects. Some even described becoming more aware of their 
health, and making appropriate lifestyle changes regarding nutrition, for example. This 
finding is not supported by some studies that suggested that the level of fatigue did not 
improve despite advanced cancer patients’ use of several fatigue-reducing strategies.49,50 
Additional research is warranted to explore potential causes for discrepancy.  
Sexual dysfunction was found to be the most troubling unmet physical need for 
almost half of all participants. Although some differences in the study approach and sample 
can exist, this prevalence is similar to findings in other studies.16,48 The survivors explained 
that they would have opted for alternative treatments other than prostatectomy or ADT if they 
had known the true impact on libido and sexuality. Decision regret has been highlighted as a 
common experience by many PC survivors. Past studies have associated decision regret with 
lack of literacy or self-education utilizing the Internet as their primary source for information. 
51,52 To ensure that the treatments fulfill the survivor’s expectations and preferences regarding 
expected side effects, clinicians must provide individualized information about the expected 
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impact of the different treatments on sexual and other body functions consistently and in a 
proactive manner.51,53 
Another area of convergence included the emotional and psychological domains. As 
in other similar studies, many participants felt fortunate having PC over other types of cancer. 
They acknowledged several coping mechanisms in dealing with the disease, such as 
acceptance or looking at it in a more positive light.54 However, some men also revealed 
anxiety and fear regarding their own mortality, the cancer spreading, the future, and the 
results of treatments, making them extremely aware about their current situation. These 
findings coincide with previous research reporting that 54% of advanced PC survivors 
manifest uncertainty, anxiety, or regret about treatment decisions.55,56 Further, it has been 
found that between 66% and 84% of survivors from PC and other cancers (i.e., lung) 
experience long-term psychological distress and up to 30% clinically relevant levels of 
anxiety that need professional involvement.57,58   
On the surface, the findings regarding physical and emotional needs appear to be 
foreseeable, as the extant literature has associated advanced PC therapies with fatigue, pain, 
decreased libido, impotence, anxiety, and existential concerns.4,12,13,21,25 However, the high 
prevalence of physical and emotional needs is concerning and may be clinically relevant. 
Despite the profound impact that physical and emotional unmet SC needs have on survivors, 
despite all the current ACS and ASCO survivorship guidelines, and despite recommendations 
to connect survivors to appropriate physical and psychosocial screening and interventions, 
the SC they received beyond routine clinical care appears to be suboptimal at best.19,20,56,59  
Even though the quantitative and qualitative questions did not match in the practical 
needs domain, a lower number of practical SC needs were reported in both strands of data. 
Survivors voiced that areas such as choice of treatment, healthcare team, and transportation 
were sufficiently met throughout their disease trajectory. However, a few of these men 
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encountered difficulties dealing with housework and finances. One previous U.S study 
suggested that the survivorship stage can be the most expensive of all.25 The few survivors 
still employed struggled with medical expenses or insurance premiums. This burden will 
likely continue as they will need further treatments to keep advanced PC under control. More 
research is necessary to develop and implement strategies that mitigate practical needs and 
prevent financial toxicity among this subset of survivors.60 
We found several areas of divergence during the integration process. As reported in 
Table 2, quantitative reports of unmet informational needs were relatively low. Furthermore, 
no informational needs were included in the top 12 needs categorized in Table 3. This finding 
is significant and somewhat unexpected, as during the interviews, 80% of the participants 
voiced informational deficiencies at some point during the care process. Although a few 
survivors felt highly confident about the amount and type of information received from their 
medical team, many highlighted the importance of becoming more knowledgeable through 
self-education as a way to cope and stay ahead of the illness.  
Treatment side effects affecting QOL, or the existence of more novel therapies that 
could have provided long-term benefit were never explained to some of the participants 
making them “feel unprepared for future possibilities.” This finding correlates with past 
reports of variability in the amount and quality of information that is given to advanced PC 
survivors during routine care.61 The discrepancy among the data indicates that more research 
is warranted to determine the true sources of these informational deficiencies and the timing 
of informational needs. Causes may include medical factors (i.e., healthcare providers seeing 
larger amounts of survivors, prioritizing survival to SC), information overload, or patient-
related factors (i.e., stoicism, lack of readiness to learn about harmful effects, 
misunderstanding), as suggested by several studies on prostate and rectal cancers.54,62,63  
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Findings regarding the spiritual domain were also somewhat mixed. Advanced cancer 
may lead to loss of hope, affecting the individual’s body, mind, and soul.64 Up to 79% of 
Americans identify with some type of spiritual doctrine despite differences in what 
spirituality may mean to them.65 Further, many advanced cancer patients tend to rely on 
spirituality to cope with the disease, suggesting that higher levels of spirituality are associated 
with better overall QOL and less prevalence of SC needs.66 The majority of our cohort 
described various coping strategies and identified that spirituality played an active role in 
their life. Despite peace and faith subscales scoring above average, 30% spoke about the 
conversion of spiritual health into a different process: “I'm more content now to see myself as 
part of a much larger process…” Additional empirical evidence is needed to determine the 
true impact of advanced PC on spirituality, a domain that continues to be relatively under 
investigated.21 
 Additional areas of divergence included urinary dysfunction (physical domain) and 
depression (emotional domain). While only 44% of the survey respondents reported urinary 
dysfunction, a different picture unfolded as the interviews progressed, with 70% identifying 
urinary SC needs as a priority. The qualitative findings are congruent with multiple studies 
suggesting that urinary functional needs are an unavoidable consequence of some common 
advanced PC therapies.11 The same applies to depression, usually associated with ADT and 
the times when test results are revealed. This discrepancy makes it difficult to determine if 
the depression suffered by these survivors requires professional consideration. More research 
in this area is needed to quantify depression and make appropriate recommendations. 
The findings from this study categorize the unmet SC needs in advanced PC survivors 
from the United States, highlighting the magnitude of the problem. Understanding these 
needs is essential as advanced PC survivors will live with these needs for the remainder of 
their lives. Most of the identified unmet needs stem directly from the harmful effects of the 
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aggressive treatment approaches usually taken to treat more advanced PC stages. However, 
some of the SC needs may also be the result of other factors, such as a lack of physical 
activity, insufficient contact with an oncology nurse, not having a life partner, not knowing 
about the availability of specific treatments or counseling, or informational 
deficiencies.25,47,55 For example, several past studies found that survivors who exercise in a 
consistent manner or saw cancer specialist nurses throughout the care process reported higher 
vitality scores, improved sexual functioning, lower anxiety, and higher wellbeing.67-71 A 
study by Oliffe et al. found that married or partnered PC survivors were more prone to seek 
help, lowering their chance to suffer from SC needs. Regardless of the cause, men described 
an array of ongoing unmet SC needs that warrants further research and addressing by the U.S. 
healthcare system.72   
Studies exploring the SC needs in advanced PC and other cancers are not new in the 
literature. Our results support the assertion that the high prevalence of fatigue, sexual, 
emotional, psychological, and informational needs coincides with countries such as Canada, 
Spain, France, or the United Kingdom.16,47,63 However, some inconsistencies were also 
evident, particularly within the physical (urinary), spiritual, informational and practical needs 
compared with past needs assessments conducted in the United Kingdom, Australia, or 
Malasya.30,48,73 The similarities and discrepancies may very well be due to cultural context of 
the people or the healthcare systems, but they could also be the result of gender differences. It 
has been demonstrated that women with breast cancer for example, are more likely to voice 
their concerns and needs, and obtain the necessary help.55 Although it was not always the 
case of this study, many men still hold fiercely to traditional masculine stoic roles, and it is 
possible that they are reluctant to discuss sexual, emotional or physical needs with their 
healthcare team. Further research is needed to clarify the implications that these important 
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geographical and gender-related factors may have in order to achieve a more patient-centered 
SC delivery for all advanced PC survivors. 
It is important to note the challenges using the SCNS and the SCFCC. Despite being a 
validated instrument previously used on multiple needs assessments, it was difficult to assess 
social, practical, psychological, and spiritual needs. This short-coming has already been 
reported by at least one other mixed-methods study. Fong et al. recommended the inclusion 
of 11 additional items assessing needs in the spiritual, practical, and social domains to 
supplement the existing SCNS-SF34, justified by the constructs of Fitch’s SCFCC.74 Using 
the SCFCC made the categorization of some of the needs difficult, due to an overlap within 
several of the domains. For example, based on the framework, sexual unmet needs could be 
classified as either a physical or a psychological need, depending on the investigator’s 
perspective. Also, some themes resulting from the study are not currently contemplated 
within the SCFCC constructs (i.e., masculine roles, cognitive decline). These minimal but 
relevant categorization obstacles might have led to different conclusions and omissions 
depending on the researchers’ opinions and interpretations.  
Strengths and Limitations 
One of the primary strengths of this study includes the use of Fitch´s SCFCC. Despite 
some minimal aspects not captured by the framework (e.g., cognitive decline), it addresses a 
broad cluster of SC needs experienced by PC cancer survivors, providing a robust structure to 
conducting holistic needs assessments in this subset of survivors.26 Additionally, with a 
convergent mixed-methods design, the quantitative findings could be further crossmatched 
with the qualitative data for common trends, places of disconnect, and aspects that were 
missed by the data. Lastly, we chose previously well-validated instruments with high 
reliability and validity coefficients used in diverse several cancers past SC needs assessments. 
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This study had several limitations. The study was cross-sectional, providing only a 
snapshot at the unmet needs at a particular point in time. The sample size was adequate but 
was primarily comprised of White, married, retired participants holding a college degree. 
However, the sample reflected diversity regarding age, advanced PC stage, treatments 
received, and age at diagnosis. Some caution is advised when interpreting these findings. The 
needs assessment must be repeated using a larger and more diverse sample of survivors with 
advanced PC. Convenience and purposive sampling strategies were used in the quantitative 
and qualitative phases respectively. Self-selection bias is likely, and results may not be 
generalizable to all advanced PC populations. Although the use of one coder to analyze both 
strands of data is a limitation, the tables and the codebook were developed in collaboration 
among all the authors, holding regular meetings to enhance trustworthiness. Also, a female 
researcher conducted all the data collection. A male researcher may have prompted different 
responses from some of the participants.  
Implications for Research 
The findings of this study complement the existing literature but highlight several 
important gaps. First, most previous studies assessing the unmet SC needs in advanced PC 
survivors were conducted in countries other than the U.S. More research is warranted to 
understand the true impact of these unmet SC needs in this specific population. We also 
emphasized some significant variations in the type and prevalence of SC needs compared to 
previous work. Most of these men expressed high levels of satisfaction with the overall 
cancer care they received. However, ongoing unmet SC needs were present in a relatively 
large proportion of survivors regarding physical, and emotional/psychological domains, and, 
to a lesser degree, the informational and spiritual domains. Although some survivors felt like 
they could go on with their life with a positive attitude and self-education, others were 
evidently seeking help. These results are significant enough to recommend further SC 
 
 89 
research. Lastly, quantitative results suggest a preliminary but moderate negative association 
between unmet SC needs and QOL—the more unmet SC needs the survivors had, the lower 
their QOL. However, for the purpose of this study, this relationship was not evaluated based 
on socio-demographic and clinical variables. Additional research is needed to determine if 
these needs are dependent or vary according to individual demographic and clinical 
characteristics. 
Conclusion 
Men with advanced PC suffer from a complex incurable disease. Despite being cross-
sectional, our study provides comprehensive information to understand the prevalence and 
types of SC needs in a population that has received limited attention in the survivorship 
literature so far. The needs assessment confirms and extends previous work describing the 
specific unmet SC needs in a sample of diverse American advanced PC survivors.The 
development and implementation of adequate SC is essential, as the prevalence of SC needs 
remains high, especially among the physical, emotional/psychological, and informational 
domains. To improve QOL and outcomes, the SC must be individualized, multidisciplinary, 
and delivered continuously long after the treatments are finalized, as PC is a cancer with a 
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Background: Individualized supportive care has been recommended to prevent and manage 
the debilitating effects of advanced prostate cancer and its treatments. Yet, the 
implementation of supportive care in practice remains limited and inconsistent.  
Methods: PubMed, SCOPUS, CINAHL Complete, ProQuest, and PsycINFO were searched 
for relevant studies published between 2011 and 2020. The sample included studies with 
original research reporting on a supportive care intervention and including a description of 
implementation barriers and/or facilitators. The Theoretical Domains Framework was used to 
characterize implementation barriers and facilitators. 
Results: We identified 620 articles, out of which 13 met the inclusion criteria. Primary 
barriers related to the domains Environmental Context and Resources (time constraints, 
reduced access, limited resources), Knowledge (insufficient knowledge on availability and 
efficacy of supportive care and technology), and Beliefs About Capabilities (lack of 
confidence in materials, difficulty navigating the system, limited competency). The main 
facilitators fell under Environmental Context and Resources (partnerships with local services, 
uninterrupted availability, supervised group approach), Reinforcement (partners inclusion, 
flexible scheduling, multimodality), and Skills (delivery by professionals, specialty nurse). 
Conclusions: This review highlighted barriers and facilitators that affect supportive care 
implementation. Future research that focuses on overcoming barriers and maximizing 
facilitators is vital to improve, modify, or supplement existing supportive care 
implementation practices.  
Implications for Survivors: As the number of advanced prostate cancer survivors continues 
to rise, supportive care has the potential to become standard of care. Future interventions 
must incorporate the following: increased knowledge and funding, alternative delivery 









According to a recent American Cancer Society report, the most common cancers 
found in males include prostate cancer, colorectal cancer, and lung cancer [1].  Prostate 
cancer (PC) survivors make up to 22% of all United States’ cancer survivors, currently 
numbering more than 3.7 million men [2]. Recent incidence data from the Global Cancer 
Observatory suggest that the number of new PC diagnoses will rise from 1.3 million in 2018 
to 2.3 million by 2040 [3]. Most men are diagnosed with PC at a localized stage. However, 
30% of men will progress into regionally advanced or metastatic disease or will suffer a 
recurrence at some point during the illness [4,5].  
Effectively managing diverse PC morbidities has become a substantial health and 
financial challenge. Despite progress in treatments that prolong life, some population-based 
studies have reported that many advanced disease PC survivors continue experiencing 
devastating and sometimes life-long side effects requiring ongoing supportive care [5,6]. The 
American Society of Clinical Oncology and the American Cancer Society have published 
guidelines advocating for comprehensive supportive care at all stages of PC. The 
Multinational Association of Supportive Care in Cancer (MASCC), founded in 1990, has 
defined supportive care as “the prevention and management of the adverse effects of cancer 
and its treatment” [7], and includes PC surveillance, evaluation and management of all 
treatments’ harmful effects, and psychosocial support [8]. The concept of supportive care has 
progressively evolved from the 1960s modern hospice movement, gaining momentum in the 
past few years among worldwide health providers and researchers [9]. Furthermore, 
supportive care entails the provision of all necessary individualized interventions to meet the 
advanced PC survivors’ physical, emotional, social, informational, practical, spiritual, and 
psychological needs through the entire cancer care continuum, as advanced PC has a 
tremendous impact on the person’s life beyond the physical body [10]. 
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Despite enhancing PC survivors’ experience of care, rehabilitation, and quality of life 
(QOL), the prevalence of supportive care delivery continues to remain consistently low 
[11,12,13]. A recent study determined that up to 81% of cancer survivors had unmet 
supportive care needs and reported dissatisfaction with current supportive care services [14]. 
Advanced PC survivors report an array of overlapping supportive care needs encompassing 
the emotional, social, psychological, informational, physical, practical, and spiritual domains 
[4,5,13,14]. Left untreated, these unmet needs may lead to additional morbidity and distress. 
In order to be most effective, supportive care interventions must follow a multidimensional 
approach and be provided by a multidisciplinary team in a timely manner [15,16]. Since 
every PC survivor is unique, the interventions need to be tailored to the patient’s specific 
needs, objectives, and coping style [13].  
Given the increasing number of advanced PC survivors and the multidomain needs 
they experience, several organizations and agencies have recommended integrating 
supportive care services into standard cancer care [16]. However, the implementation remains 
complex. The extant literature primarily focuses on the functional outcomes of PC therapies, 
survivors’ needs assessments, and barriers and facilitators of PC survivors’ individual 
behavior [6,12]. A closer exploration of the barriers and facilitators affecting the 
implementation of supportive care in PC using a theoretical framework is critical to 
advancing knowledge on the factors that contribute to more sustained and cost-effective 
delivery [12]. Thus, the aims of this scoping review are to (1) identify supportive care 
interventions for advanced PC survivors using the Supportive Care Framework for Cancer 
Care (SCFCC), and (2) synthesize the barriers and facilitators to implementing supportive 
care interventions through the lens of the Theoretical Domains Framework (TDF) as reported 







Scoping reviews are helpful in exploring the extent of the literature for topics that are 
under-researched [17]. This scoping review was performed with the guidance of two 
theoretical frameworks.  First, supportive care was defined and the supportive care 
interventions in the selected studies were identified using the SCFCC for advance PC. The 
SCFCC framework was initially developed to assist clinicians in meeting the unique and 
complex needs of cancer patients. It outlines a comprehensive taxonomy of seven domains of 
needs, including physical, emotional, informational, social, practical, psychological, and 
spiritual [13]. The SCFCC has been used in multiple prior needs assessment studies as well 
as in guiding supportive care interventions development worldwide [13,18,19].  
Once the interventions were identified using the SCFCC, the TDF provided structure 
for classifying and synthesizing the barriers and facilitators in implementing those supportive 
care interventions. TDF was initially developed to guide implementation research and has 
proved useful in identifying factors affecting the implementation of many types of care 
interventions [20]. The TDF can be applied to qualitative and quantitative studies to 
understand patients and HCPs behaviors [20]. It is an integrated theoretical framework 
consisting of 14 domains: Knowledge; Skills; Memory, Attention, and Decision Processes; 
Behavioral Regulation; Social/Professional Role and Identity; Beliefs About Capabilities; 
Optimism; Beliefs About Consequences; Intentions; Goals; Reinforcement; Emotions; 
Environmental Context and Resources; and Social Influences [20,21].  
The TDF uses an evidence-based schema derived from theory that has been 
successfully used in many past literature reviews [22]. In a 2020 scoping review, Moncion et 
al. used the TDF to describe factors influencing aerobic exercise implementation in stroke 
rehabilitation [23]. In addition, TDF was also used by Adrian et al. to identify the barriers and 
facilitators influencing HCPs’ behavior in the care of infants with neonatal abstinence 
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syndrome [24]. Accordingly, the TDF provides a useful framework to identify and synthesize 
behavioral factors that may affect the implementation of supportive care interventions in PC 
survivors suffering from advanced disease. 
Design and Search Strategy 
 This scoping review followed Arksey and O’Malley s’ methodology, which includes 
five well-distinguished stages: (1) research problem identification; (2) literature search; (3) 
selection of appropriate studies; (4) extraction of the data into a matrix; and (5) summary and 
report of the results [25]. The search strategy started by consulting an expert reference 
librarian who suggested the use of Boolean operators and MeSH terms to find the most 
relevant studies. The following electronic databases were searched: PubMed, SCOPUS, 
CINAHL Complete, ProQuest, and PsycINFO. The following key search terms were 
searched in each database: (prostate cancer OR prostate neoplasm) AND (interventions OR 
intervention OR programs OR program) AND (supportive care). We decided not to include 
the term implementation in the search strategy, as this may have significantly limited the 
number of studies involving supportive care interventions relevant to the review. Hand 
searching of the resulting studies’ reference lists identified additional pertinent articles for 
evaluation. 
Inclusion and Exclusion Criteria 
Studies were eligible for inclusion in this review if they reported quantitative, 
qualitative, or mixed methods original research. Studies had to (1) include a supportive care 
intervention or program directed at advanced disease PC survivors and (2) have a direct or 
implicit description of the barriers and/or facilitators to implementing the intervention. For 
the purpose of this review, a barrier was defined as any “circumstance or obstacle that keeps 
people or things apart and /or prevents communication or progress,” whereas a facilitator was 
described as “a person or thing that makes something possible” [22]. Exclusion criteria 
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consisted of other types of cancers, studies focusing on solely localized PC, reviews, and 
unrelated subjects such as pharmacological or surgical interventions. The search was limited 
to studies published in English from 2011 to 2020 to ensure that the most recent studies were 
included. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) statement guided the articles selection to ensure methodological rigor (Figure 1) 
[26]. 
Data Extraction and Analysis  
The database search identified 620 potentially relevant articles. Two additional 
articles were added from the reference lists hand searches due to relevance to the topic. After 
duplicates were removed, the first author independently screened 478 titles and abstracts for 
eligibility. A final count of 35 articles underwent a full-text evaluation by the first author 
with 22 articles excluded for being non-original research (n=9), describing other than 
supportive care intervention implementation (n=12), or investigating localized PC only (n=1). 
Twenty percent of the title, abstracts, and full text were reviewed by a second reviewer (SQ) 
for validity and trustworthiness of the studies selected. Ultimately, all authors agreed to 
include a total of 13 articles meeting the inclusion and exclusion criteria.  
The primary goal of data extraction includes drawing a rigorous conclusion about the 
research problem by ordering, coding, categorizing, and synthesizing the data from the 
selected studies [25]. The data extraction process was based on prior literature and guidance 
to perform systematic scoping reviews. The following data were ordered, extracted, and 
exported into a comprehensive evidence table: author(s), year, purpose, design, setting, 
sample, intervention, key results, TDF domain, and level of evidence (Table 1). Any 
facilitators or barriers identified in the selected studies were critically appraised and classified 
according to the 14 domains of the TDF to facilitate the analysis of issues and variable 
characteristics (Table 2 & 3). Despite not being required for scoping reviews, the sample’s 
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Table 1 displays an overview of the selected studies’ characteristics. The sample of 
studies included original intervention research, and all were published between 2011 and 
2020. Six of the studies used a quantitative methodology, of which three were randomized 
controlled trials [29-31], one was a retrospective cohort study [6], and two were cross-
sectional descriptive studies [32,33]. The remaining seven studies utilized either a qualitative 
design (n=4) [22,34-36], a mixed-methods methodology (n=2) [37,38], or a quality 
improvement design (n=1) [28]. The chosen studies also represent wide geographic settings, 
as they were undertaken in Canada [7,28,33,37], Australia [22,29,34,36,38], or the United 
Kingdom [30-32,35]. All 13 studies included a sample of advanced stage PC survivors 
(stages III, IV), either exclusively or in combination with other stages. Five studies included 
the partners or caregivers in the program [28,30,33,35,37]. Only one study applied the TDF 
or any other conceptual theory to guide the design and the categorization of the results [22]. 
Regarding the studies’ levels of evidence, three provided a level I, two studies a level II, and 
eight studies a level III. Every study was included in the review due to the relevance to the 
topic and the valuable information it provided regarding barriers and facilitators to supportive 
care implementation. 
Supportive Care Interventions   
Numerous resources, including past literature and several published clinical 
guidelines, assist HCPs in developing and implementing appropriate interventions according 
to the survivor’s domains of need (physical, emotional, social, spiritual, informational, 
practical, and psychological) [13,39,40]. Figure 2 displays the supportive care interventions 
implemented in the sample of selected studies, categorized according to the SCFCC domains 
of needs. Many interventions in the selected sample of studies addressed the SCFCC 
informational domain (n=6). PC survivors were informed or educated about various topics 
such as nutrition, side effects of the treatments, psychological management, or available 
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resources for PC [28,30-32,35,37]. Five interventions addressed the physical domain, 
whether it was by implementing an exercise program, a pelvic muscle rehabilitation 
intervention, yoga training, or by applying principles of a healthy diet [7,28,29,33,34]. 
Mindfulness, psychosexual therapy, and yoga covered the emotional domain in three of the 
studies [32,33,38]. Most interventions (n=9) addressed the social domain by implementing 
them in a group format, motivating relationships, collaborative activities, and camaraderie 
[22,29,30,32-37]. Interventions delivered by teleconference, conducted online, or 
emphasizing individual needs assessment addressed the practical domain by decreasing the 
demands on the individual’s life at home [22,30,35,36,37].  
 
 
Some programs aimed at alleviating several domains of needs, such as psychosexual 
counselling or coping skills development, which addressed not only the emotional domain 
but also the psychological domain [7,31]. By contrast, the spiritual domain was the only 
domain not addressed directly by any intervention; however, programs focusing on support-
building or yoga may have an effect in strengthen PC survivors’ personal sense of meaning in 
life and spirituality [13,22,33,36]. Some interventions involved the survivor alone, and some 
involved the survivor and their partner/caregiver [30,33,35]. The instruction methodology 
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differed from accredited HCPs being in charge of the implementation [22,29,31,32-34,36] to 
nurses or implementation [22,29,31,32-34,technicians facilitating the sessions [7,28,30,35,37, 
38]. 
Barriers and Facilitators to Supportive Care Interventions Implementation  
 
All 13 studies in this sample included facilitators and/or barriers to implementing  
supportive care interventions for advanced PC survivors, whether they were directly 
mentioned or indirectly discussed [7,22,28-38]. For each study, the number of barriers ranged 
from zero to 15, and the number of facilitators ranged from zero to 10. A total of 137 factors 
were identified in the selected articles, with 58 coded as barriers and 79 as facilitators, 
according to the TDF constructs. In nine studies, patient-related and healthcare providers-
related (HCPs) barriers and facilitators were identified [7,22,28,30,31,33-35,37,38], while the 
remaining four studies involved HCP perspectives exclusively [29,30,32,36]. Twelve studies 
addressed both barriers and facilitators, with one study addressing only facilitators [29].  
All 14 TDF domains were represented across the sample, and barriers and facilitators 
were coded across the 13 out of 14 TDF domains. No barriers were mapped under Emotion 
and no facilitators were found coded under Behavioral Regulation. The TDF domains most 
frequently identified for barriers included Environmental Context and Resources 
[7,22,28,29,31-38], Knowledge [22,28,30,32-34,36,37], and Beliefs about Capabilities 
[21,27,30,34,36]. Facilitators fell most frequently under Reinforcement [7,22,28,30,32-
35,37,38], Skills [28,30-33,35,37], and again Environmental Context and Resources. Two 
factors —“partners/caregivers’ involvement” and “accessibility to the program” (one 
centralized location)—were identified as both barriers and facilitators, depending on the 
stakeholders’ perspective. Three other factors were given codes from two different TDF 
domains. For example, “discomfort posting on forums” and “muted preferences on 
supportive care due to stoicism” were coded under Social/Professional Role and Identities 
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and Social Influences. The facilitating factor of “materials/software easy to understand” was 
mapped to the TDF domains of Skills and Beliefs about Capabilities. The results were 
arranged giving a special emphasis to the three most influential TDF domains under which 
the numerous barriers and facilitators were found. Then, factors under the remaining TDF 
domains were subsequently described. To summarize the data, Table 2 lists the frequencies 
and percentages of every barrier and facilitator found per TDF domain. Table 3 summarizes 




1.1.Environmental Context and Resources Domain 
 
 The most predominantly identified barriers to supportive care implementation appear 
to be in the Environmental Context and Resources (ECR) domain, which includes constructs 
such as resources/materials used during the intervention, organizational climate or culture of 
the facility, interactions between the persons (HCPs/patients) and the interventional 
environment, or environmental stressors (e.g., location, time of the day) [21]. All studies 
except for one identified barriers under the ECR domain. Major barriers to supportive care 
implementation included time constraints, lack of sufficient resources, and reduced 
accessibility to the programs. For example, additional survivors could have benefited from a 
yoga program if accessibility had been boosted by a clearer physician referral pathway [33]. 
Despite the benefits reported from a group mindfulness intervention, only 38.5% of the 
participating survivors agreed with the excessive time commitment to carry out all the 
program activities and requirements [38]. HCPs specifically reported challenges with their 
conflicting schedules as well as time constraints to promote or deliver supportive care due to 
an increase in patient overload during office hours [33,36]. Scarce resources (e.g., 
technology) and lack of funding to offer the interventions to larger groups of survivors were 
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two of the largest barriers to appropriate implementation, reported in four of the studies 
[22,28,31,32]. Further, limited funds leading to long waiting lists for survivors to be called 
has been suggested to impact optimal program implementation [32]. 
1.2 Knowledge Domain 
 
The second most predominant domain was Knowledge, which includes knowledge 
about how to proceed with a supportive care intervention as a patient or as a provider, 
knowledge about the condition/scientific rationale (e.g., benefits) regarding the intervention 
implementation, and knowledge of task environment [21]. In five separate studies, both 
survivors and HCPs described lack of knowledge regarding supportive care programs 
availability and effectiveness, variations in HCPs’ expertise on supportive care, challenges 
maintaining knowledge currency, and deficient technology proficiency, as barriers to 
implementing supportive care programs appropriately (Table 3) [22,28,30,36,37]. For 
example, two studies reported HCPs’ notable unawareness of the importance and benefits 
that physical activity may provide to these survivors [33,34]. Ralph et al. conducted two 
consecutive studies in 2019 and 2020. The first one aimed at understanding the 
implementation context of a telephone-based nurse-led supportive care intervention, and the 
second one at identifying barriers and potential solutions for an optimal implementation 
[22,36]. The data collected during those two studies suggested that the frantic speed at which 
treatment options for advanced disease PC are progressing and the uncertainty about which 
treatment provides survivors the most benefit (based on their clinical characteristics) create 
challenges for clinicians to keep up with the latest developments on supportive care in terms 
of effectiveness. Since advanced PC is a progressive disease with a long trajectory, being 
aware of the newest advances is essential, as information may lose relevance over time [22]. 
Additionally, wide variations in HCPs’ knowledge and expertise regarding supportive care 
 
 109 
within the same health system or region create difficulties for developing more standardized 
supportive care plans that meet the recommended survivorship guidelines [30].  
1.3 Beliefs About Capabilities Domain 
 
The third most common TDF domain, Beliefs About Capabilities, addresses HCPs’ self-
confidence in implementing a supportive care intervention or in carrying out the activities of 
the intervention, perceived professional competence, self-efficacy, perceived behavioral 
control, beliefs in being capable of delivering or receiving the intervention, self-esteem, and 
empowerment [21]. Five separate barriers were identified in three studies concerning this 
domain. The barriers were associated primarily with the program materials/resources or the 
delivery methodology. For example, many survivors expressed their discomfort with posting 
personal or clinical information on the online program forum, because they believed that they 
lacked the necessary proficiency to avoid unforeseen loss of confidentiality [37]. In the same 
study, HCPs believed that a purely online format was not always an acceptable format for 
intervention delivery, advocating for more hybrid formats that facilitate every survivor’s 
capability and learning style [37]. A separate qualitative study exploring the experiences of 
survivors, partners, and the interprofessional team with a multimodal supportive care 
intervention found that patients were not always capable of navigating the health system in 
search for adequate supportive care [35]. Additionally, HCPs experienced a moderate degree 
of frustration addressing certain topics with their patients, such as sexual dysfunction, 
therefore not meeting the survivors’ needs and expectations effectively [31]. This frustration 
could stem from a lack of competency in those fields or conflicting professional capabilities 
[35,41].  
1.4. Additional Identified Barriers 
 
Several other barriers were identified in the sample of studies (Table 3). Three studies 
found that limited training of HCPs in oncological supportive care (Skills) was a major 
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barrier to the implementation of the intervention [22,28,31]. Interprofessional disagreement 
regarding the intervention focus (e.g., weight management versus disease progression), 
coordination challenges, and persistence of survivors’ traditional masculine roles 
(Social/Professional Role and Identity) decreased the uptake of supportive care despite the 
high demand [22,28]. Survivors also described feelings of discomfort and anxiety posting 
personal information in interventional online forums or voicing personal preferences 
regarding certain supportive care modalities (i.e., sexual rehabilitation, mental health) due to 
fear to opinions and reactions from the surrounding environment (Beliefs about 
Consequences) [22,37].  
Three barriers were identified under Goals, which were associated with not meeting 
the survivors’ needs, the partners’ expectations, or not easing coordination of the program 
[22,28,32]. For example, data from a nutritional education intervention suggested that 
additional objectives, such as describing the role of certain nutritional components, 
addressing individual nutritional concerns, and practical meal planning tips, should have been 
included as part of the intervention description [28]. One other study reported that survivors 
tend to prioritize treatments that extend life over supportive care, complicating HCPs’ 
referrals to appropriate programs (Intentions) [22].  
Because of the existing social norms and stigma around PC, survivors identified 
social pressure as a barrier to seek supportive care when needed (Social Influences) [22,36]. 
However, they also found motivators to participating in certain programs involving 
mindfulness or peer navigation, for example. Studies that prevented caregivers from 
participating in the intervention activities or that lacked a complete in-person interaction were 
found to incentivize participation and continuity the least (Reinforcement) [37,38]. In some 
cases, successful implementation meant empowering survivors enough for them to break old 
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habits (e.g., sedentarism or poor diet) or make them believe in the benefits that the supportive 
care intervention can bring into their daily life (Behavioral Regulation) [22,31].  
Some pessimism was identified among survivors whose PC was managed exclusively 
by urologists (Optimism) [22]. One study specifically reported that supportive care is a field 
that may fall outside the scope of practice of this type of HCPs. Thus, survivors are forced to 
live for long periods of time with the side effects of the treatments believing that they cannot 
obtain an appropriate referral from these medical specialists leading to gloomy feelings. 
Furthermore, many of these specialists did not revisit important information regarding PC 
and supportive care processes (Memory, Attention, and Decision Processes).  
Facilitators 
2.1 Environmental Context and Resources Domain 
 
The most predominantly identified facilitators also fell under the ECR domain and 
included recognition of the extra resources (e.g., locations, educational materials) and 
capacity (e.g., staff) needed to deliver the intervention (Table 2) [32]. Partnerships with local 
PC support groups and supportive services enabled to approach and care for larger groups of 
survivors with different needs at once [32,37]. Uninterrupted availability of supportive care 
programs during longer periods, such as in exercise programs, as well as increased 
accessibility to the program professionals via in person or technology were essential to 
maintain the beneficial effects of the intervention over time [28,29,31,35]. Cultural 
competency, such as using translators and linguists, brought a robust sense of self-efficacy to 
the providers in charge in the ability to implement a supportive care program more 
effectively [36]. Structured, supervised group approaches were also reported in two separate 
studies, not only as implementation facilitators, but also as a way to deliver more cost-
effective programs reaching a greater number of survivors simultaneously [34,38]. 




The second most predominant domain for facilitators was Reinforcement, which 
relates to rewards (e.g., benefits) from completing an intervention or program, incentives for 
participation (e.g., financial compensation, further referrals), consequences from not meeting 
the patients’ needs or not completing all the prescribed activities, reinforcement, 
contingencies, and sanctions due to procedural errors, for example [21]. Fifteen facilitators 
were identified in ten separate studies under Reinforcement. These facilitators were primarily 
associated with the inclusion of the partners/caregivers during the intervention, flexibility in 
scheduling interventional sessions, and the multicomponent approach taken with the 
intervention. Four of the studies found that involving direct caregivers in the intervention 
activities led to higher patient engagement, increased social and emotional support, and 
enhanced information retention due to the additional reinforcement provided by the 
partners/caregivers [33-35,37]. HCPs reported that flexibility in scheduling the intervention 
sessions helped meet the survivors’ needs in terms of time and location, encouraging 
accessibility and reach [32,38]. Multimodality in intervention delivery (i.e., combining 
several different modules or activities) was also essential to incentivize participation among 
advanced PC survivors [22]. Furthermore, five separate studies determined specifically that 
the multicomponent delivery option offered a more comprehensive view of the disease and 
the treatment side effects, promoting a more holistic care to meet the survivors’ supportive 
care needs and expectations [7,28,32,35,38]. 
2.3. Skills Domain 
 
 The Skills domain was the third most prevalent domain, and it is associated with the 
necessary skills to deliver supportive care, skills development (e.g., HCPs’ continuing 
education on the latest developments; patients’ increasing abilities in terms of the 
intervention activities), competence to implement this type of programs, ability, skill 
assessment, interpersonal skills to encourage participation, and practice/professional 
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experience with this line of work [21]. Interventions that were supervised and moderated by 
accredited, trained professionals, such as nutritionists or exercise physiologists, reported 
positive results on the outcomes and a higher level of satisfaction among participants 
[29,31,32,34,36,38]. For example, in a mixed-methods study to investigate the acceptability 
and effectiveness of a supervised mindfulness-based cognitive therapy delivered by 
psychologists, the authors reported statistically significant improvements in the survivors’ 
level of anxiety (p=.027), avoidance (p=.032), and mindfulness skills after three months of 
implementation (p=.019) [38]. Through qualitative interviews, exercise physiologists were 
identified as pivotal in helping participants understand the physiological and psychosocial 
benefits of exercise [34]. Two additional studies endorsed the use of trained nurse specialists 
in the delivery of supportive care, as it was found that this approach enhanced survivors’ 
well-being [31,36]. This delivery strategy is well supported in the existing literature and has 
demonstrated feasibility and cost-effectiveness. Additionally, the ability to develop 
alternative gentle physical activity options for advanced disease PC survivors such as yoga, 
was found to be a facilitating factor. Not only was the program successfully implemented, but 
it also reported high adherence (87%) and statistically significant results in improving mood 
(p=.000), fatigue (p=.000), and stress (p=.004)[33].  
2.4. Additional Identified Facilitators 
 
When HCPs had clear referral pathways and evidence-based information at hand on 
how to provide patient-centered supportive care (Knowledge), it facilitated survivors in 
obtaining appropriate interventions in a more timely manner [32,36]. Further, when 
supportive care interventions and health awareness campaigns were individualized with 
tailored shared objectives (Goals), it helped address supportive care needs in a more holistic 
manner, whether it was by increasing participation or reducing social stigma about advanced 
PC [22,30,31,35,36]. Interventions that intentionally approach supportive care holistically 
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have been found to be more cost-effective in addressing more supportive care needs at once 
(Intentions) [35]. 
Certain intervention materials and resources provided confidence to support goals or 
intentions in facilitating a supportive care intervention (Beliefs about Capabilities). For 
example, a Peer Navigation Training Program was found to be feasible, acceptable, and 
effective in promoting eHealth literacy and satisfaction because participants felt capable of 
using the intervention materials [37]. User-friendly sessions enhanced empowerment and 
benefits in a separate nutrition educational program [28]. However, an optimistic team 
climate has also been found to be helpful (Optimism) as the demand for specific supportive 
care interventions can sometimes be high when the availability is low [36]. 
Appropriate program length, inclusion of a multidisciplinary team, and adapting the 
intervention to the most common masculine ideals were reported as facilitators in four 
separate studies (Social/Professional Role and Identity). These factors led to a network of 
services that was more comprehensive, had better control of advanced PC side effects, and 
higher completion rates (88%) [28,31,32,34]. Likewise, small group and social learning 
formats indicated better intervention adherence (87%), social identification, information 
retention, and a strong bond of camaraderie among participating survivors [29,33,34,37,38]. 
Equally important for implementation success were 
continuous program evaluations and diary keeping (Memory, Attention, and Decision 
Processes) or program safety (Beliefs About Consequences) as they helped facilitating 
session planning, benefits, sustainability, and currency over time [29,31-33].  
In addition to all added benefits, supportive care interventions have also been found to 
be the optimal setting to share experiences. These opportunities often led to higher emotional 
cohesion among the participating survivors, which subsequently, increased attendance 
(Emotion) [33]. The same benefits were seen in the case of authentic in-person interaction 
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and role-playing formats, which were highly valued and contributed to enhancing self-
efficacy and e-Health literacy [37].  
Discussion 
 
 This scoping review examined the barriers and facilitators to supportive care 
implementation in advanced PC, focusing primarily on the most prevalent domains of the 
TDF. Advanced PC survivors report a wide range of supportive care needs due to the effects 
of cancer and its various therapies. Effective supportive care interventions can assist with 
preventing and managing the harmful effects at the physical, emotional, social, 
psychological, informational, practical, and spiritual levels to improve outcomes [13]. All the 
studies in this review focused on supportive care and identified barriers and facilitators to its 
implementation. However, there was considerable variation among the supportive care 
interventions regarding focus (e.g., physical activity and mindfulness), content (e.g., nutrition 
education and aerobic exercise routines), method of delivery (e.g., in-person, online and 
group sessions), and expected outcomes (e.g., domain of needs) (Table1). The studies 
revealed a wide range of barriers and facilitators related to all TDF domains, further 
sustaining the multifaceted nature of supportive care implementation in advanced PC. 
Stakeholders consistently reported that the absence of the barriers or the enhancement of 
facilitators would significantly benefit the implementation of more patient-centered 
supportive care programs [7,12,22,28-36,38,42]. Therefore, future research and action must 
be directed towards these goals. It is important to note that the study sample explored patient 
and HCP perspectives regarding barriers and facilitators, with slightly more studies focusing 
on HCPs alone [7,21,29,31-33,35-38]. For both barriers and facilitators, individual factors 
(e.g., time constraints, in-person interaction) and contextual factors related to all organization 
levels (e.g., scarce resources, multiapproach programs) were identified. 
Barriers Affecting Supportive Care Implementation 
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The majority of the studies’ participants viewed supportive care implementation 
positively, highlighting more facilitating factors than barriers (Tables 2 and 3). More barriers 
were referenced under ECR, Knowledge, and Beliefs about Capabilities domains. Commonly 
perceived barriers under Knowledge included unawareness of supportive care interventions 
availability and/or effectiveness, variations in providers’ knowledge and expertise, lack of 
technical proficiency, and challenges keeping up with the latest developments in PC 
supportive care  [22,28,30,33,36,38]. This mirrors the results of published studies conducted 
with PC and other cancer survivors which found that many supportive care programs are not 
accessed either because the survivors are unaware of the programs or because the HCPs lack 
adequate prostate-specific expertise [10,43]. Further, some of those studies reported that 
HCPs often focus on seeking information regarding disease progression, prognosis, or the 
physical aspects of the disease, encouraging patients to seek support through peer groups 
[10]. In order to provide PC survivors with optimal supportive care that meets all their 
complex needs, it is vital for HCPs to possess the requisite knowledge regarding supportive 
care during survivorship and act proactively in prescribing the appropriate interventions 
[16,43]. HCPs have expressed willingness to further their PC supportive care-specific 
knowledge so that needs identification and care coordination can be carried on more 
effectively [43]. 
Survivors and HCPs have expressed that a lack of adequate resources and 
accessibility to interventions, as well as time commitments, are major barriers under the ECR 
domain [7,22,28,31-33,36,38]. Previous studies have reported that the urologist is the 
provider who predominantly delivers information and prescribes services to advanced PC 
survivors [12]. Furthermore, some researchers have found that HCPs are sometimes 
responsible for caring for a growing number of survivors in already overly stressed healthcare 
systems, inhibiting them from allocating sufficient time and attention to their patients’ 
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supportive care needs [10,43]. For example, in line with our findings, a study conducted with 
metastatic PC survivors and their partners showed that up to 36% of the HCPs shared an 
apparent desire to improve supportive care by allocating further resources, such as increased 
access to specialty nurses, in-home nursing care and education, more time and locations, or 
access to support groups [10,14,23].   
Additional barriers worth mentioning included “discomfort to post in online forums” 
(Beliefs About Capabilities, Beliefs About Consequences), “male stoicism or stigma” 
(Social/Professional Role, Social Influences), “a purely online as an always acceptable 
format” (Beliefs About Capabilities), and “lack of program comprehensiveness” (Goals) 
(Table 3). Many studies have highlighted the fact that men are often reluctant to seek support 
as it reflects traditional male norms of being stoic, strong, and capable [5,44]. “Masculinized” 
supportive care interventions (e.g., exercise and education) that connect survivors could 
promote male camaraderie, positive masculinities, and commitment to solving shared 
advanced PC issues, particularly pertaining to emotional support [45,46]. Despite the Internet 
offering a convenient and cost-effective way to provide supportive care to advanced PC 
survivors by narrowing social disparities, many providers have expressed that an exclusively 
online format is not always an acceptable format [37,47]. Survivors favored care modalities 
with additional in-person interaction, which has also demonstrated a better acceptance in a 
study conducted with breast cancer survivors [48]. 
Facilitators Affecting Supportive Care Implementation 
Most perceived facilitators were derived from the ECR, Reinforcement, and Skills 
domains. Stakeholders particularly appreciated interventions that were conducted in small 
groups [29,33-35,38], involving additional local PC support services [32,37], and providing 
greater access to a specialty nurses or accredited therapists [29,31,32,34,36-38]. Supportive 
care interventions delivered in a group format, whether in person or via technology, were 
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found to significantly improve outcomes such as social support or social well-being in past 
studies [35,49,50]. In addition, supportive care interventions based on established 
partnerships with available PC support groups and community services increase accessibility, 
reduce centralization, and address individual survivors’ needs more effectively [32,37]. This 
finding is supported by a study conducted in Michigan that tested a partnership between 
several academic health providers, PC support groups, and PC survivors and their partners in 
facilitating broader dissemination of supporting information materials directed at PC 
survivors [51]. 
A notable finding of this review is that a nurse specialist in the role of primary 
intervention deliverer was regarded positively in more than 50% of studies [29,31,32,34,36-
38]. Despite supportive care interventions being implemented by providers from diverse 
health disciplines, a significant imbalance of nurse specialists in caring for PC survivors was 
found in several studies [10,52]. For example, a qualitative study conducted in Australia with 
PC survivors found that the inclusion of nurses with oncology expertise in the 
multidisciplinary team increased care coordination and overall well-being in this population 
[46]. Additional separate studies determined that supportive care delivered by PC specialist 
nurses improved satisfaction, coordination, and continuity of care at the different points of 
the cancer journey making the role of nurses an increasingly integral part of multidisciplinary 
supportive cancer care [10,52,53]. Limited nursing-led supportive care may be due to 
insufficient training in provision of supportive care, limited resources for coordination, or the 
actual structure of the specialty cancer services [54,55]. However, it appears evident that 
despite the existing variations, nurse-led programs demonstrated higher retention and 
satisfaction rates and have the potential to overcome some of the implementation barriers 
previously mentioned (e.g., time constraints, better use of limited resources, disjointed care).  
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Other facilitators to supportive care implementation included “multimodal 
intervention” (Reinforcement), “inclusion of partners/caregivers” (Reinforcement), 
“appropriate intervention length” (Social/Professional Role and Identities), and 
“materials/software easy to use and understand” (Skills and Beliefs About Capabilities) 
[7,22,28,32,35,37,38]. Despite the benefit of connecting with other men facing similar needs, 
involving caregivers in the programs appears to have a reinforcing role and to improve the 
wide range of unmet needs of the dyad as a whole [35,56].  
There were three additional findings from this review. First, some factors, such as 
“discomfort posting on forums,” “muted preferences on supportive care due to stoicism,” or 
“materials/software easy to understand” were coded under several TDF domains. Additional 
work needs to focus on developing clearer operational definitions of each domain and the 
associated constructs so as to avoid “overlap” between domains [57]. Second, there were no 
facilitating factors found under the Behavioral Regulation domain. This can be an area of 
potential future research as behavioral regulation is key to sustain new healthier habits over 
time. Third, there was a notable lack of information available regarding barriers and 
facilitators of supportive care implementation from the United States, as all 13 studies were 
conducted in Australia, Canada, or the United Kingdom. This review has synthesized some of 
the factors but the extent of their role as well as the actors involved remain unknown. 
Strengths and Limitations 
There are several strengths to this scoping review. An expert reference librarian 
assisted with the search keywords, databases, and overall strategies. There was a variety of 
settings, supportive care programs, and study designs within the selected sample of studies. 
Additionally, Arksey and O’Malleys’ rigorous methodological framework, along with the 
SCFCC and TDF, helped guide the synthesis of the evidence and the organization and 
interpretation of the findings, respectively. The use of theory has proven to enhance the 
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understanding of how and why the interventions are developed and implemented successfully 
[58]. 
However, several limitations must also be acknowledged. Although most studies 
included both survivor and HCP perspectives on supportive care implementation, more 
studies focused on the HCPs’ opinions exclusively, which could have altered the 
interpretation of the results [7,22,28,30-33,35 -38]. In addition, despite their high 
methodological quality, only three out of the 13 studies provided level I evidence. Studies 
were limited to the English language and the last 10 years, resulting in the possible omission 
of relevant information. Finally, the review was primarily conducted by one reviewer, 
increasing the risk of bias. 
Implications for Survivors 
As therapies for advanced PC continue to improve, there will be a growing number of 
advanced PC survivors, particularly in developed countries [48]. This scoping review 
expands understanding of the factors that may influence supportive care implementation for 
this population. Overcoming existing barriers and enhancing facilitators has the potential to 
better inform future research regarding how to develop and implement more cost-effective, 
patient-centered supportive care interventions that meet all PC survivors’ needs. Based on the 
results of this scoping review, future supportive care initiatives must focus on the following 
critical elements to close the existing knowledge gap: (1) improving accessibility and 
knowledge, increasing resources, considering several formats of supportive care, and 
overcoming masculine help-seeking behaviors; (2) giving special attention to factors that are 
coded under the ECR domain, whether as a barrier or a facilitator, as they are significantly 
more prevalent, and (3) developing and implementing nurse-led programs, as they have 




Our scoping review has highlighted the multifactor barriers and facilitators affecting 
the implementation of supportive care in advanced PC survivors. The findings from this 
review are unique because, for the first time, these factors were categorized and classified 
according to the TDF domains. The resulting knowledge provides details about the barriers 
that need to be addressed and the facilitators that can be maximized to develop and deliver 
supportive care to advanced PC survivors. Future research must focus on improving, 
modifying, or supplementing current supportive care implementation practices. This scoping 
review contributes to the existing literature with novel findings that will help bridge the 








































[1] American Cancer Society. Cancer facts for men, 2021. Available at 
https://www.cancer.org/healthy/find-cancer-early/mens-health/cancer-facts-for-men.html 
 
[2] National Cancer Institute. Statistics, graphs, and definitions, 2021. Available at 
https://cancercontrol.cancer.gov/ocs/statistics 
 





[4] Holm M, Doveson S, Lindqvist O, Wennman-Larsen A, Fransson P. (2018). Quality of 
life in men with metastatic prostate cancer in their final years before death- a retrospective 
analysis of prospective data. BMC Palliative Care, 17:126-133 
 
[5] Chambers SK, Hyde MK, Laurie K, Legg M, Frydenberg M, Davis ID, Lowe A, Dunn J. 
(2018). Experiences of Australian men diagnosed with advanced prostate cancer: A 
qualitative study. BMJ Open, 8: 1-12 
 
[6] Cockle-Hearne J, Charnay-Sonnek F, Denis L, Fairbanks HE, Kelly D, Kav S, Leonard K, 
Muilekom E van, Fernandez-Ortega P, Jensen BT, Faithful S. (2013). The impact of 
supportive nursing care on the needs if men with prostate cancer: A study across seven 
European countries. BJC, 109: 2121-2130 
 
[7] Berman R, Davies A, Cooksley T, Gralla R, Carter L, Darlington E, Scotte F, Higham C. 
(2020). Supportive care: An indispensable component of modern oncology. Clin Oncol, 
32(11): 781-788 
 
[8] Hedden L, Pollock P, Stirling B, Goldenberg L, Higano C. (2019). Patterns and predictors 
of registration and participation of a supportive care program for prostate cancer survivors. 
Supportive care in Cancer, 27: 4363-4373 
 
[9] Hui D, De la Cruz M, Mori M, Parsons HA, Kwon JH, Torres-Vigil I, Kim SH, Dev R, 
Hutchins R, Liem C, Kang DH, Bruera E. (2013). Concepts and definitions of “supportive 
care”, “best supportive care”, “palliative care”, and “hospice care” in the published literature, 
dictionaries and textbooks. Support Care Cancer, 21(3): 659-385 
 
[10] Carter N, Miller PA, Murphy BR, Payne VJ, Bryant-Lukosius D. (2014). Healthcare 
providers’ perspectives of the supportive care needs of men with advanced prostate cancer. 
Oncology Nursing Forum, 41(4): 421-430 
 
[11] Catt S, Matthews L, May S, Payne H, Mason M, Jenkins V. (2019). Patients’ and 
partners’ views of care and treatment provided for metastatic castrate-resistant prostate 
cancer in the UK. Eur J Cancer Care, 28: e13140 
 
[12] Yannitsos D, Murphy RA, Pollock P, Di Sebastiano KM. (2019). Facilitators and 
barriers to participation in lifestyle modification for men with prostate cancer: A scoping 
review. Eur J Cancer Care, 29: e13193 
 
 123 
[13] Fitch MI. (2008). Supportive care needs framework. Canadian Oncology Nursing 
Journal, 18(1): 6-14 
 
[14] Mazarello-Moore TH, King AJL, Sharp M, Persad R, Huntley AL. (2015). Supportive 
care for men with prostate cancer: Why are the trials not working? A systematic review and 
recommendations for future trials. Cancer Medicine, 4(8): 1240-1251 
[15] Carter N, Lukosius DB, DiCenso A, Blythe J, Neville AJ. (2011). The supportive care 
needs of men with advanced prostate cancer. Oncology Nursing Forum, 38(2): 189-198  
 
[16] Kumar P, Casarett D, Corcoran A, Desai K, Li Q, Chen J, Langer C, Mao JJ. (2012). 
Utilization of Supportive and Palliative Care Services among Oncology Outpatients at One 
Academic Cancer Center: Determinants of Use and Barriers to Access. J Palliat Med, 15(8): 
923-930 
 
[17] Weir A, Kitto S, Smith J, Presseau J, Colman I, Hatcher S. (2020). Barriers and enablers 
to conducting cluster randomized controlled trials in hospitals: A theory-informed scoping 
review. Evaluation and Program Planning, 80: p 101815 
 
[18] Busolo DS, & Woodgate RL. (2016). Using a supportive care need framework to  
understand and improve palliative care among cancer patients in Africa. Palliative Supportive 
Care, 14(3): 284-301 
 
[19] Fitch MI, Steel R. (2010). Identifying supportive care needs of women with ovarian 
cancer. Canadian Oncology Nursing Journal, 20(2): 66-74 
 
[20] Cane J, O’Connor D, Michie S. (2012). Validation of the theoretical domains framework 
for use in behaviour change and implementation research. Implement Sci, 7(1):37. 
 
[21] Atkins L, Francis J, Islam R, O´Connor D, Patey A, Ivers N, Foy R, Duncan EM, 
Colquhoun H, Grimshaw JM, Lawton R, Michie S. (2017). A guide to using the Theoretical 
Domains Framework of behavior change to investigate implementation problems. 
Implementation Science, 12: 77-95 
 
[22] Ralph N, Chambers SK, Laurie K, Oliffe J, Lazanby M, Dunn J. (2020). Nurse-led 
supportive care intervention for men with advanced prostate cancer: Healthcare 
professionals’ perspective. Oncology Nursing Forum, 47(1): 33-43 
 
[23] Moncion K, Biasin L, Jagroop D, Bayley M, Danells C, Mansfield A, Salbach NM, 
Inness E, Tang A. (2020). Barriers and facilitators to aerobic exercise implementation in 
stroke rehabilitation: A scoping review. JNPT, 44: 179-187 
 
[24] Adrian A. (2019). Factors influencing healthcare providers’ behaviors in the care of 
infants with neonatal abstinence syndrome (NAS): An integrative review. J Neonatal Nurs. 
https://doi.org/10.1016/j.jnn.2019.07.006 
 
[25] Arksey H, O’Malley L. (2005). Scoping studies: Towards a methodological framework. 
Int. J. Social Research Methology, 8(1): 19-32 
 









[28] McLaughlin K, Hedden L, Pollock P, Higano C, Murphy RA. (2019). Assessing the 
nutritional needs of men with prostate cancer. Nutrition Journal, 18: 81-92 
 
[29] Cormie P, Taaffe DR, Spry N, Joseph D, Hamid MA, Galvao DA. (2013). Exercise 
maintains sexual activity in men undergoing androgen suppression for prostate cancer: A 
randomized controlled trial. Prostate Cancer and Prostatic Disease, 16: 170-175 
 
[30] Paterson C, Primeau C, Nabi G. (2018). A randomized controlled trial of a multimodal 
supportive care (ThriverCare) intervention for managing unmet supportive care needs in men 
with metastatic prostate cancer on hormonal treatment and their partner/caregivers. European 
Journal of Oncology Nursing, 37:65-73 
 
[31] Watson EK, Shinkins B, Matheson L, Burns RM, Frith E, Neal D, Hamby F, Walter FM, 
Weller D, Wilkinson C, Faithfull S, Sooriakumaran P, Kastner C, Campbell C, Neal RD, 
Butcher H, Matthews R, Wolstenholme J, Rose PW. (2018). Supporting prostate cancer 
survivors in primary care: Findings from a pilot trial of a nurse-led psycho-educational 
intervention (PROSPECTIV). European Journal of Oncology Nursing, 32:73-81 
 
[32] Ferguson J & Aning J. (2015). Prostate cancer survivorship: A nurse-led service model. 
British Journal of Nursing, 24(18): S14-21 
 
[33] Ross Zahavich AN, Robinson JA, Paskevich D, Culos-Reed SN. (2012). Examining a 
therapeutic yoga program for prostate cancer survivors. Integrative Cancer Therapies, 12(2): 
113-125 
 
[34] Cormie P, Turner B, Kaczmarek E, Drake D, Chambers SK. (2015). A qualitative 
exploration of the experience of men with prostate cancer involved in supervised exercise 
programs. Oncology Nursing Forum, 42(1), 24-33 
 
[35] Primeau C, Paterson C, Nabi G. (2017). A qualitative study exploring models of 
supportive care in men and their partners/caregivers affected by metastatic prostate cancer. 
Oncology Nursing Forum, 44(6): E241-E250 
 
[36] Ralph N, Chambers S, Pomery A, Oliffe J, Dunn J. (2019). Nurse-led supportive care 
intervention for men with advanced prostate cancer. Oncology Nursing Forum, 46(1): 92-103 
 
[37] Bender JL, Flora PK, Milosevic E, Soheilipour S, Maharaj N, Dirlea M, Parvin L, 
Matthew A, Kazanjian A. (2020). Training prostate cancer survivors and caregivers to be 
peer navigators: A blended online/in-person competency-based training program. Supportive 
Care in Cancer, https://doi.org/10.1007/s00520-020-05586-8 
 
[38] Chambers SK, Foley E, Galt E, Ferguson M, Clutton S. (2012). Mindfulness groups for 
men with advanced prostate cancer: A pilot study to assess feasibility and effectiveness and 












[41] Mehta A, Pollack CE, Gillespie TW, Duby A, Carter C, Perry ST, Witmann D. What 
patients and partners want an intervention that support sexual recovery after prostate cancer 
treatment: An exploratory convergent mixed-methods study. Sexual Medicine, 2019; 7(2): 
184-191 
 
[42] Garne-Dalgaard A, Mann S, Bredahl TVG, Stochkendahl MJ. (2019). Implementation 
strategies, and barriers and facilitators for implementation of physical activity at work: A 
scoping review. Chiropractic and Manual Therapies, 27: 48-60 
 
[43] Clarke AL, Roscoe J, Appleton R, Dale J, Nanton, V. (2019). “My gut feeling is we 
could do more…” a qualitative study exploring staff and patients’ perspective before and 
after the implementation of an online prostate cancer-specific holistic needs assessment. 
BMC Health Services Research, 19: 115-126 
 
[44] Medina-Perucha L, Yousaf O, Hunter MS, Grunfeld EA. (2017). Barriers to medical 
help-seeking among older men with prostate cancer. Journal of Psychosocial Oncology, 
35(5): 531-543 
 
[45] Oliffe JL, Mroz LW, Bottorff JL, Braybrook DE, Ward A, Goldenberg LS. (2015). 
Heterosexual couples and prostate cancer support groups: A gender relations analysis. 
Support Care in Cancer, 23: 1127-1133 
 
[46] Kirkman M, Young K, Millar J, Fisher J, Mazza D, Ruseckaite R. (2017). Men´s 
perceptions of prostate cancer diagnosis and care: Insights from qualitative interviews in 
Victoria, Australia. BMC Cancer, 17: 704-715 
 
[47] Bender JL, Feldman-Stewart D, Tong C, Lee K, Brundage M, Pai H, Robinson J, 
Panzarella T. (2019). Health-related internet use among men with prostate cancer in Canada: 
Cancer registry survey study. Journal of Medical Internet Research, 21(11): e14241-e14253 
 
[48] Setoyama Y, Yamazaki Y, Nakayama K. Comparing support to breast cancer patients 
from online communities and face-to-face support groups. Patient Education and Counseling, 
85: e95-e100 
 
[49] Chambers SK, Occhipinti S, Foley S, Clutton S. Legg M, Berry M, Stockler MR, 
Frydenberg M, Gerdiner R, Lepore, SJ, Davis ID,  Smith DP. (2017). Mindfulness-based 
cognitive therapy in advanced prostate cancer: A randomized controlled trial. Journal of 
Clinical Oncology, 35(3), 291-300 
 
[50] Taaffe DR, Newton RU, Spry N, Joseph D, Chambers SK, Gardiner RA, Wall BA, 
Cormie P, Bolam KA, Galvao DA. (2017). Effects of different exercise modalities on fatigue 
 
 126 
in prostate cancer patients undergoing a Androgen deprivation therapy: A year-long 
randomized controlled trial. European Urology, 72, 293-299 
 
[51] Skolarus TA, Ragnoni JA, Garlinghouse C, Schafenacker A, Webster D, Hagger P, 
Wittman D, Northouse L. (2017). Multilingual Self-Management Resources for Prostate 
Cancer Survivors and Their Partners: Results of a Long-Term Academic-State Health 
Department Partnership to Promote Survivorship Care. Urology, 110, 92-97 
 
[52] O’Shaughnessy K, Laws TA, Esterman AJ. (2015). The prostate cancer journey: Results 
of an online survey of men and their partners. Cancer Nursing, 38(1), E1-E12 
 
[53] De Leeuw J, Larrson M. Nurse-led follow-up care for cancer patients: What is known 
and what is needed. Supportive Care in Cancer, 2013; 21: 2643-2649 
 
[54] Turner J, Clavarino A, Yates P, Hargraves M, Connors V, Hausmann S. Oncology 
nurses’ perceptions of their supportive care for parents with advanced cancer: Challenges and 
educational needs. Psyho-oncology, 2007: 16:149-157  
 
[55] Song Y, Lv X, Liu J, Huang D, Hong J, Wang W, Wang W. Experience of nursing 
support from the perspective of patients with cancer in mainland China. Nursing and Health 
Sciences, 2016; 510-518  
[56] Carter N, Bryant-Lukosius D, DiCenso A, Blythe J, Neville AJ. (2010). The supportive 
care needs of family members of men with advanced prostate cancer. Canadian Oncology 
Nursing Journal, 20(4): 166-176 
 
[57] Phillips CJ, Marshall AP, Chaves NJ, Jankelowitz SK, Lin IB, Loy CT, Rees G, 
Sakzewski L, Thomas S, To TP, Wilkinson SA, Michie S. Experiences of using the 
Theoretical Domains Framework across diverse clinical environments: A qualitative study. 
Journal of Multidisciplinary Healthcare, 2015; 8: 139-146 
 
[58] Nilsen, P. Making sense of implementation theories, models, and frameworks. 


























E, et al. 
(2020) 
To evaluate the 
feasibility, 
acceptability, and 

















Online training program 
feasible and acceptable 
 


















Beliefs about capabilities 












E, Galt E, et 
al. (2012) 
 
To investigate the 
acceptability and 
effectiveness of  
mindfulness- 
based cognitive 






















Improvements in anxiety 
(p<0.027), avoidance  
(p<0.032), and fear of 
recurrence (p<0.062) 
 





Urban group quotas ideal; 
low quotas in regional 
groups 
Qualitative themes: (1) 
group identification; (2) 














(3) peer learning; (4) 







E, et al. 
(2015) 
 
To provide an in-
depth description of 
the experience of 
exercise programs 
among men  
with prostate cancer 
and to identify 
elements critical to 
optimizing patient 
engagement and 


















benefits: physical and 
mental well-being 
 



























Spry N, et 
al. (2013) 
 
To report the effect 
of a 12-week 
exercise program on 



















Moderate to high 
intensity group 
resistance and 








changes in general health, 
vitality, physical health 
 
Statistically significant 
higher percentage in 
interest in sex 
 
No difference in sexual 















& Aning J. 
(2015) 
 
To describe the 
early experience 

















with nurse  
specialist 
(tailored care)  
and Living With 
& Beyond 
 
90% participants reported  
engaged in at least one  
component of the program 
 












































































Men on ADT had 
significantly lower odds of 
registering 
 
Men with larger travel 
distances and lower 
income had lower odds of 
registration 
 
Radical prostatectomy was 
a predictor in participation 
(4 times more) 
 
Kaplan-Meier curves 
varied significantly by 
treatment modality and 
Gleason score 
 
85.58% of registrants 
completed the program 
 
No difference in 
participation by age, 
distance to clinic, 





















understanding of (1) 
the nutritional needs 
of men with 





























Patients and partners: 
88% agreed session was 
right length 
 
94% found it useful 
 










Social/Professional role and 
identity 
Beliefs about capabilities 


















(1) high level satisfaction 
 
(2) inclusion of partners 
useful for processing 
information and 
supporting changes at 
home 
 
(3) 27% reported gaps in 
information – dietary 
components, individual 








60% agreed that patients 
need more nutritional 
support 
No significant differences 
in responses between 
physicians and dietitians 
except for focus on 
nutritional support 
 
67% believed that 







Nabi G.  
(2018) 
 
To determine the 




prevalence of unmet 
needs in men with 
advanced prostate 





























No significant difference 
in prevalence of unmet 
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Greatest improvements in 
physical symptoms, fear 
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changes in sexual feelings, 
concerns of those closest 
to you 
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Patients and partners 
themes: 
(1) emotional support: 
given time for expression 
and provided additional 
support 
 
(2) Informational support: 





facilitated referrals to 




(4)  Evidence-based 
educational group 
seminar: perceived benefit 
in looking after 
themselves at home 
 
Interprofessional team: 
(1) Reported benefits in 
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Gap in care coordination 
Traditional male roles 
influence uptake of care 
 
Patients don´t know how 
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being stoic does not allow 
men to express their 
preferences for supportive 
care 
 
Several modalities of care 
necessary 
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patients prioritize living 
longer than QOL 
 
Participants called for a 
decentralized access to 
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processes 
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implement 
 
Intervention met the needs 
of patients and HCPs 
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continuity of supportive 
care 
 
Intervention will be 
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services network with 
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High attendance (6.1/7) 
 
Statistically significant 
improvements in survivors 
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significant changes in 
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social support higher for 
those bringing a partner 
 
Improvement in flexibility 
(p< 0.048) 
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95% interventional group 
 
All participants found 




sense of well-being and 
emotions 
 
Few participants reported 
no changes in physical 
symptoms 
 
Program useful for men 
avoiding help seeking 
 
Nurses praised the tailored 
follow-up design but were 
disappointed to find some 
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- Discomfort posting in  
An online forum 
- Need for more in-   person interaction  
(not all online) 
- Lack of technology proficiency 
        
- Motivation to guide other survivors  
- Intensive but manageable workload  
- Flexible online environment  
- E-learning software easy to use  
- Authentic in-person role-playing 
   and interaction 
 
Knowledge 
Beliefs about capabilities 







     
- Lack of prior knowledge on 
qualities needed to recruit effective peer 
navigators 
- Purely self-study online not always 
acceptable format               
  
 
- Partnerships with local PC support groups  
- Use of social learning (forum)  










FOLEY E, GALT E, 
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Patients - Lack caregivers’ involvement 
-Excessive time commitment  
 
- Group approach   





                   
HCPs 
      
- Lower attendance from regional areas  
vs. urban  
 
 
-  Supervised sessions facilitated by trained 
psychologists  
-  Intervention implemented in    
multiple locations  
-  Cost-effectiveness group approach  









KACZMAREK E, ET 
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Patients - Acknowledgment   
importance of     
exercise 
      
     
 
- Pivotal role of exercise  
physiologists on compliance  
- Value of group format (support)  
- Humor as contributing element to foster 
supportive group dynamic  
- Exercise fits masculine ideals  
- Positive feedback from  













- None identified 
 
- Structured, supervised program  






 - Run by accredited exercise physiologists  
- Program free of charge  
 
Social influences 
CORMIE P, TAAFFE 
DR, SPRY N, ET AL. 
(2013) 
 




- None identified - Small group approach  
- Supervised by expert  exercise 
physiologists 
- Exercise is non-invasive  
- Intervention highly accessible  
 
Skills 
Beliefs about consequences 
Environmental context/resources 
Social influences 
FERGUSON J & 
ANING J. 
(2015) 





- Waiting lists due to limited resources and 
funding  
- Program did not address partners’ needs  
 
- Recognition of extra capacity needed to 
deliver program  
- Innovative patient-centered program  
delivered by nurse  
specialist  
- Inclusion of multidisciplinary team 
in program planning/ development  
- Involvement of several local services  
accessible to patients  
- Clear referral pathway  
- Flexibility in scheduling sessions  
- Multiapproach: counseling and education  
- Homely environment 
- Continuous program evaluation  













STIRLING B, ET 
AL. 
(2019) 
Patients - Lack of continuity due to treatments    
- Long travel distance  
       







- Low income  
- One centralized location  
- Program for patients/partners  
 
- Multimodal: group educational and 
individual clinical sessions  








Patients - Not comprehensive 
(missing topics)  
- Materials easy to understand  
- Appropriate length  
Skills 
Social/Professional role and identity 
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POLLOCK P, ET 
AL. (2019) 
- Inclusion of partners  Beliefs about capabilities 







- Unaware of current nutritional programs 
for PC  
- Belief of nutrition not being critical for 
PC  
- Interprofessional disagreement focus  
of nutritional program 
- Lack of funding  




- Individual benefit from various formats            
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- Variation in providers’      
knowledge/expertise  
 
- Personalized program  
- Precise standardization of 
EB self-management interventions  
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Patients - Difficult phone access to nurse 
after appointment  
 
- Individualized information  
- Ample time with nurse  
- Non-technical language  
- Focus on self-management  
- Inclusion of partners 








    
- None identified 
 
- Holistic approach  
- Greater access to specialty nurse  
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Patients  - Inability to navigate  
 health system  
 - Muted preferences       on additional SC 
due to stoicism  
 - Prioritizing extension of life 
vs. quality life  
- Stigma  
- Fear, stress and unawareness of 
symptoms on psychosocial well-being 
- None identified Beliefs about capabilities 










- Low awareness of  
SC programs 
- Challenging to maintain 
knowledge currency  
- Uncertainty on SC effectiveness 
- Lack of skills on SC and care 
coordination 
- Patient stoicism 
- Pessimism about specialists engaging on 
SC  
- Centralized access of SC  
- Lack of revisitation  
- Scarce resources 
- Lack of specialty nurses  
- Challenges breaking habits 
 
- Various formats of SC  
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(2019) 
Patients - None identified - None identified  
  
HCPs 
   
- Knowledge base on  
 nurses’ teleconference 
 delivery 
- Concerns on adding program to nurses’ 
workload 
- Coordination challenges  
- Time constraints  
- Peer pressure  
 
 
- Easy delivery via teleconference  
- Individualized program  
- Intervention delivered by specialty 
   nurses  
- EBP intervention  
- High level of adaptability  
- Care continuity  
- Cosmopolitanism  
- Ideal team climate-optimism 











AN, ROBINSON JA, 
PASKEVICH D, ET 
AL. (2012) 
Patients - Time constraint  
- Accessibility  
     
- High acceptance   
- Safe intervention  






    
- Lack of knowledge optimal physical 
activity for PC 
- Lack of referrals  
 
 
- Feasible activity  
- Group format enhances support 










Patients - None identified - Appropriate length 
- Welcoming and safe environment  


































- Strain meeting patients’ needs  
- Lack of right timing for all patients 
- Frustration dealing with some topics  
- Hard to motivate some patients  
- More training needed  
- Need for more resources/funds  
 
     
 
- Nurse delivered intervention  
- Program based on self-management  
- Tailored individual follow-up  
- Open availability  















 This dissertation compendium includes three manuscripts investigating interrelated 
and essential aspects of supportive care among advanced disease prostate cancer (PC) 
survivors. The first manuscript describes an integrative review that critically appraised the 
availability of supportive care interventions for this population and its effects on quality of 
life using the Supportive Care Framework for Cancer Care (SCFCC). In the second 
manuscript, results are reported from a holistic needs assessment conducted using a mixed-
methods approach, also guided by the SCFCC. The third and final manuscript delineates a 
scoping review identifying common supportive care interventions and exploring barriers and 
facilitators to their implementation using the Theoretical Domains Framework (TDF). 
 Prior research has reported that advanced PC survivors suffer from greater unmet 
needs that affect all individual dimensions, lowering their quality of life (QOL).1 Ongoing 
and consistent supportive care has demonstrated to be an effective way to prevent and 
manage these overlapping unmet needs, maximizing QOL and rehabilitation.2-4 However, 
despite all the recommendations from the Institute of Medicine, the American Society of 
Clinical Oncology, and the American Cancer Society, implementation of supportive care 
among this subset of survivors is limited and irregular.5 The contributing results from the 
integrative review confirmed that, in fact, supportive care interventions for advanced PC 
survivors are not as widely available as they should be, despite some positive results on the 
outcomes. Supportive care efforts focus mainly on exercise, cognitive-behavioral, and 
educational interventions, leaving domains such as the spiritual, practical, and psychological 
lacking appropriate addressing in need for development of additional interventions. This 
deficiency doesn’t but amplify even more supportive care needs in this population. Therefore, 
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a mixed-methods study that explored these needs in a comprehensive manner was necessary 
to strategize additional supportive care interventions. 
The results from the mixed-methods convergent study indicated that advanced PC 
survivors have unfulfilled needs in every domain and that in fact, more needs were associated 
with lower quality of life. Up to 30% of the survivors reported having needs in at least half of 
the items, which is highly concerning. Areas of data convergence included sexual 
dysfunction and fatigue (physical domain), anxiety and existential concerns (emotional 
domain), and help around the house (practical domain). Numerous other needs identified in 
the mixed-methods study did not triangulate, leading to divergence among the data. Needs 
related to information were found to be most prevalent and important during the qualitative 
interviews but barely identified in the quantitative survey. The same was true for spiritual 
needs and urinary dysfunction, but not for depression, which had a higher prevalence in the 
quantitative data. In order to develop and implement successfully supportive care 
interventions that address the multidomain needs identified during the mixed-methods study, 
it was necessary to have a better understanding of the barriers and facilitators that have an 
effect on supportive care delivery. 
The 13 studies included in the scoping review revealed a myriad of factors 
influencing supportive care implementation. Despite vast differences in supportive care 
interventions regarding focus, content, methodology, and outcomes, most of those barriers 
and facilitators fell primarily under three TDF domains. Barriers were identified under 
Environmental Context and Resources (ECR), Knowledge, and Beliefs About Capabilities, 
while most facilitators were categorized within the ECR, Reinforcement, and Skills domains. 
Primary barriers included lack of knowledge on supportive care interventions availability 
and/or effectiveness from both perspectives, patients and healthcare providers, variations in 
providers’ expertise, insufficient technical proficiency, limited resources and access, time 
 
 144 
constraints, lack of self-confidence in the intervention materials, hardships navigating the 
health system, and little competency. Main facilitators included making partnerships with 
local services, continuous availability, supervised group formats, partners inclusion, flexible 
scheduling, multimodality, delivery by professionals, and specialty nurse involvement. 
Additional barriers and facilitators from other TDF domains were also identified and 
included in the findings to better understand all potentially influencing factors to supportive 
care implementation.  
Implications for Nursing and Cancer Care 
 Extensive past research has focused primarily on PC survivors’ unmet needs at the 
early stages of the disease or undergoing specific treatments, such as androgen deprivation 
therapy.6,7 More nursing research efforts in this area of cancer care are needed to decrease the 
morbidity associated with advanced PC and reduce disparities in supportive care 
implementation. For example, five out of the 12 most prevalent supportive care needs 
identified in the mixed methods study belong to the psychological/emotional domain. The 
integrative review findings support these results as they indicated insufficient interventions 
addressing this specific domain, potentially contributing to the higher prevalence of unmet 
needs. That limitation in interventions may be due to some of the barriers identified on the 
scoping review with the TDF guidance (knowledge, resources). Healthcare providers must 
concentrate their efforts on researching novel ways to provide patient-centered, cost-
effective, multimodal supportive care that improves QOL and maximize health outcomes. In 
particular, as direct providers of care, specialty nurses are in an optimal position to assess the 
evolving needs of advanced disease prostate cancer survivors and become primary deliverers 
of supportive care.8-10 Although the implementation of these interventions by accredited 
multidisciplinary professionals is vital, results from the three manuscripts emphasize the role 
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of specialty nurses. Although limited, interventions that were nurse-led reported higher levels 
of satisfaction and well-being among participating survivors.10 
Future Directions 
 There are several diverse areas for future research based on this dissertation work. 
This was the first study exploring the unmet supportive care needs of advanced PC survivors 
living in the United States at a national level. Additional needs assessment in this population 
guided by multidomain frameworks is needed to confirm the study results and their 
generalizability, mainly longitudinally. Further, there is a need to investigate if the unmet 
needs in this subset of survivors vary according to socio-demographic and clinical 
characteristics and if needs predict QOL. The results also provide a future opportunity to 
conduct a review on all available instruments used to collect information regarding unmet 
supportive care needs and quality of life to determine their efficacy in providing 
comprehensive and accurate information. Additionally, the next steps necessarily include 
expanding and testing new patient-centered, cost-effective interventional research in order to 
narrow down the existing gaps in supportive care implementation. Interventions must focus 
on the needs with the highest prevalence, such as information regarding advanced PC 
treatments and self-care, physical and sexual functionality, and emotional/psychological 
support. However, it must also promote spiritual and practical well-being, as these domains 
can significantly improve QOL and sense of overall meaning among these survivors. Lastly, 
special attention must be given to the areas of data divergence (urinary dysfunction, 
depression, information and spiritual well-being). Further exploration is necessary to confirm 
these points of disconnect and the possible causes behind the differences.  
Lessons Learned 
Despite reaching the sample size for both the quantitative and the qualitative arms, 
participants were primarily non-Hispanic White, married, retired, and with higher education, 
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limiting the generalizability of the findings. It is possible that the recruitment efforts and 
settings led to this lack of diversity of survivors. The same was true for the sample of studies 
selected for the integrative review. Future work must ensure sociodemographic diversity and 
larger samples to increase generalizability. Further, investigators need to start incorporating 
diversity based on sexual orientation as well, since the supportive care needs can differ 
between heterosexual and homosexual advanced PC survivors. 
The use of the SCFCC and TDF frameworks provided a solid structure for this 
dissertation work. This is unique, as the extant literature on supportive care for advanced PC 
survivors typically lacks guidance from theoretical or conceptual models. Selecting 
appropriate theoretical frameworks eases the understanding of how and why supportive care 
interventions are successfully or unsuccessfully implemented and if they address supportive 
care needs effectively, for example.11 The SCFCC was a key element in categorizing not only 
the available supportive care interventions but also the unmet supportive care needs, all based 
on its holistic view of cancer.12 However, some challenges were faced with the use of the 
TDF in synthesizing barriers and facilitators to supportive care implementation, mainly due 
to its numerous domains. Additional exploration of these factors is warranted using other 
suitable frameworks, such as the social-ecological model. 
Conclusion  
 The three manuscripts of this dissertation explore several aspects of supportive care in 
advanced PC survivors. This research has indicated that this subset of survivors has a wide 
variety and prevalence of supportive care needs that do not appear to be appropriately 
addressed by existing cancer care services. This may be due to supportive care interventions 
being limited and inconsistent because of the existing barriers to their implementation. In the 
coming years, as the number of advanced PC survivors continues its ascending trend, more 
holistic, cost-effective supportive care will be vital to meet those multidomain needs and 
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optimize the QOL and overall health outcomes. The findings of this dissertation can be 
applied to the development of new interventional programs that focus on areas of most need, 
maximizing community partnerships, availability, multimodality, and specialty nurse 
involvement. 
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May 29, 2020  
 
Alejandra Schimmel, MSN, MBA, BSN, RN  
Doctoral Student  
Department of Nursing  
Medical University of South Carolina  
Charleston, SC 29425  
 
 
Dear Dr. Schimmel:  
 
 
At the May 29, 2020 meeting of the Protocol Review Committee (PRC), your research protocol 
entitled “A Mixed-Methods Study to Investigate the Unmet Supportive Care Needs in Advanced 
Disease Prostate Cancer Survivors” (CTO #: 103280/Sponsor: MUSC; protocol version May 27, 
2020) was approved as written for use at Hollings Cancer Center.  
 
As required by the NCI for all Designated Cancer Centers awarded a Cancer Center Support 
Grant (CCSG), MUSC-HCC must report all oncology clinical trial activity occurring at MUSC. 
Because the abovementioned study has qualified for PRC review and approval, this study is 
subject to ongoing reporting requirements to the PRC to ensure compliance to CCSG standards. 
Furthermore, since this trial is an investigator-initiated trial sponsored by MUSC faculty, 
additional reporting requirement to the NCI Clinical Trials Reporting Program (CTRP) is 
required.  
 
As Principal Investigator, it is your responsibility to ensure the following information is 
submitted to the HCC PRC at hccprms@musc.edu. Please make sure that CTO#103280 is 
listed in any email correspondence.  
 
 
 1) MUSC IRB Initial Approval Letter and Date of Study Activation  
Please note that consideration for approval of this study by the MUSC IRB is pending. The 
MUSC IRB will require the provision of a PRC approval letter within your IRB application. Once 
a study is IRB approved, please submit the IRB approval letter to the PRC. If the study does not 
receive IRB approval and the study is withdrawn, please contact the PRC of this status. Study 
Activation is defined as the time when the study is eligible to begin enrollment to the trial. When 







 2) All Significant Protocol Amendments require PRC approval  
Significant Protocol changes are defined as changes in any of the following: a) Study objectives, 
b) Research plan or study design, c) Eligibility, d) Statistical Consideration, e) Patient population 
and/or accrual figures. Any significant change requires PRC approval prior to IRB submission. 
It is required that a marked document and/or detailed summary of changes and the PRC 
Amendment Form be provided to the PRC. The PRC form is located at 
http://horseshoe.musc.edu/hcc/clinical-trials/prc.The PRC Chair will initially review the 
documents and may approve under expedited review. Should there be additional concerns, 
the PRC chair has the authority to request full board review of the amendment. 
 
3) Monthly Accrual Updates and Biannual Accrual Review 
On a monthly basis, it is required that updated accrual information is provided. In addition, 
PRC conducts a biannual trial performance review in which the level of accrual is reviewed. 
Should your predicated accrual period or accrual estimate change from your in initial form 
submission, please contact the PRC. 
 
4) Changes in Study Status 
When the study is closed to accrual or terminated, it is required that the updated status be 
provided to the PRC. Any applicable IRB letter regarding this change in status should be 
provided. 
 
5) Copies of all Protocol and/or Consent amendments and Continuing Renewal Applications 
The PRC helps ensure compliance to NCI’s CTRP reporting requirement by submitting 
protocol updates on your behalf. Please notify the PRC of any changes to current study 
documents and related approval letters to the PRC. As an ancillary entity of the MUSC eIRB, 
PRC may request guest access to eIRB applications. However, should your study use an 
external IRB, you would be required to notify the PRC of protocol or consent changes and 
renewal approvals as they occur. All protocol or consent amendments and continuing renewal 
approvals require submission to the NCI’s CTRP. For more information about CTRP please 
visit http://www.cancer.gov/aboutnci/organization/ccct/ctrp. 
 
Conducting research is a critical component of our University’s mission. Thank you for your 
efforts and should you have any questions regarding PRC, please feel free to contact the PRC 





Graham Warren, MD, PhD 
Chair, Protocol Review Committee 
 




APPENDIX C. Study Protocol 
 
SPECIFIC AIMS 
Prostate cancer is the fourth most common cancer globally and a tremendous physical, emotional 
and financial burden for individuals, families, and healthcare systems.1 From the 3.6 million prostate 
cancer (PC) survivors living in the United States, 30% suffer from advanced disease stages 
(regionally advanced-III, metastatic-IV, recurrent or refractory).2,3,4 Advanced disease in survivors, 
considered treatable but no longer curable, is managed with chemotherapy, radiation, androgen-
deprivation, or trials. Although the exact prevalence remains unknown, men with PC report 
substantial unmet supportive care (SC) needs due to a more prolonged illness pathway and the 
debilitating effects of therapies, leading to poor quality of life (QOL) and health outcomes.5 These 
unmet needs, more widespread in advanced PC, are due primarily to physical, emotional, social, 
spiritual, informational, and practical impairments such as pain, urinary incontinence, bowel and 
sexual dysfunction, fatigue, hot flashes, depression, distress, anxiety, isolation, deteriorating bone 
health, weight changes, risk for suicide, cognitive decline, and financial burdens, costing the U.S. 
health system more than $9 billion annually.4,6-13 Extensive research has examined QOL predictors 
and the impact of PC treatments on survivors who have completed curative treatment.10,14-17. Research 
also reports the lived experiences of PC survivors but have not specifically focused on advanced 
disease. 5,18,19 Most studies attempting to examine unmet SC needs have been conducted with PC 
patients in earlier stages of the disease and using quantitative or qualitative approaches alone.7,15,17,19,20 
Therefore, there is a major gap surrounding the perceptions of the vulnerable subset of advanced PC 
survivors regarding their unmet SC needs.12,13 
A preliminary integrative review revealed a significant lack of SC interventions for advanced 
disease PC survivors. This finding is supported by recent studies in which 33% - 81% of the surveyed 
survivors reported inadequate SC care despite guidelines recommending survivorship care for all PC 
survivors.5,10 Given the magnitude of the problem, it is essential to develop and implement holistic, 
cost-effective, patient-centered SC interventions that maximize the QOL of advanced disease PC 
survivors. However, a critical first step is to examine this population’s existing unmet SC needs, any 
additional difficulties faced during crisis such as the 2020 COVID-19 pandemic. Also, it is important 
to evaluate the feasibility of the research methodology used to measure unmet needs and QOL in this 
population (recruitment, enrollment, and data collection methods).7,8,11,15,18-20 The rationale for 
conducting this study with advanced disease survivors solely is that they face different, and often 
underestimated and underreported, unmet SC needs than survivors at earlier stages.12,13,21 If 
demonstrated to be feasible, the study’s methodology can provide a more comprehensive picture of 
the needs in this subset of survivors and contribute as empirical evidence for optimizing their overall 
cancer survivorship care. 
The purpose of this convergent parallel mixed-methods study is to conduct a supportive care 
unmet needs assessment in advanced disease prostate cancer survivors through the lens of 
Fitch’s Supportive Care Needs for Cancer Care Framework (SCNCCF) while assessing the 
feasibility of the research methodology. The overarching research question that guides the study is: 
"What are the unmet supportive care needs in advanced disease prostate cancer survivors, and 
how do they relate to the quality of life and disease stage? 
The specific aims are as follows: 
Aim # 1: To characterize unmet supportive care needs and QOL in advanced disease PC survivors 
using a nationally administered survey. 
a. Determine the prevalence of unmet needs according to the different SCNCCF domains. 
b. Examine the relationship between SC unmet needs and QOL as well as analyze differences in 
SC unmet needs by age, race/ethnicity, insurance status, marital status, time since diagnosis, 
treatments, stage, and confinement for COVID-19. 
Hypotheses include: (1) QOL will be negatively correlated to the prevalence of SC unmet needs, and 
(2) SC unmet needs will be higher in those with more advanced disease stage. 
Aim #2: To explore the implications of physical, emotional, social, psychological, spiritual, 
informational, psychological, and practical needs in advanced disease PC survivors’ quality of life. 
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a. Conduct key-informant, semi-structured interviews with a small subset of advanced disease 
PC survivors. 
b. Perform interviews deductive-inductive content analysis to identify common themes per 
SCNCCF domains. 
Aim # 3: To identify advanced disease PC survivors’ unmet SC needs by synthesizing survey and 
interview findings. 
Secondary Aim: To evaluate the feasibility of the research methodology in assessing advanced PC 
survivors’ unmet SC needs for future applicability in similar clinical problems and populations 
(participant recruitment, enrollment, and consenting strategies as well as the data collection methods - 
survey and interview). 
 
Impact 
The results of this study may provide valuable understanding of the unique unmet SC needs of an 
understudied population that has been “suffering in silence” the devitalizing effects of cancer, and the 
prolonged treatments they complete.20,22 Moreover, the findings will highlight the feasibility of future 
research utilizing mixed-methods designs and will inform the development of culturally appropriate, 
patient-centered, comprehensive SC strategies aimed to improve the QOL of this vulnerable and 
progressively growing population. 
 
A. Significance 
A.1. There is limited holistic needs assessment research for advanced-stage prostate cancer 
survivors. 
PC is the leading cause of cancer death in American men.23 Although the total yearly incidence 
rate has progressively fallen due to improvements in screening and curative treatments, it is projected 
that the burden of advanced PC will steadily increase in the upcoming years, particularly in younger 
men (≤ 69 years).24,25 It has been well documented that advanced disease PC survivors suffer from a 
vast array of SC needs as they live with this chronic illness for the remainder of their lives 7,12,14 The 
available various therapeutic modalities are critical to them for staying alive but are often associated 
with profound and long-term side effects.8,9,13,18,20 Past needs assessment studies done with advanced 
stage PC survivors have focused primarily on physical and informational needs.18,19,21 However, many 
suffer disproportionately from multiple overlapping SC needs that significantly diminish overall QOL 
and impact health outcomes negatively. Since up to 30% of all PC patients will eventually progress 
into advanced disease, it is essential to address this gap by conducting further holistic SC needs 
assessment research to improve these survivors’ QOL.8,21 The proposed study may provide significant 
insight into the prevalence and type of specific SC needs in advanced disease PC survivors, which are 
not being met within the current U.S. health care system. This insight is vital to improving their SC 
throughout survivorship until the end of life, particularly at times of need such as during the 2020 
COVID-19 pandemic or other potential future public health crises.16  
 
A.2. Failure to address traditional male roles may prevent optimal supportive care. 
 An extensive body of evidence indicates that PC is a threat to masculinity.26,27,28 This is 
particularly true in men who hold traditional male role identities. One study highlighted that sexual 
dysfunction, urinary incontinence, and the emasculating way in which these issues are discussed in 
media and support forums can be particularly threatening and emotionally debilitating for many 
men.26 This fact and other individual barriers - such as the need for control, self-blame, a more 
restricted emotional response, personal perception of the disease, and embarrassment - may hinder the 
verbalization of their unmet SC needs. Subsequently, there prompt SC may be delayed, leading to a 
negative impact on the QOL and the morbidities associated with more advanced stages of the 
disease.27,28 These unmet needs remain largely unknown and unmanaged by healthcare providers. 
Therefore, this study will examine the prevalence and type of unmet SC needs of this population, so 
that holistic, patient-centered SC interventions that respect culturally accepted masculine roles can be 
better informed and developed. These interventions may promote higher engagement and potentially 




A3. Current guidelines recommend holistic and continuous supportive care throughout 
survivorship. 
The Institute of Medicine (IOM), the American Society of Clinical Oncology (ASCO) and the 
American Cancer Society (ACS) recommend uninterrupted individualized SC across healthcare 
delivery settings for PC cancer survivors, including during times of global health pandemics.29,30 
However, the implementation of this SC varies widely across health systems partially due to needs 
remaining unknown and the differences in screening and care between advanced and localized stages. 
As a result, advanced disease PC survivors continue to suffer in silence from a considerable number 
of unmet needs, may not receive the recommended care they require, and many times die from these 
and other long-term effects of the various cancer therapies.29,31 Recent evidence indicates that up to 
52.9% of PC survivors suffer from unmet emotional needs, 47.1% from physical needs, 23.5% from 
practical and spiritual needs, and 11.8% from social needs.29 
Supportive care focuses on person-centered interventions to manage symptoms, improve coping, 
optimize decision-making, and minimize impairments in overall functioning.31,32 This study is 
significant as it can be a first step to advancing knowledge that can inform the development of more 
comprehensive, cost-effective, patient-centered SC interventions that lessen the economic burden of 
cancer care on healthcare systems, while still providing holistic, individualized care.31 Given current 
recommendations and guidelines for cancer survivorship care, and the increasing survival rates of 
patients with advanced disease, SC should become a standard to optimize QOL in this population. 
 
A4. Unmet needs may be related to poorer quality of life. 
Several past studies on PC survivors have investigated the relationship between QOL and specific 
socio-demographic and clinical characteristics such as race/ethnicity, stage of the disease, 
comorbidities, and time since the initial diagnosis. Results from those studies suggest a significant 
relationship between lower QOL and the Black race.16 QOL also decreased -as time since diagnosis or 
number of comorbidities increased, or as more advanced stage was reached.12,16,33 However, the 
relationship between unmet SC needs and QOL in advanced disease PC survivors has not been 
determined. Some evidence reports that the prevalence of unmet needs increases as age and time since 
diagnosis increases.33,34 Further research is needed to validate the hypothesis that QOL in advanced 
PC survivors varies depending on the prevalence and type of unmet SC needs. This information will 
be valuable in developing and implementing SC interventions more efficiently. 
 
B. Innovation 
This study is innovative in several ways. First, it will be conducted with all types of advanced 
disease PC survivors solely (III, IV, recurrent). Past needs assessment research has combined PC 
survivors in all stages of the illness or has been limited to advanced disease patients receiving a 
specific treatment (e.g., androgen-deprivation therapy, chemotherapy).7,10,31 Second, only a handful of 
studies have examined the prevalence of a comprehensive set of unmet S0C needs in this subset of PC 
survivors. However, the relationship between unmet needs and QOL and socio-demographic and 
clinical variables have not been explicitly investigated, warranting further exploration. It is 
hypothesized that higher unmet SC needs will be associated with worse QOL and higher disease 
stage, for example. Results from this study may provide a more comprehensive perspective of the 
types of unmet SC needs experienced in PC and how they relate to QOL and several socio-
demographic and clinical variables, so that future development of more specific, patient-centered, SC 
interventions can be better informed. Third, the study will be guided by the SCNCCF. This 
framework has been proven suitable for investigating unmet needs with other conditions such as 
ovarian cancer or a sample of advanced cancer patients undergoing radiation for symptom control.35,36 
However, it has never guided a mixed-methods study conducted with adult PC cancer survivors. 
Fourth, as mentioned above, this study is the first to investigate unmet SC needs in advanced disease 
PC survivors using a mixed-methods approach with a large sample. To the best of our knowledge, 
only one study has used this methodology but with a small sample of 31 survivors.12 
 
C. Diversity and Social Determinants of Health 
We will recruit a sample of advanced disease PC survivors who are diverse in terms of 
race/ethnicity, age, disease stage, treatments, time since diagnosis, level of education, marital status, 
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geographical location to capture the perspective of potentially neglected populations. Statistics show 
that both the overall incidence of advanced PC and the death rate from the illness are higher in Blacks 
and Asian Americans/Pacific Islanders than in all other races/ethnicities.37-39 This trend also holds true 
for increased age. Prior research has shown that minority race and lower socioeconomic status are 
associated with increased unmet SC needs and lower QOL in advanced PC cancer, partially due to the 
influence of masculinity and cancer stigma.32 Additional studies also showed that stage, clinical 
treatment, and time since diagnosis usually lead to some common and some very distinct unmet SC 
needs in this population.13 All of this evidence emphasizes the need for a deeper exploration of the 
unmet SC needs in a diverse sample of advanced PC survivors. The results of this study will 
complement previous research adding a level of insight by addressing person-level factors such as 
age, race/ethnicity, or stage and social determinants of health such as geography. Gender diversity is 
not achievable because of the male-specific nature of the illness.40  
 
D. Guiding Theoretical Framework 
This mixed-methods study will use the SCNCCF as the guiding theoretical framework (Appendix 
A).41 The SCNCCF outlines a comprehensive taxonomy of seven domains, which include physical, 
psychological, emotional, informational, social, spiritual, and practical needs. It was developed by Dr. 
Margaret Fitch as a tool to assist clinicians in meeting the overlapping complex SC needs of cancer 
patients throughout the various stages of the illness, including survivorship. The SCNCCF is 
appropriate for this research because it has been used successfully in previous needs assessment 
studies with various types of cancer survivors.35,36 The SCNCCF will be employed in the current 
study for several purposes. During the preliminary integrative review (IR), it was used to identify 
interventions targeting one or several needs domains (physical and informational) as well as the 
domains that have been historically neglected in interventional research (spiritual). It has helped 
identify a validated instrument to measure the SC needs of advanced disease PC survivors due to the 
similarities between the framework, and the Supportive Care Needs Survey (SCNS) domains (Aim 
1).32 It will help inform the development of the qualitative interview guide because of its holistic view 
of SC for cancer (Aim 2).32,42-44 Finally, it will guide the categorization and interpretation of the 
findings, identifying needs across domains that are particularly prevalent and can impact these 
survivors’ QOL negatively and ultimately, their health outcomes (Aim 3).29,32,38 
 
E. Approach 
E.1. Preliminary work 
The PI conducted an IR previously on SC interventions with reported outcomes for advanced 
disease PC survivors. Guided by the domains of the SCNCCF, the review showed that SC 
interventions are limited, often representing the physical and informational domains only, despite the 
high prevalence of overlapping unmet needs in this population and current survivorship care 
guidelines and recommendations. SC interventions have the potential to improve the QOL and health 
outcomes of advanced disease PC survivors. However, advanced PC survivors should be recruited to 
help inform the development of holistic, patient-centered, multi-domain SC interventions. 
 
E.2. Interprofessional Team 
The research team for this mixed-methods study includes a vast array of complementary expertise. 
Mrs. Alejandra Schimmel is the primary investigator (PI) and has expertise in urological surgical 
oncology. She has worked with multidisciplinary teams for over 10 years. Dr. Qanungo is the 
committee Chair and brings unique expertise in both cancer research and overall research 
methodology. She has investigated physical, emotional, and psychosocial needs in diverse 
communities, both locally and globally. Dr. Newman brings extensive expertise in qualitative 
research methodology and has extensively investigated quality of life-related issues in patients with 
several chronic conditions. Dr. Sterba is a behavioral scientist whose work in cancer survivorship care 
and QOL has been widely recognized. Dr. Mueller is an advanced nurse expert in conducting 
complex biostatistical analyses; she will provide statistical support for the study. 
 
E.3. Design Overview 
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This study will employ a convergent parallel mixed-methods design guided by the SCNCCF. This 
design aims at obtaining a more in-depth understanding of the unmet SC needs of advanced disease 
PC survivors, as well as the relationship of these with QOL, disease stage, and several other socio-
demographic and clinical variables, by collecting and analyzing two independent sets of 
complementary data concurrently (quantitative and qualitative). Equal priority and importance will be 
given to both methods in addressing the research question.45 The quantitative data collection will be 
done at a national level, and it will include a survey specifically developed to measure the perceptions 
of unmet SC needs and QOL. The qualitative data collection will focus on the survivors’ perceptions 
of unmet SC needs and QOL through key-informant semi-structured interviews. Deductive-inductive 
content analysis (coding) of the interviews will then be performed using the SCNCCF as a guide to 
identify and quantify common themes.45-47  The merging and integration of the two sets of results will 
occur during the combined interpretation of the findings. This integration will allow a well-rounded 
new interpretation about the prevalence and type of unmet SC needs, so future development and 
implementation of comprehensive, holistic, patient-centered, guideline-based, and culturally 
appropriate SC interventions can be better informed.45 Due to the current COVID-19 extraordinary 
circumstances, all recruitment and data collection efforts will be performed remotely. 
 
E.4. Mixed-Methods Methodology 
The three study aims, and the secondary aim, are presented individually below. 
 
Aim #1: To characterize unmet supportive care needs and QOL in advanced disease PC 
survivors using a nationally administered survey. 
We will administer a cross-sectional online survey nationally using REDCap (Research Electronic 
Capture Data) with the goal of collecting quantitative data from 200 participants who have advanced 
disease PC over 3 months. The survey will include a cover page with relevant study information, the 
PI’s contact for questions, and a screening questionnaire with 5 questions. The survey will include a 
brief sociodemographic and clinical questionnaire and several validated instruments aimed to capture 
unmet needs and QOL in cancer populations. A descriptive, correlational design will be used to 
measure the participants’ perception of the prevalence and type of unmet SC needs according to the 
domains of the SCNCCF. We will also examine the relationship between unmet SC needs and QOL, 
as well as age, race, ethnicity, insurance status, marital status, time since diagnosis, disease stage, 
treatments, and time confined for COVID-19. Although not suitable to establish a causal relationship, 
this approach may give a better understanding of the underlying mechanisms accounting for the 
possible relationship between the study variables.48  
 
E.5. Setting 
After securing approval from both, the MUSC Hollings Cancer Center Protocol Review Committee 
(PRC) and the Institutional Review Board (IRB), participants for the survey will be recruited from 
several settings: 
• MUSC urological clinics including Hollings Center Clinics. MUSC is one of the most 
recognized centers for urological services nationally. It possesses the most modern 
diagnostic, staging, and multi-modal therapeutic capabilities for PC, providing 
comprehensive care to more than 2000 PC patients currently.49  
• Online research volunteer websites such as Research Match (RM). 
• Online PC support groups and organizations including but not limited to American Cancer 
Society (ACS), Prostate Cancer International (PCI), Prostate Cancer Research Institute, 
Cancer Support Network (CSN), The Reluctant Brotherhood, The South Carolina Cancer 
Alliance (SCCA), and YANA.  
• Online Social Media advertisement (Facebook, Instagram) 
 
E.6. Sample Population and Eligibility 
The PI will use a convenience, non-probability sampling strategy to recruit participants. This 
sampling approach, which prioritizes accessibility and availability, is one of the most applicable and 
widely used methods in nursing clinical research.45,50 Inclusion criteria are having an advanced 
disease PC diagnosis (stages III, IV, recurrent); being 18+ years; being able to read, understand, and 
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speak English; and residing in the United States. Minors are excluded because it is extremely rare 
having a PC diagnosis during that stage of the lifespan. Exclusion criteria are being enrolled in 
palliative/hospice care and having a physical or mental impairment preventing from computer use to 
complete the survey (Appendix B).  
 
E.7. Sample size determination and Power Analysis 
A correct sample size is critical to ensure accurate conclusions and not lose study rigor.51 The 
sample size was determined using GPower version 3.1.9.6 to calculate the observable effect size 
(correlation here r=0.2, based on Alpha=0.05, Power=80% and an expected sample size of at least 200 




E.8.1. Recruitment and Retention Strategies 
The quantitative component will require a representative cohort of 200 socio-demographically diverse 
men who suffer from advanced PC. For MUSC-wide urological clinics, the PI will submit a SPARC 
Research Data Request, which will be performed via an Honest Broker, to assist with identification 
and recruitment of potential eligible participants with PC from MUSC medical records. Through the 
Honest Broker, the PI will gather the telephone number, and email of prospective participants who 
have agreed to be contacted for future research by logging their MUSC Research Permissions 
preferences in MyChart. All MUSC eligible participants who did not opt-out will be recruited by 
sending the secure link to the survey directly via email. For eligible potential participants who did not 
opt-out but did not have an email address listed on their chart, recruitment will be done by phone; the 
PI will verbally explain the study answering any questions and if interested, will ask for an email 
address to send them the secure survey link. For RM participants, an initial invitation will be sent 
through the RM electronic site, after the PI fills up a recruitment request. A de-identified “contact 
volunteers” page will be provided to the PI by RM with all potential participants. The PI will select 
diverse, potentially eligible participants to send them a contact message with the secure REDCap 
survey link. Potential participants through PC support groups and organizations will be recruited by 
posting an electronic flyer with or without the secure survey link (depending on the organization 
policies) on their social media sites (e.g., Facebook, Instagram), news web site, discussion forums, or 
invitations to meetings (Appendix C). If the potential participant contacts the PI, all relevant 
information about the study will be explained. Any questions will be answered and if the potential 
participant is interested, they will be asked to provide a valid email address so that the secure survey 
link can be sent.The opportunity to participate in the online survey will be also electronically 
disseminated through general and public advertising on various social media platforms and outlets 
(including  Facebook and Instagram). For all participants, no matter the setting, the survey will finish 
with an option to express interest in participating in the qualitative interview (Aim #2). Retention 
strategies to minimize attrition will include an electronic $10 gift card as compensation upon 
completion of the entire survey. The participants will be asked to provide an email address of their 
preference at the end of the survey so that the PI can send them the gift card. The PI will be 
responsible for funding and sending all the compensation electronic gift cards. 
E.8.2. Screening and Assignment of Participants 
The eligibility screening, regardless of the setting, will be determined solely on the inclusion and 
exclusion criteria. The screening will be performed via a screening questionnaire with 5 questions 
located on the survey cover page. The ones meeting the criteria will be assigned as participants 
enrolled in the study. For participants who do not meet the criteria, REDCap will take them to a 
screen that will thank them for their time, and they will automatically exit the survey.  
E.8.3. Informed Consent 
The PI will request a MUSC Hollings Center PRC since potential participants may be recruited 
from its urological clinics. The PI will also request a waiver of informed consent to the MUSC IRB 
under qualifying category 2, since no interventions will be performed during the proposed study. A 
statement of research will appear on the cover page of the survey, and it will include the study 
purpose, risks, as well as study aspects being measured, how long the survey should take to complete, 
and an assurance of confidentiality. Potential participants will also be informed that they are free to 
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exit the survey at any time and for any reason. To progress to the screening questions, they will need 
to check a box that indicates their agreement to participate.  
 
E.9. Data Safety and Management 
During the MUSC Research Data Request, the Honest Broker will provide the PI with the name, 
email, and phone number of potential participants who have agreed to be contacted for future research 
for recruitment purposes only. The data will be kept in a password protected MUSC server. 
Participant’s email address will be requested at the end of the survey so that the gift-card 
compensation can be sent. A telephone number will also be collected at the end of the survey, but 
only if the participant records their interest to be contacted for the qualitative interview (Aim #2). 
REDCap, provided through South Carolina Translational Research (SCTR), will be used to develop 
and store the survey following MUSC s’ data storage requirements. REDCap is a password-secure, 
web-based application created with the objective to support data capture for research.52 The PI will 
perform all the data management procedures (assessment of completeness and analysis). The 
participants’ identifying information (name/email/phone) will not be connected to any survey 
responses and will not be disclosed to any non-study or non-regulatory personnel. Each participant 
will be assigned a case number that will be referenced on all study procedures. The PI will be 
responsible for safeguarding the data (e.g., survey, SPSS files) throughout the study by monitoring the 
secure data storage daily and appropriately reporting any protocol deviation, including privacy 
breaches and conflicts of interest, to the IRB and the study team. The passwords for the access to the 
REDCap study database will be available to the PI, with rights assigned to the study team (for 
consultations regarding emerging results but not for editing the actual database). 
E.10. Data Collection 
E.10.1. Instruments 
Supportive Care Needs Survey-Short Form 34 (SCNS-SF34): The participants’ unmet SC needs will 
be measured with the SCNS-SF34. The SCNS-SF34 is a self-administered questionnaire that consists 
of 34 items mapped onto five domains: physical & daily living (5 items), health care & information 
(11 items), psychological (10 items), patient care & support (5 items), and sexual (3 items). 
Responses are scored on a five-point Likert scale dichotomized by need level to distinguish between 
those with “no current needs” (1-2), versus those with “some degree of need” (3-5). Scoring will be 
done by calculating a Likert summated scale: summing the individual items within each domain. The 
summated scale can be standardized by summing the individual items, subtracting m (the number of 
questions within a subscale), and then multiplying the resulting value by 100.32,42,53,54  This instrument 
has robust similarities with most relevant domains of the framework guiding this study and was 
originally created to obtain a direct index of cancer patients’ perception of their unmet SC needs.32,53,55 
Although the long and the short forms are recommended for use in assessing unmet needs in cancer 
patients, the second-generation core SF-34 survey has been recently created from the long-form after 
further psychometric development.53 The SCNS-SF34 has been successfully utilized in multiple 
studies with advanced cancer patients and has an excellent patient acceptance rate. Scores are reported 
standardized. The SCNS-SF34 possesses high internal reliability, internal consistency, and strong 
content validity.55  
SCNS PC Module: This module will be used to measure PC-specific unmet needs. It is self-
administered and applies to any PC disease stage, treatment modality and time since initial diagnosis. 
It consists of 7 additional items (with the same SCNS response set) assessing unmet needs associated 
with urinary and bowel functions, as well as masculine self-image.53 Scoring will be done the same 
way as the SCNS-SF34. 
Functional Assessment of Chronic Illness Therapy - Spiritual Well- Being (FACIT-Sp): The 
integrative review findings showed that the spiritual domain is as influential for this population as the 
other 6 domains, primarily as a coping resource. However, so far, this domain has been neglected in 
advanced cancer needs assessment questionnaires and interventional research. Since the SCNS-SF34 
does not include a spiritual domain, the PI will use the FACIT-Sp 12 questionnaire. The FACIT-Sp 12 
is a subscale of a longer questionnaire and it is the most widely used scale for spiritual well-being in 
patients with cancer.56 It contains 12 items with summary scores ranging from 0 to 48. The instrument 
identifies the items that must be reversed before being summed. Once reversed, all subscale items are 
 
 159 
summed to a total. A higher subscale score indicates greater spiritual well-being. This subscale has 
been validated across multiple cultures and has strong reliability.56,57  
European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire 
(EORTC QLQ-C30):  Participants’ health-related QOL, will be measured with the EORTC QLQ-
C30. The EORTC QLQ-C30 is an integrated system consisting of 30 items and intending to measure 
global health in patients who have cancer. It is composed of multi-item subscales and single-item 
measures. It includes 5 functional scales (physical, role, cognitive, emotional, social), 3 symptom 
scales (fatigue, pain, nausea & vomiting), a global health status (1 item) and a QOL (1 item) scale, 
and 6 single items for symptom measures. It uses a 4-point response set for all the items except for the 
health status and QOL scales, which are measured on a 7-point scale. Scores are calculated by scale or 
by item and transformed into a 0 to100 scale with higher summary scores representing higher QOL or 
higher level of symptomatology. The mean score, standard deviation, and range will be reported. The 
EORTC QLQ-C30 is considered an excellent instrument to measure QOL and has been widely 
employed in studies with different cancer populations, including PC.4,12,58                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
E.10.2. Data Collection 
The PI will collect quantitative data through a survey distributed electronically using REDCap. 
The actual survey will have two sections: first, a brief sociodemographic and clinical questionnaire, 
and then, several reliable and validated instruments (Appendix D). To adapt the instruments for this 
study, the PI made a minor change to the FACIT-Sp questionnaire, modifying its time frame from 7 
days to one month so that all the unmet needs findings are meaningful around the same specific 
timepoint.59 If possible, The PI will pretest the survey with 1-2 volunteers for clarity and flow. Data 
will be collected at a single point in time. To overcome commonly existing survey low response rates, 
participation  and completion will be encouraged by ensuring confidentiality, by reposting the 
advertisement on support groups and organizations sites every 2 weeks, by sending 3 friendly 
reminders to potential participants who did not complete the survey the first time (after 3, 6 weeks, 
and 9 weeks) and by offering compensation for their time.48,60 The survey will be available for 
potential participants for 3 months. Table 1 summarizes a description of the variables in this study, as 
well as the data sources for all the variables and the psychometric properties of all the instruments. 
The completion of the survey will take approximately 15-20 minutes. 
 
Table 1- Study variables and measures  
 
VARIABLE MEASURE PSYCHOMETRIC PROPERTIES 
Age, race, ethnicity, marital status, education 
level, employment status, insurance status 
 
Brief socio-demographic/clinical survey n/a 
PC stage at diagnosis, time since initial 
diagnosis, treatments received, current stage 
 
Brief socio-demographic/clinical survey n/a 
Quality of Life (subjective) - EORTC QLQ-C30 
 
- EORTC QLQ-C30: Cronbach’s α coefficients 
between .70 and .96.58 
 
Perceived Unmet Needs (subjective) - SCNS-SF34 
- SCNS PC module 
- FACIT-Sp 12 
- SCNS-SF34: Reliability coefficients Cronbach 
Alpha .86-.95 and internal validity coefficients .87-
.96 53 
- SCNS-PC: Preliminary evidence indicates 
internal consistency & reliability 53 
- FACIT-Sp 12: Cronbach’s α coefficient .87 57 
 
 
E.11. Data Analysis 
Rigorous data analysis in mixed-methods research involves several steps: 1) prepare the data for 
analysis, 2) explore the data, 3) analyze the data, 4) represent/display the data, 5) interpret the results, 
and 6) validate the data and results.45 The PI will prepare the quantitative data for analysis by 
exporting the data from REDCap into SPSS v26 software, by visually checking for errors in the 
database, and by recoding variables as appropriate. The exploration of the data will include creating 
frequency distributions to determine missing data and checking the amount and pattern of the missing 
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data, which is paramount to maintain the overall integrity of the research. If the missing data represent 
less than 5% of the entire data, SPSS will use listwise deletion by default.51,63 If missing data are 
between 5% and 30%, multiple imputation (MI) will be performed using SPSS so that participants are 
not lost due to SPSS deletion. MI uses available data to predict respondents’ missing values, given 
their observed values on other variables. This procedure has been demonstrated to yield the best 
estimations of missing data. Its benefits include no loss in statistical power and maintenance of 
internal and external validity against biases resulting from nonresponse.51,63 If more than 30% of the 
data are missing, the variable will be deleted altogether. 
The PI will analyze the data using the SPSS v. 26 software package. Descriptive statistics will be 
used to summarize the sample characteristics – means and standard deviations for continuous 
variables and frequencies, proportions, and ranges for categorical variables – and the level of unmet 
needs – by reporting the prevalence (%, mean, standard deviation, range) per domain and individually 
per item, as well as the total score. 
The PI will also assess the frequency with which respondents reported each item as moderate/high 
need (at least 25% of the sample).34 Assuming normal distribution, a bivariate correlational analysis 
with Pearson’s r computation will be performed to determine the strength and direction of the linear 
relationship between each domain of unmet SC needs and QOL as well as between each domain of 
unmet needs and several socio-demographic and clinical variables (age, race/ethnicity, marital status, 
insurance status, stage, time since diagnosis, treatments received, and confinement time for COVID-
19). If data are non-normally distributed but the sample is large (above 20), type I and II errors will be 
minimized by calculating non-parametric Spearman s’rank-order instead. 51 The PI will also conduct 
appropriate statistical analyses to compare socio-demographic (age, race/ethnicity, insurance status, 
marital status, confinement time), and clinical characteristics (disease stage, years since diagnosis, 
treatments received) by SC unmet needs domain. In addition, the PI will perform a series 
of regression analyses to examine whether unmet SC needs can be predicted by age, stage, treatment 
received, years since diagnosis, race/ethnicity, insurance status, marital status, and confinement time. 
Also, linear regression will be conducted to investigate if QOL is predicted by SC unmet needs. The 
results of both, the descriptive statistics and the inferential statistical tests, will be represented using 
tables and graphs for a better visualization. The results of the tests will be compared and contrasted 
with the two Aim 1 hypotheses and interpreted with reference to prior studies from the literature, 
considering the limitations of the proposed study. Data validation will rely on the already established 
construct validity and reliability of all the instruments used during the data collection.45,51  
 
Aim #2: To explore the implications of physical, emotional, social, psychological, spiritual, 
informational, psychological, and practical needs in advanced disease PC survivors’ quality of 
life. 
This component will follow a qualitative descriptive methodology and involves a separate brief 
socio-demographic and clinical questionnaire and an individual semi-structured key-informant 
interview conducted via telephone or Doxy.me, a secure telehealth platform that uses encryption 
protocols ensuring data integrity and privacy. Doxy.me is free, user-friendly, and HIPAA compliant 
platform that enables real-time audio-visual communication.64  Qualitative description is the optimal 
methodology as the proposed study has a mixed methods design and it seeks information to 




The participants will be recruited from several settings. All of the participants enrolled in the 
quantitative component of the study (Aim #1) will be invited to participate in the qualitative 
component (Aim #2). In addition, the online PC support groups and organizations will advertise the 
study via flyer as described in Aim #1 for both, the survey and /or the qualitative interview. For this 
qualitative portion, the PI will solely interview PC survivors who suffer from advanced disease PC 
(stages III, IV, recurrent). 
 
E.13. Sample and Eligibility 
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To ensure a diverse representation of all PC advanced stages, ages, and races/ethnicities, the PI 
will use a purposive sampling plan. The PI will select and recruit up to 30 participants until data 
saturation - no new information from the participants’ interviews - is achieved.65 The primary 
inclusion criteria will be advanced disease PC (stages III, IV, recurrent); being +18 years; being able 
to read, speak, and understand English; and residing in the United States. Exclusion criteria will 
include being enrolled in palliative/hospice care and having a physical or mental impairment that 
prevents telephone or computer use (Appendix B). 
 
E.14. Procedures 
E.14.1. Recruitment and Retention Strategies 
The PI will select and contact a diverse sample of enrolled participants who have completed the 
survey (Aim #1) and who have provided a phone number. Participants will also be recruited via flyer 
from online support groups and organizations, until data saturation is achieved. The PI will schedule 
the key-informant interview at a day/time of the potential participant’s choice, either via telephone or 
electronically (Doxy.me). The PI will maintain a recruitment log to track all participants who were 
selected, contacted, recruited, screened, and enrolled for the interview.  
Retention strategies will include scheduling the interview at a day/time of the participant’s choice. 
Interviews will be held by telephone or Doxy.me based on availability and participant’s preference. 
Attrition will be minimized by obtaining additional contact information during the first contact (a 
family member or friend), by offering a $20 electronic Amazon gift card as compensation upon 
completion of the socio-demographic questionnaire and interview, and by sending an electronic 
thank-you card as a way to leave a more long-term positive effect.66 The PI will request an email 
address of their preference at the end of the interview so that the gift-card compensation and the 
electronic thank-you card can be sent. The PI will be responsible for funding and deliver all the 
electronic gift cards and the thank-you cards. 
E.14.2. Screening and Assignment of Participants 
Eligibility screening will vary according to the recruitment setting. For the participants enrolled 
via quantitative survey, the PI will explain the study purpose and risks involved and answer any 
questions during the initial contact. Once the potential participant expresses interest in participating in 
the interview, the PI will screen for eligibility based on the inclusion/exclusion criteria by asking the 
same 5 screening questions than on the survey. If agreed, the participant will be enrolled in the 
qualitative part of the study. For potential participants who contact the PI via electronic flyer through 
support groups and organizations, the PI will explain all the pertinent aspects of the study (purpose, 
risks, confidentiality) and answer any questions during that first contact. If interested, the PI will 
screen them for eligibility based on the inclusion/exclusion criteria by asking the 5 same screening 
questions. If the criteria are met, the PI will enroll the potential participant for the semi-structured 
interview. 
E.14.3. Informed Consent 
The PI will secure a PRC from the Hollings Center and a waiver of informed consent under 
qualifying categories 2 for both aims since no interventions will be performed. Regardless of the 
interview method, prior to start, the PI will provide a statement of research to inform the enrolled 
participants about all pertinent aspects of the study, including risks, benefits, special protections, 
audio recording, and assurance of confidentiality. The PI will answer all of their questions. The PI 
will also inform them how long the interview will take to complete and that they can take a break or 
withdraw from the interview altogether at any time and for any reason. The participant will have to 
provide verbal consent to continue with the interview. 
 
E.15. Data Safety 
The PI will perform all the data management procedures. The participant’s name will be collected 
during the interview for addressing purposes only. The participants’ telephone and email will be 
collected during the recruitment for eligibility screening, and interview scheduling purposes. 
However, all identifiable information used prior and during the interview will not be connected to any 
data on the interview transcripts or the brief socio-demographic and clinical questionnaire files. The 
brief socio-demographic survey will be computer-based and will be uploaded securely into a 
password protected REDCap database according to MUSC storage requirements. Interview audio 
 
 162 
recordings will be transcribed for analysis using Rev.com (MUSC-approved), and then, uploaded, de-
identified, to a password-protected MUSC Box storage folder to maintain participants’ 
confidentiality. Afterwards the hard copies of the recordings will be erased from the portable device. 
The recruitment log and the reflective journal notes (de-identified) will be uploaded into password-
protected secure Box files. Each participant’s transcription will be assigned a case number to be 
referenced on all study procedures. Data safeguarding and passwords handling are described above on 
E.9. 
 
E.16. Data Collection 
Up to 30 semi-structured, in-depth, one-time interviews will be performed over 3 months to 
explore the implications of physical, emotional, social, psychological, spiritual, informational, and 
practical needs in advanced PC survivors’ QOL. The interviews will take place via telephone or 
Doxy.me. The interviews will be scheduled at a day/time that is convenient to the participants. Before 
the interview, the PI may ask every participant to complete a separate brief demographic and clinical 
questionnaire, which will include race/ethnicity, age, education level, marital status, employment 
status, insurance status, PC stage at the time of diagnosis and currently, time since the initial 
diagnosis, treatments received, and some COVID-19-related questions. The PI developed an interview 
guide informed by the literature and guided by the SCNCCF with the objective to capture the seven 
domains of needs (Appendix E). Two open-ended, non-directive questions will encourage 
participant’s free expression regarding life with PC and current needs. The remaining guided 
questions will allow participants to elaborate on what is relevant to them about their current unmet 
needs, including any existing differences during COVID-19 pandemic, and care planning based on the 
7 domains of the framework. The PI will use probes throughout the interview to elicit clarifications 
and/or additional explanations or to redirect the participant.45,67 Notes on a reflective journal will also 
be taken to describe the PI’s impressions and feelings about the interview. The interview will take 
between 45-60 minutes to complete. All interviews will be audio-recorded with an external portable 
recorder and transcribed using a professional MUSC-approved transcription service (Rev.com). The 
transcripts will be de-identified, uploaded into a secure folder in Box, and entered into NVivo12 data 
analysis software for coding and analysis. 
 
E.17. Data Analysis 
E.17.1. Demographic characteristics 
The socio-demographic and clinical data collected via the brief survey will be stored securely in 
REDCap and analyzed using the NVivo12 software. The PI will use descriptive statistics to analyze 
and present the sample characteristics. Measures of central tendency (mean & standard deviation), 
frequencies, and measures of dispersion (range) will be reported for all the participants’ demographic 
and clinical variables. 
E.17.2. Analysis of the survivors’ interview 
The unit of analysis will be the interview. After each interview is transcribed using Rev.com, the 
PI will perform a comparison between the transcript and the original audio-recording to ensure 
content accuracy. Qualitative deductive-inductive content analysis will be conducted as soon as 
possible after the interview using NVivo12 qualitative data analysis software to provide a rich account 
of the data collected during the interviews.68,69  Commonly used in nursing research, deductive-
inductive content analysis aims at both, quantifying and describing the phenomenon under 
investigation so that new insight or knowledge can be established.70,71  For each interview, the PI will 
use the following analytic strategies: (1) read the transcript, (2) deductively-inductively code the data 
until common themes related to unmet SC needs emerge, (3) consider the emergent needs within the 
domains of the SCNCCF, (4) look for commonalities and differences among the data and the codes, 
(5) determine on common themes generated from the data/codes, (6) use the analysis of each 
interview to inform subsequent interviews, by adding questions to the interview guide based on the 
data collected/analyzed from prior interviews.45,70,71 The PI will follow an iterative comparative 
method throughout the entire data collection and analysis period until data saturation is achieved. The 
PI will keep a codebook with coding schemes and definitions as part of the study audit trail. The 
outcome of the qualitative component of the study will include a descriptive summary of the data 
contents organized according to the SCNCCF domains of needs. The representation of the qualitative 
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data analysis results will include a thematic description of the examples of participants’ vivid quotes 
for each of the emerging theme categories. 
 
Aim # 3: To identify advanced disease PC survivors’ unmet SC needs by merging and 
synthesizing survey and interview findings. 
E.18. Overview 
 In Aim 3, the results from the surveys (Aim 1) and the semi-structured interviews (Aim 2) will be 
merged for analysis. Both strands of data will be given equal emphasis. The goal is to compare both 
quantitative and qualitative data to find similarities, differences, and/or inconsistencies (Figure 1).45 
The PI expects to identify the prevalence and type of unmet SC needs in advanced disease PC 
survivors, to determine a correlation between those needs and QOL/disease stage, and how some 
socio-demographic and clinical characteristics may affect or predict SC unmet needs so that future 
research and development of holistic, patient-centered SC interventions can be informed.  
 






          
 





E.19. Data Analysis 
  
The data from Aims 1 (quantitative) and 2 (qualitative) will be collected concurrently but analyzed 
independently. Merging and integration of both threads of results will occur in a separate, subsequent 
step. The PI will review and  synthesize both sets of results to compare and contrast emerging themes 
and understand mechanisms underlying unmet needs experiences, which will be organized according 
to the domains of the SCNCCF. For example, a SC need that appears disparately burdensome seen 
during an interview will be compared/looked for evidence in the quantitative data and vice versa.45,68 
A joint display will be created to assist with the interpretation of the results – focusing on the extent to 
which both sets of results produce a more comprehensive understanding of the prevalence and type of 
unmet SC needs in advanced disease PC survivors.45  
 
Secondary Aim: To evaluate the feasibility of the research methodology in assessing advanced 
PC survivors’ SC unmet needs for future applicability in similar clinical problems and 
populations (participant recruitment, enrollment, and consenting strategies as well as the data 
collection methods - survey and interview).  
E.20. Overview 
 To the best of our knowledge, the SC unmet needs of advanced disease PC survivors have not 
been examined using a mixed-methods design with a large sample. Several sources of data will be 
used to measure and evaluate the preliminary feasibility of the research methodology in assessing the 
unmet SC needs of this population. The feasibility components and quantifications for are displayed 
in Table 1. These quantifications will be measured for both, the quantitative and qualitative 
components using logs. 
 
Table 1. Feasibility components/Quantification measures 
 
 Study component Feasibility quantification 
Recruitment plan & procedures Recruitment (survey & interview) Number of participants sent the survey/ contacted the PI or 
by the PI 
Quantitative data 
collection & analysis 
Qualitative data 










 Attempts to contact / reminders (survey & 
interview) 
Number of attempts necessary more than initial 
 Approaching (survey & interview) Number of participants being informed about study 
 Screening (survey & interview) Number of eligible & ineligible participants  
 Response (survey & interview) Response rate  
Data collection procedures Completion rate Number of surveys/interviews with complete data & 
reasons for not completion 
 Psychometric properties (survey only) Established reliability & convergent validity coefficients 
 Reliability of questionnaires (survey only) Calculation of Cronbach Alpha for existing sample 
 COVID-19 response Number respondents shared COVID-19 info versus PC info 
 
E.21. Data Collection 
Data collection on the recruitment and procedures will be an iterative process and will last 3 
months. As potential participants for Aims 1 and 2 are approached, contacted, recruited, screened, and 
enrolled, entries will be recorded on logs (for the quantitative and qualitative aims). As surveys are 
received or interviews are conducted, the data (response and completion) will also be recorded on the 
same logs, which will be securely stored in Box. The psychometric properties of the instruments will 
be obtained from the literature and recorded on the log as well. The PI will calculate the reliability 
coefficient Cronbach's alpha to determine the suitability of the questionnaires for this specific sample. 
 
E.22. Data Analysis and Reporting 
The feasibility outcomes, their definition, and the results will be represented as a table or figures 
for a better visualization. All the rates will be calculated and reported as amounts and percentages. 
The PI will also provide a 95% confidence interval (CI) for means for all continuous feasibility 
outcomes. 
 
E. 23. Potential Problems and Alternate Approaches 
The study faces several challenges: convenience and purposive sampling plans, unequal 
quantitative and qualitative sample sizes, participants’ fatigue/boredom, erroneous data, recall bias 
(inability to recall properly due to a prolonged illness pathway) , social desirability response bias 
(responses to survey and/or interview questions are intended to please the study team), failure to 
resolve conflicting results, and study rigor.71,72 To minimize these challenges, the PI’s recruitment 
plans include several and varied settings to add diversity. The PI has secured support from several PC 
support groups and organizations gatekeepers to advertise the electronic study flyer on their sites. The 
survey and the interview are designed to be completed in the least amount of time to prevent fatigue 
or boredom from happening. Erroneous data will be overcome by exploring the data carefully and 
implementing the appropriate strategies as needed (e.g., deletion). The social desirability response 
bias will be mitigated by establishing appropriate rapport with the participants, educating them about 
the importance to respond to all the questions honestly, by emphasizing that there are no right/wrong 
responses, and by ensuring them that all the responses will be treated confidentially.71 To overcome 
recall bias, the interviews will be scheduled as soon as possible after the recruitment and with the 
participants preferences in mind (method, day, time). The PI will also engage in strategies to explain 
and represent potentially conflicting results from both components.45  
Quantitative rigor will be maintained by recruiting a diverse sample of participants, by reaching 
the sample size target, by applying sound statistical processes, and by using previously validated 
instruments to collect the data. Qualitative study rigor will be maintained in several ways. The PI will 
ensure trustworthiness through credibility, dependability, confirmability, and transferability. 
Credibility will be established by the statement of research conducted before the interview to create 
rapport and by conducting several levels of data coding. Dependability and confirmability will be 
achieved through an audit trail of data collection and analysis procedures, description of the sample 
characteristics, and the inclusion of direct quotations as evidence of the raw data collected. 
Transferability will be ensured by applying the sampling strategy, and by providing sufficient details 
regarding the data collection process, so that replicability can be achieved.48,65,67 
 




Table 1. Study timeline 
Study Objectives 
 
Anticipated Time of Completion 
Secure PRC approval 4/2020-5/2020 
Secure IRB approval 5/2020-6/2020 
Participant recruitment 6/2020-9/2020 
Data collection 7/2020-9/2020 
Data analysis 7/2020-9/2020 
Manuscript preparation 9/2020-10/2020 
Submission of entire compendium 10/2020-11/2020 
 
 
F. Human Subjects 
F.1. Risks to the Subjects 
 
a. Human Subjects Involvement and Characteristics 
 
There will be 200 study participants for Aim #1 who will be recruited from MUSC urological clinics, 
RM, several online support groups and organizations as well through general and public advertising 
on various social media platforms and outlets (including  Facebook and Instagram). Eligibility 
screening will be performed via the 5 questions on the survey cover page. To ensure diversity, the 
sample will include various adult ages, races/ethnicities, disease stages, current treatments, time since 
diagnosis, level of education, marital status, and national locations. A preliminary feasibility report 
done at MUSC urological clinics in February 2020 determined that there were 2,490 potentially 
eligible participants, with ages ranging from 36 to 90 years. The races were distributed as 57% White, 
40% Black, and 3% unknown. Ethnicity was 96% non-Hispanic (Appendix F). We anticipate 
recruiting a sample with similar sociodemographic characteristics.  
For Aim #2, all of the participants enrolled for Aim #1 will be invited to participate in the 
qualitative component (Aim #2). Additionally, study participants will be recruited from online support 
groups/organizations. A purposeful sampling approach will be used to select and recruit a diverse 
sample with regard to age, race/ethnicity, and advanced stage. The PI will attempt to recruit up to 30 
participants for semi-structured interviews until data saturation is achieved. The interviews will be 
conducted via telephone or Doxy.me according to the participant’s preference and availability. We 
will request a PRC to the Hollings Center and an exemption of the informed consent based on 
qualifying category 2 to the MUSC IRB prior to sending any survey or conducting any interview. 
 
b. Sources of Materials 
 
The PI will collect potential participants’ name, email, and telephone from the SPARC Research Data 
Request (conducted by an Honest Broker service) if they have indicated on MyChart that they would 
like to be contacted for future research. The only sources of data obtained from human subjects are 
described in the above research protocol. These include: 
• Sociodemographic and pertinent clinical data  
• Electronic data from survey information  
• Audio-recordings, transcriptions, and reflective journal notes from the qualitative 
interviews 
• A telephone number on the survey only if the respondent is interested in participating 
in the interview  
• A preference email address to send the electronic gift card and the thank-you cards 
• A name for addressing purposes during the interview 
 
This information will be stored in password protected MUSC servers REDCap and Box. All data 
will be used for research purposes only and the PI will make every effort possible to keep these data 
confidential. No identifiers will be connected to any survey or interview data. Neither will identifiers 
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be used in any publications resulting from this study. However, the survey and/or interviews 
transcripts data may be used in future studies and/or publications. 
 
c. Potential Risks 
 
The PI does not expect significant risks to human subjects related to the completion of the 
electronic survey and the semi-structured interviews. It is possible that collecting this information 
poses a minimal risk to confidentiality. There is also minimal risk that participants may experience 
emotional distress, boredom, or fatigue as they reflect on past experiences or as they answer a specific 
question or survey item. But the study poses no physical, social, or legal risks.  
To mitigate potential risks, the PI will provide participants with a statement of research with all the 
pertinent study information before the survey/interview. The PI also will conduct a debriefing session 
after the semi-structured interview. In case the debriefing fails to relieve any emotional distress that a 
participant experiences, the PI will arrange a referral to an available health care provider or an 
emergency room for further evaluation. All participants will be reminded that they can discontinue 
their participation in the study at any time and for any reason. In the event of a life-threatening 
emergency, the PI will call emergency services (911). 
 
F.2. Adequacy of Protections Against Risks 
 
a. Recruitment and Informed Consent 
 
Aim #1: For MUSC-wide urological clinics, the PI will submit a SPARC Research Data Request via 
an Honest Broker, to assist with the identification and recruitment of eligible participants (who have 
advanced prostate cancer diagnosis - stages III, IV, recurrent) from MUSC medical records. The 
Honest Broker will provide the PI with the name, telephone number, and email of prospective 
subjects who have agreed to be contacted for future research by logging their MUSC Research 
Permissions preferences in MyChart. These participants will be approached, recruited screened, and 
enrolled directly by sending the secure link to the REDCap survey via email. For MUSC eligible 
participants who did not opt-out but did not have an email address on file, approaching and 
recruitment will be done by phone; the PI will verbally explain the study answering any questions, 
and if interested, the PI will ask for an email address to send them the secure survey link. Screening 
and final enrollment will be done via the survey link. RM participants will be sent an initial invitation 
via electronic flyer through RM, after the PI fills up a recruitment request. RM will provide the PI 
with a de-identified “contact volunteers” page with all potential participants. The PI will select 
diverse, potentially eligible participants to send them a contact message with the secure REDCap 
survey link. Potential participants through PC support groups and organizations will be recruited by 
posting an electronic flyer with or without the secure survey link (depending on the organization 
policies) on their social media, news web site, discussion forums, or invitations to meetings, as 
described in E.8.1. If the potential participant contacts the PI, all study pertinent information will be 
explained, and any questions will be answered. If interested, a valid email address will be asked to 
send the secure survey link. The opportunity to participate in the online survey will be also 
electronically disseminated through general and public advertising on various social media platforms 
and outlets (including  Facebook and Instagram). Regardless of the setting, the survey participants 
will have the choice to indicate their willingness to participate in the qualitative semi-structured 
interview by selecting the option at the end of the survey. REDCap will notify the PI of all 
participants interested in doing the interview so that the PI can select them based on age, stage, and 
race/ethnicity diversity and contact them via telephone to screen for eligibility. Participants who 
complete the entire survey will receive an electronic $10 Target gift card as compensation. 
 
For Aim #2, participants will be invited to participate via the quantitative survey, which will 
provide a checkmark at the end as well as a space to submit a phone number for contact. Participants 
will also be recruited by electronic flyer via several online support groups and organizations. 
Regardless of the setting, all study pertinent information will be explained, and any questions will be 
answered during the initial telephone contact. If interested, screening will be conducted as described 
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in E.14.2., and the interview will be scheduled at a day/time of the participant’s choice via telephone 
or Doxy.me depending on availability and/or preference. Participants who complete the brief socio-
demographic and clinical questionnaire interview will receive an electronic $20 Amazon gift card as 
compensation for their time. 
 
The PI will request a PRC to the Hollings Cancer Center and a waiver of informed consent for the 
entire study to the MUSC IRB based on qualifying category 2, since the proposed study does not 
involve any interventions. On the survey, a cover page will serve as a written statement of research 
and it will include the study purpose, potential risks, the study aspects being measured, time that the 
interview will take to be completed, and an assurance of confidentiality. Participants will also be 
informed that they are free to exit the survey at any time without any reason. Respondents will need to 
check a box to agree to participate and continue on the survey (Appendix D).  
 
For the qualitative component, the PI will provide a verbal statement of research before the 
interview by informing the potential participants about all aspects of the study, including potential 
risks, special protections, topics discussed, time needed to complete the interview, and assurance of 
confidentiality. The PI will answer all of the questions and inform them that they can take a break or 
withdraw from the interview at any time and for any reason. The participant will need to provide 
verbal consent to participate All participants, from both, the survey and the interviews, will be 
provided with the PI telephone and email address in case they need to contact the PI at any time. 
The PI and all other study team members have completed the required human participants research 
training courses (e.g., Miami CITI) as well as the mandatory HIPAA training. A log will be kept in a 
password-protected Box folder and will include information regarding participant’s date of approach, 
recruitment, screening, enrollment, and survey/interview completion as well as the survey completion 
rate for analysis purposes of the secondary aim (feasibility).  
 
b. Protection Against Risk and Data Management  
 
The PI anticipates minimal risk of adverse events (AE) based on the study design and the absence 
of interventions and invasive procedures. However, if an AE occurs, the participant will be instructed 
to contact the PI immediately. Any AE or protocol deviation will be recorded and reported to the IRB 
as well as the study team members, following all MUSC institutional requirements and procedures. 
There are no anticipated physical, social, or legal risks from participating in the survey or the 
interviews.  
 
The PI will undertake every possible measure to ensure the safety of all study participants. Before 
the survey, participants will be instructed how to contact the PI and how to exit the survey if they feel 
fatigued, or do not want to continue answering the questions. The PI will provide breaks during the 
interviews to participants that feel fatigued or frustrated. The interview will also be rescheduled or 
interrupted if the participant feels that he cannot continue, with no consequences. All participants will 
be reassured that they do not have to answer to any question they do not want to answer. In the event 
of a study-related question illness or injury, participants will be instructed on how to contact the PI 
and how to access appropriate health care. The participants will be assured that taking part in this 
study will not interfere with the clinical care that they are receiving at MUSC or elsewhere. 
 
Several plans are in place to protect all participants’ data confidentiality. For the quantitative 
component, personal identifiers (name/email/phone number) will be collected from the Honest Broker 
and from the participants at the end of the survey, for recruitment, interview scheduling, and sending 
the gift card purposes only. The potential participant’s contact information (name/email/phone) will 
not be connected to any data on the survey and will be stored in password protected MUSC servers. 
Each participant will be assigned a unique case number that will be referenced on all study 
procedures. All the survey data will be stored in the secure password-protected REDCap database. 
The password to that database will be accessible only to the PI, with rights assigned to the study team 




For the semi-structured interviews, confidentiality will be assured by conducting the interview in a 
privately connected session via telephone or Doxy.me (from a private office). The interview transcript 
data will be de-identified for analysis. The PI may collect the email address and phone number of 
participants, but for recruitment and scheduling the interview purposes only. The contact information 
will not be connected to any data on the interview transcripts or the brief socio-demographic and 
clinical survey. Each transcript will be assigned a unique case number that will be referenced on all 
study procedures. The interview audio recordings will be uploaded and transcribed for analysis from a 
portable recorder into an MUSC-approved transcription service (Rev.com) after each interview 
session. The resulting transcripts will be de-identified and uploaded into a secure password-protected 
storage file in Box. Afterwards, the recordings will be erased from the portable device. The 
enrollment log and the reflective journal notes taken during the interview will be also confidential and 
will also be kept in a password-protected storage file in Box. The data from the brief 
sociodemographic and clinical survey will also be de-identified and kept in a REDCap database 
following all MUSC storage requirements. Access to the password-protected REDCap database and 
the Box storage files will be limited only to the PI, with rights assigned to the study team members for 
consultations regarding emerging results. To further ensure participants’ confidentiality, there will be 
no paper copies of any data. However, the digital audio recording transcripts will be stored in a secure 
database for a minimum of 6 years. 
 
The PI will perform all the data management procedures for both, the survey and the interview 
components, and will ensure that the study is being conducted following the written proposal. The PI 
and the study team will adopt all possible measures to ensure that any data and private personal 
information are not disclosed to anyone outside the study team. Caution will be used when presenting 
the findings from the qualitative interviews. We will provide participants’ quotations from the 
transcripts that can support the study results while avoiding unintentional disclosure of the 
participant’s identity. 
 
F.3. Potential Benefits of the Research to Human Subjects and Others 
 
The participants may not benefit directly from the proposed study. The minimal risks of the study 
outweigh the inconvenience to the participants in terms of the anticipated new knowledge that may be 
gained from the study. Participant contributions may hopefully provide health researchers and 
clinicians with a better understanding of the unmet SC needs in advanced disease PC survivors so that 
more culturally appropriate, patient-centered, efficient SC interventions can be informed and 
developed to improve their QOL and health outcomes. In addition, all participants, from both the 
quantitative and the qualitative components, will receive compensation for completion of the survey 
and the interview.  
 
F.4. Importance of the Knowledge to be Gained 
 
The knowledge to be gained from the proposed study may provide significant insight into the 
prevalence and type of unmet SC needs in advanced disease PC survivors. The information obtained 
from the study participants may provide a foundation for the development of more culturally 
acceptable, comprehensive, cost-effective, and patient-centered SC interventions that improve this 
vulnerable population’s QOL and overall health outcomes. The findings may also help validate two 
hypotheses: first, that QOL will be negatively correlated to the prevalence of SC unmet needs, and 
second, that SC unmet needs will be higher in those with more advanced disease stage. In addition, 
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ARE YOU A 
PROSTATE CANCER SURVIVOR? 
 
 














research study is being 
conducted to better understand 
the supportive care needs and 
quality of life in individuals 
with ADVANCED disease prostate cancer. Individuals with advanced 
prostate cancer are invited to participate in an online survey and/or interview. 
Some compensation may be available. 
 
Below you will find the direct secure survey link (copy and paste into your 




For more information, please contact: 
         Alejandra Schimmel 
      schimme@musc.edu 




STATEMENT OF RESEARCH 
 
My name is Alejandra Schimmel and I am a doctoral student at the Medical University of 
South Carolina College of Nursing. You are being asked to volunteer for a research study. 
Research studies are voluntary and include only people who choose to take part. You are 
being asked to participate in this study because you have diagnosis of advanced prostate 
cancer. The purpose of this study is gathering information about the different supportive care 
needs that advanced prostate cancer survivors may have. By surveying survivors like you, we 
hope to understand better the unmet needs that you may have related to your prostate cancer 
and help you to care for them better. I am very interested in knowing how important each of 





Thank you very much for speaking with me today about your illness. I would like to talk to 
you for about 45 to 60 minutes if that’s OK. Our conversation will be private. The interview 
will be digitally recorded. The digital audio files will be transferred from the external 
recorder to a secure password protected computer for storage within 48 hours after the  
interview is completed. The digital audio files will be deleted from the recorder after that. We 
will transcribe the digital recordings, removing any identifying information such as 
individual names. These are standard procedures for interviews. 
 
Taking part in the study should not put you at risk for any physical harm.  You may feel 
uncomfortable, fatigued, or frustrated discussing certain aspects of your cancer. You will be 
reminded several times that you are not required to respond to any questions that make you 
feel uncomfortable. You may ask for a break or to stop the interview at any time and for any 
reason (if you feel fatigued, or bored, or frustrated…).  
 
There is a risk of loss of confidentiality of your information that is used in this study. To 
minimize this risk, we will maintain the confidentiality of your information in accordance 
with all national and local regulations. All digital recordings and interview transcripts will be 
stored on a password protected MUSC server with access limited to the study team only. 
Your name will not be on the transcripts. In return for your time and effort, you will receive 





I will first ask you some questions about you and your cancer, if that´s OK. Then, we will 
continue on with the interview. Are you ready to start? 
 
 
First, we will go through a few screening questions:  
 
1. HAVE YOU BEEN DIAGNOSED WITH ADVANCED PROSTATE CANCER BY 
A MEDICAL PROFESSIONAL (stages 3, 4, recurrent)? 
2. ARE YOU 18 YEARS OF AGE OR OLDER? 
3. ARE YOU ABLE TO READ, UNDERSTAND, AND SPEAK ENGLISH? 
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4. DO YOU RESIDE IN THE UNITED STATES OR ITS TERRITORIES? 
5. ARE YOU CURRENTLY ENROLLED IN PALLIATIVE OR HOSPICE CARE? 
 
 




PART 1. BRIEF SOCIO-DEMOGRAPHIC AND CLINICAL 
QUESTIONNAIRE 
I am aware that you may have already completed this questionnaire, but if 
you don´t mind, I would need to gather this information again. 
 
What is your age? 
  ------   
  ------  Prefer not to respond  
 
What is your current marital status?  
 ------- Never married 
 ------- Partnership (unmarried) 
 ------- Married 
 ------- Separated 
 ------- Divorced 
 ------- Widowed 
 ------- Prefer not to respond  
 
Are you Hispanic or Latino?  
------   Yes  
------   No  
------   Prefer not to respond 
 
What is your race (check all that apply)?  
  ------  Black / African American 
  ------  White 
------  American Indian/Alaskan 
------  Asian             
------  Pacific Islander 
------  Other    
------- Prefer not to respond 
 
 





How many years of school have you completed?  
  ------  Elementary school/Junior high  
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  ------  High school graduate or GED 
  ------  Some college 
  ------  College graduate and beyond 
  ------  Prefer not to respond 
 
 
What is your employment status? 
 ------    Full-time 
 ------    Part-time 
 -----     Unemployed-Actively looking for employment 
 ------    Unemployed-Not looking for employment 
 ------    Disabled 
 ------    Retired 
 ------    Student 
 ------    Prefer not to respond 
 
 
Do you have medical insurance? 
-------  Yes 
-------  No 
-------  Prefer not to respond.   
 
 
What treatment have you received for your prostate cancer (check all that apply)? 
 
 
-------  Surgery 
-------  Radiation therapy 
-------  Chemotherapy 
-------  Androgen Deprivation Therapy (hormonotherapy) 
-------  Radioactive seeds implantation 
-------  Cryotherapy 
-------  Other (clinical trial, vaccine) 
-------  Prefer not to Respond 
 
 




What year were you first diagnosed with prostate cancer? 
-------  
------- Prefer not to respond 
 
What was the stage of your prostate cancer at the time of your initial diagnosis? 
-------  I  – very localized cancer inside the prostate only 
-------  II – cancer has not spread outside the prostate 
-------  III – cancer has not spread outside the prostate but has spread to surrounding tissues or 
the lymph nodes 
-------  IV – cancer has spread to lymph nodes or other organs 
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-------  Unknown 
-------  Prefer not to Respond 
 
 
What is the stage of your prostate cancer right now? 
-------  I - very localized cancer inside the prostate only 
-------  II - cancer has not spread outside the prostate 
-------  III - cancer has not spread outside the prostate but has spread to surrounding tissues or 
the lymph nodes 
-------  IV - cancer has spread to lymph nodes or other organs 
-------  Unknown 
-------  Refuse to Respond 
 
 




Thank you very much for answering these questions. We will now start with the interview 




PART 2. INTERVIEW GUIDE 
 
Opening, non-directive questions: 
 
1. Can you please tell me what is a typical day like for you? 
2. What is different in your life related to living with prostate cancer? 
 
The following questions will be formulated based on the (7) domains of the 
Supportive Care Needs for Cancer Care Framework. Aside from the listed 
probes, a general probe will be used as needed in case the PI needs to re-direct 
the participant to talk about more current needs: “…that sounds like a 
challenging time, …can you comment on any 




3. What physical changes in your regular daily functions have you experienced related 
to your prostate cancer treatments? 
- PROBE - needs from the illness or the medical treatments, for example, 
fatigue, pain, urinary or sexual symptoms, changes in bowel habits, 
difficulty sleeping, weight changes, or hot flushes, changes in sexuality. 
- PROBE – are you able to maintain the same hobbies, activities as before? 
-  
EMOTIONAL NEEDS: 




-  PROBE – do you experience excessive worry, anger, fear about cancer 
spreading, distress, anxiety, depression. 




5. Tell me about your social life. 
6. How has your prostate cancer impacted your relationships and roles towards others? 
- PROBE - communicating with others?  
7. What support systems do you have? Family? Friends? Community? 
 
SPIRITUAL NEEDS: 
8. What role does spirituality have for you in your life?  
- PROBE: Have you experienced any changes regarding your spirituality 
since your diagnosis – changes in personal values, any spiritual crisis? 
- PROBE – do you maintain the same spirituality (religion…)? 
 
PRACTICAL NEEDS: 
9. Tell me about any practical issues or needs that you may have. 
- PROBE- like inability to work, assistance at home, access to support 
services, or difficulties with transportation (not being able to drive to your 
medical treatments or check-ups) 
- PROBE – any major changes at home/car? 
10. Do you have any financial needs or worry about paying the bills, or not being able to 
work, or not having enough income/pension? 
INFORMATIONAL NEEDS: 
11. What information have you received regarding your prostate cancer and treatments? 
Is there any information that you wished you had but did not received? 
- PROBE - Do you know where to go for resources or help?  
- PROBE - Do you know what information to trust? 
- PROBE - Have you received information about all your treatment 
choices? From who? 
 
PSYCHOLOGICAL NEEDS: 
12. How do you cope with your illness? 
13. Please, tell me how you feel about your body and how your PC has affected your 
body image.  
14. What is the most difficult aspect of your condition? 
- PROBE - How do you handle or care for it? 
 
15. What information might have helped you better adapt and make choices that felt right 
for you? 
- PROBE - Did you have or currently have help making decisions regarding 










------- Prefer not to Respond 
 
 




18. Do you believe your needs regarding your prostate cancer have changed due to the 
COVID-19     pandemic? 
-------- YES 
-------- NO 
-------- Prefer not to respond 
 
 
19. If YES, how have those needs changed? ¿Can you tell me how you have lived this 




20. Is there anything else that you would like to tell me today? 




We have finished the interview. I greatly appreciate you sharing this information about your 
illness with me. If necessary, would it be acceptable for me to contact you for further 
clarifications during the transcription and analysis of the information? I will provide you with 
a brief summary of the study results once the study is finalized.  
 
Could I ask you your zip code please?  ------------------- 
 
 
Also, if you could provide me with an email address, I will be happy to send you the 




















Dear Alejandra Schimmel, 
Thank you for registering on the EORTC Quality of Life Group website. 
Your registration to obtain permission to use our tools has been approved. During 
the registration process you agreed to our terms and conditions regarding the 
academic use of our questionnaires. You can review the terms and conditions here. 
Please find below the links to the requested tools:  
QLQ-C30 Core Questionnaire - English 
Scoring Manuals:  






This email was automatically generated. Since this email is an automatic notification, we 




2) FACIT-SP 12 
 
 
FUNCTIONAL ASSESSMENT OF CHRONIC ILLNESS THERAPY 
(FACIT) LICENSING AGREEMENT 
 
 
The Functional Assessment of Chronic Illness Therapy system of Quality of Life questionnaires 
and all related subscales, translations, and adaptations (“FACIT System”) are owned and 
copyrighted by David Cella, Ph.D.  The ownership and copyright of the FACIT System - resides 
strictly with Dr. Cella. Dr. Cella has granted FACIT.org (Licensor) the right to license usage 
of the FACIT System to other parties. Licensor represents and warrants that it has the right to 
grant the License contemplated by this agreement. The terms of this license will grant 
permission Licensor provides to Alejandra Schimmel (“Investigator”) the licensing agreement 
outlined below.  
 
This letter serves notice that Alejandra Schimmel (“Investigator”) is granted license to use 
the Spanish version of the FACIT-Sp in one not for profit study:  
 
This current license is only extended to Investigator’s research project subject to the following 
terms: 
 
1) (Investigator) agrees to provide Licensor with copies of any publications which come about 
as the result of collecting data with any FACIT questionnaire. 
 
2) Due to the ongoing nature of cross-cultural linguistic research, Licensor reserves the right 
to make adaptations or revisions to wording in the FACIT, and/or related translations as 
necessary. If such changes occur, Investigator will have the option of using either previous 
or updated versions according to its own research objectives. 
 
3) (Investigator) and associated vendors may not change the wording or phrasing of any 
FACIT document without previous permission from Licensor. If any changes are made to 
the wording or phrasing of any FACIT item without permission, the document cannot be 
considered the FACIT, and subsequent analyses and/or comparisons to other FACIT data 
will not be considered appropriate. Permission to use the name “FACIT” will not be granted 
for any unauthorized translations of the FACIT items. Any analyses or publications of 
unauthorized changes or translated versions may not use the FACIT name. Any 
unauthorized translation will be considered a violation of copyright protection. 
 
4) In all publications and on every page of the FACIT used in data collection, Licensor 
requires the copyright information be listed precisely as it is listed on the questionnaire 
itself. 
 
5) This license is not extended to electronic data capture by third party vendors. Electronic 
versions by third party vendors of the FACIT questionnaires are considered derivative 
works and are not covered under this license. Permission for use of an electronic version 
of the FACIT must be covered under separate agreement between the electronic data 




6) In no cases may any FACIT questionnaire be placed on the internet without password 
protection. To do so is considered a violation of copyright.  
 
7) Licensor reserves the right to withdraw this license if Investigator engages in scientific or 
copyright misuse of the FACIT system of questionnaires.  
 
8) There are no fees associated with this license. 
 
9) This license is effective upon date issued by FACIT.org and expires at the completion of 
Investigator’s project.  
 
10)  Investigator agrees to provide FACIT.org with a copy of any publication which results 
from this study.  
 
Issued on:  January 15, 2020 by: 
 
Shannon C Romo 
Licensing and Financial Administrator 
FACIT.org 
151 Bay Cove Drive 









Thank you for your email.  Attached are a copy of the long and short versions of the SCNS 
for use in your study, as well as the User Manual. 
Please don’t hesitate to contact me if you have any questions. 





Dr Allison Boyes | NHMRC Early Career Fellow 
Faculty of Health & Medicine | School of Medicine & Public Health 
 
T: +61 2 4042 0703 
E: allison.boyes@newcastle.edu.au 
W: newcastle.edu.au/profile/allison-boyes  
orcid.org/0000-0003-1721-0533 
The University of Newcastle (UON) 
University Drive, Callaghan NSW 2308 Australia 
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Marg Fitch <marg.i.fitch@gmail.com> 
Fri 10/16/2020 6:35 AM 
 
Hello Alejandra  
 
Thank you for your email and interest in the Supportive Care Framework. I am pleased to 
know it is helpful to you. 
I am happy for you to make use of it and adapt the diagram with the appropriate 
reference/acknowledgement. 
 
Regards 
 
 
 
 
